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Abstract 
Abstract 
The Type VII/Ess protein secretion system (T7SS) is found in many Gram positive bacteria, 
including the opportunistic human and animal pathogen Staphylococcus aureus. Previous work 
has shown that the S. aureus T7SS machinery comprises six core components of which four, 
EsaA, EssA, EssB and EssC are integral membrane proteins. EssC, the largest T7 component, is a 
member of the FtsK/SpoIIIE family of membrane-bound ATPases that harness the energy of ATP 
hydrolysis with the movement of macromolecules. The aim of this thesis was to probe the 
organisation of the membrane-embedded components of the secretion system and to 
determine whether EssC plays a role in substrate recognition.  
A range of detergents was tested for their ability to solubilise EsaA, EssB and EssC from the S. 
aureus inner membrane. The zwitterionic detergent Foscholine-12 was subsequently used for 
further study as it was the only detergent identified that was able to extract reasonable levels 
of each protein from the membrane. Blue-native PAGE analysis identified homomeric complexes 
of Foscholine-solubilised EsaA and EssB proteins. Crosslinking analysis in native membranes 
provided further evidence for EsaA and EssB homo-dimerisation, and also revealed the presence 
of high molecular weight multimers of EssC. Surprisingly, there was no evidence from 
crosslinking that any of the components interacted with each other, or with the EssA protein. 
Furthermore, EssC multimers detected in whole cells were not dependent upon the presence of 
any other Ess component or substrate protein for their assembly.  
The EssC protein from S. aureus strains can be grouped into four variants (EssC1-EssC4) that 
have sequence variability in their C-terminal domains. These variants are associated with unique 
clusters of candidate substrate-encoding genes. Here it was shown that each EssC variant can 
interact with the remaining Ess components from strain RN6390 to facilitate secretion of EsxA 
but not the substrate protein EsxC. Thus, EssC appears to be a specificity determinant for T7 
substrate secretion in S. aureus.  
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Chapter 1 - Introduction 
1.1 Staphylococcus aureus 
Staphylococcus aureus, a Gram-positive bacterium, is almost omnipresent in the environment 
and is commonly found in the human respiratory tract and on the skin. Three patterns of human 
carriage have been identified. Approximately 20 % of the human population are persistent 
carriers who are permanently colonised and almost always carry one type of strain. Around 60 
% of people are intermittent carriers, harbouring S. aureus periodically with the colonising strain 
changing with varying frequency. A minority of around 20 % of people almost never carry S. 
aureus and are therefore called non-carriers (Kluytmans et al., 1997).  
While S. aureus is mainly found on mucosal surfaces, the organism is also able to colonise other 
moist and soft regions of the human body. Although S. aureus is not always pathogenic, minor 
injuries such as a skin cut can provide a route for the bacterium to reach the underlying tissue 
where it can cause a wide range of suppurative infections or more serious diseases such as 
pneumonia, mastitis, toxic shock syndrome or even meningitis (Sibbald et al., 2006). Most 
staphylococcal infections are nosocomial and the cause of postsurgical wound infections. 
However, more recently an increase in numbers of cases of community-acquired, antibiotic 
resistant S. aureus infections have been observed world wide (Grundmann et al., 2002; 
Vandenesch et al., 2003; Harbarth et al., 2005).  
 
1.1.1 S. aureus virulence factors 
As a successful pathogen, S. aureus critically relies on the production and secretion of a number 
of virulence factors that allow the bacterium to adhere to surfaces, invade the host and evade 
the immune system (Kong et al., 2016). Colonisation is initiated with the help of adhesins. The 
major class of these virulence factors are the so-called MSCRAMMs (microbial surface 
component recognising adhesive matrix molecules), proteins which are covalently anchored to 
the cell wall peptidoglycan and can specifically attach to plasma or extracellular matrix 
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components (Foster et al., 2014). Additionally S. aureus secretes a wide range of exoproteins 
such as exotoxins and enzymes like nucleases, proteases and lipases (Dinges et al., 2000). The 
main function of these exoproteins is thought to be the conversion of host tissue into nutrients 
required for growth but some also have cytolytic activity, for example haemolytic α-toxin, which 
is able to form β-barrel pores in the plasma membrane leading to leakage and lysis of the target 
cell (Foster, 2005).  
Virulence of S. aureus is generally considered to be multifactorial. Necrotizing pneumonia for 
instance is associated with the activity of the MSCRAMM family member spA (staphylococcal 
protein A), α- and β-toxin which together cause cell damage, inflammation and necrosis of the 
respiratory epithelium (Gomez et al., 2004; Bartlett et al., 2008; Hayashida et al., 2009). 
Exceptions are so-called toxinoses such as toxic shock syndrome and staphylococcal food 
poisoning which are caused by the toxic shock syndrome toxin and different staphylococcal 
enterotoxins, respectively (Lowy, 1998).  
 
1.1.2 Antibiotic resistance of S. aureus 
S. aureus is known to be an astonishingly adaptable pathogen and infamous for its ability to 
become resistant to antibiotics. Infections caused by antibiotic-resistant strains often occur in 
epidemic waves. To date three waves have been described, with the first one starting shortly 
after the introduction of penicillin into clinical practice in the 1940s (Kirby, 1944). Introduction 
of methicillin marks the onset of the second wave with the first reports of S. aureus resistant to 
this antibiotic published in 1961, only one year after its introduction (Barber, 1961; Jevons et al, 
1961). This early report might be due to the fact, that S. aureus had already developed 
methicillin-resistance long before its use, back in the 1940, at the time where penicillin was still 
the main antibiotic in use (Harkins et al., 2017). While penicillin-resistance is narrow in its 
spectrum, methicillin-resistance is broad; conferring resistance to the entire class of β-lactam 
4 
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antibiotics and the third wave began in the mid to late 1990s with the emergence of a new MRSA 
(methicillin resistant S. aureus) strain. This community-associated MRSA (CA-MRSA) contains 
two particular genetic elements: a type IV staphylococcal cassette chromosome (SCC) mec 
element and a virulence gene encoding a leukocyte-killing toxin called Panton-Valentine 
leukicidin (PVL), which is not found in hospital-acquired MRSA (Vandenesch et al., 2003). 
Vancomycin has long been a last-resort antibiotic for multiple drug resistant S. aureus strains. 
However, the first strain showed reduced sensitivity to this antibiotic in 1996 and in 2002 the 
first highly-vancomycin resistant strain was isolated (Hiramatsu et al., 1997; Weigel et al., 2003).  
 
1.2 Protein secretion in bacteria 
The cell membrane represents a permeability barrier between the cell and its environment and 
forms a permanently closed system. However, approximately 20 % of polypeptides synthesized 
by bacteria are located partially or completely outside the cytoplasm (Pugsley, 1993). Therefore, 
specialised transport systems are necessary to allow direct exchange of substrates and proteins 
between the cell cytoplasm and the external medium. While some secretion systems are found 
in almost all bacteria, secreting a wide variety of substrates, some are only identified in a small 
number of bacteria. Most of the secreted proteins play essential roles in nutrient acquisition, 
respiration and competition with other organisms but are also important virulence factors 
(Sandkvist et al., 1997; Ochsner et al., 2002; Cao et al., 2016).  
 
1.2.1 General protein secretion via the Sec- or Tat-pathways 
The general secretory pathway (Sec-pathway) and twin arginine translocation pathway (Tat-
pathway) are the two major pathways that secrete proteins across the cytoplasmic membrane 
(Natale et al., 2008). They have been identified in all domains of life and are the most highly 
conserved mechanisms of protein secretion (Robinson and Bolhuis, 2004; Papanikou et al., 
5 
_____________________________________________________________________________________ 
_____________________________________________________________________________________ 
Chapter 1 - Introduction 
2007). While the Sec pathway primarily translocates proteins in their unfolded state, the Tat 
pathway mediates translocation of secretory proteins in their folded state. 
Secretion by the Sec-pathway relies on a cleavable signal sequence at the N-terminus of the 
secreted protein. Signal sequences are 20 – 30 amino acids (aa) in length containing a positively 
charged amino terminus, a hydrophobic core and a polar carboxyl-terminus (Papanikou et al., 
2007). Targeting and translocation through the Sec machinery has three major components: a 
piloting factor such as signal recognition particle or the chaperone SecB, that recognise N-
terminal signal sequences, the ATPase protein SecA that functions as a molecular motor to drive 
the translocation across the membrane and the membrane integrated protein conducting 
channel SecYEG (Natale et al., 2008).  
Genomes of Mycobacteria and some Gram-positive bacteria encode two homologues of the 
SecA protein: SecA1 and SecA2, where SecA1 is responsible for ‘housekeeping’ export while 
SecA2 exports a specific subset of proteins and is implicated in virulence (Braunstein et al., 2003; 
Lenz et al., 2003). Currently two types of SecA2 systems are known. Some bacteria which 
harbour a SecA2 also encode an accessory SecY protein, known as SecY2, and these function 
together as a SecA2-SecY2 system, while other bacteria contain SecA2-only systems lacking a 
SecY2. While proteins secreted via the SecA2-only systems probably use the SecYEG channel, 
proteins of the SecA2-SecY2 system are highly glycosylated and incompatible with the canonical 
SecA1-SecYEG pathway (Sharma et al., 2003; Rigel et al., 2009; Sardis and Economou, 2010; 
Fagan and Fairweather, 2011). Proteins secreted by the Sec apparatus can serve many roles, and 
a number of proteins that promote virulence of bacterial pathogens are transported through 
this pathway for example in the Gram-positive pathogens Listeria monocytogenes, 
Streptococcus gordonii and Staphylococcus aureus, the Gram-negative bacteria Vibrio cholerae, 
Klebsiella pneumoniae and Yersinia enterocolitica, as well as in Mycobacteria (Bensing and 
Sullam, 2002; Braunstein et al., 2003; Lenz et al., 2003; Korotkov et al., 2012).  
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Translocation of substrates by the Tat-pathway is dependent on a signal peptide containing a 
pair of arginine residues close to the amino terminus (Palmer et al., 2010). In Gram-negative 
bacteria and in actinobacteria the Tat machinery consists of the three membrane proteins TatA, 
TatB and TatC, whereas in Gram-positive firmicutes and archaea the Tat systems only contain 
TatA and TatC (Palmer and Berks, 2012). In Escherichia coli TatB and TatC form a complex that 
binds the signal peptide of the substrate leading to the recruitment and polymerisation of TatA. 
This polymerisation not only forms the transport channel but also initiates the translocation of 
the substrate protein. Finally, once the substrate is translocated the signal peptide is cleaved off 
and TatA depolymerises (Palmer and Berks, 2012). Proteins transported via the Tat-pathway 
include redox enzymes, membrane proteins but also virulence factors like the Phospholipase C 
enzyme as described for P. aeruginosa (Ochsner et al., 2002; Lee et al., 2006). 
 
1.2.2 Protein secretion systems in Gram-negative bacteria 
In Gram-negative bacteria the cell envelope consists of an inner and an outer membrane 
through which synthesised proteins need to be translocated in order to reach the extracellular 
milieu or, in some cases, be directly transported into the cytoplasm of a target cell. To achieve 
this, eight dedicated secretion systems are used by Gram-negative bacteria, numbered Type I – 
Type IX (excluding the Type VII secretion system), which all have their own characteristics 
depending on the nature of the secreted protein (e.g. folded or unfolded, with or without signal 
peptides) and their function (e.g. translocation of the protein into the extracellular milieu or 
direct injection into a host cell) (Tseng et al., 2009; Costa et al., 2015). Generally, all eight 
secretion systems can be divided into two groups: those using a two-step mechanism, and those 
which secrete proteins in a single step (Figure 1.1). When using a two-step mechanism (e.g. the 
Type II, Type V, Type VIII and Type IX secretion systems), proteins are first translocated across 
the inner membrane via the Sec- or Tat-pathways, before being secreted across the outer 
membrane in a separate step. Of the remaining four secretion systems (Type I, Type III, Type IV 
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and Type VI) only the Type I secretion system recognises substrate proteins via a C-terminal 
signal sequence, translocating the protein into the extracellular milieu. The remaining three 
secretion systems however, secrete proteins without using a recognisable signal sequence by 
directly injecting them into the host cell through their needle-like apparatus. 
The Type I secretion system closely resembles ATP-binding cassette (ABC) transport systems and 
consists of three essential structural components. The ABC transporter protein participates in 
recognition of the substrate, catalyses ATP hydrolysis to provide energy for transport, and 
interacts with the membrane fusion protein (MFP) in the inner membrane. The MFP spans the 
periplasm to associate with the outer membrane factor (OMF), which generates a pore in the 
outer membrane, through which the substrate is translocated in an unfolded state (Thomas et 
al., 2014). Substrates of the Type I secretion system rely on an uncleaved C-terminal signal 
sequence and vary widely in size from small proteins of 20 kDa up to a molecular weight of 900 
kDa (Thomas et al., 2014). They contribute to virulence in a variety of bacterial pathogens, for 
example the metalloproteases secreted by Serratia marcescens and the hemolysins secreted by 
E. coli (Delepelaire, 2004).  
The Type II secretion system is one of the two-step secretion systems and translocates 
substrates across the outer membrane that are first delivered to the periplasm via the Sec or 
Tat pathway. The Type II secretion machinery consists of four subassemblies: the outer-
membrane complex, the inner-membrane platform, the secretion ATPase and the pseudopilus 
(Korotkov et al., 2012). The outer-membrane complex resides in the outer membrane and serves 
as the channel through which folded substrates are translocated (Korotkov et al., 2011). While 
being embedded in the inner membrane, the inner-membrane platform extends into the 
periplasm and contacts the outer-membrane complex, the ATPase, and the pseudopilus to 
coordinate export of substrates (Korotkov et al., 2012). A number of bacterial pathogens use the 
Type II secretion system to transport virulence factors such as Vibrio cholerae, Yersinia pestis 
and Pseudomonas aeruginosa (Sandkvist, 2001).  
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The Type III secretion system consists of a complex structure also called the injectisome, which 
can be divided into three main components: the base complex, the needle component and the 
translocon (Abrusci et al., 2014). The base complex can be separated into three parts: The 
cytoplasmic components, two inner and two outer rings. While the inner rings interact with the 
cytoplasmic membrane the outer rings interact with the peptidoglycan layer and the outer 
membrane. Together they form a socket-like structure with a centre shaft (Kubori et al., 1998). 
The needle component originates from this centre shaft, and it is a filament which is known to 
extend into the extracellular space (Kubori et al., 1998; Worrall et al., 2016). The translocon is 
assembled upon contact with host cells and forms a pore that is essential for secretion of 
effector proteins into the host cell, a step which is essential for virulence of many pathogens, 
including Yersinia, Salmonella, and Shigella (Büttner, 2012).  
Similar to the Type III secretion system the Type IV secretion systems allows for direct transfer 
of substrates into the host cell. The Type IV secretion system is ancestrally related to bacterial 
DNA conjugation systems and is therefore able to secrete a variety of substrates such as 
individual proteins as well as protein-protein and protein-DNA complexes (Cascales and Christie, 
2003). This feature supports a variety of functions, including conjugative transfer of DNA, 
translocation of effector proteins or DNA/protein complexes and DNA uptake and release 
directly into the host cell. This secretion system plays crucial roles in the pathogenesis in a wide 
range of bacteria such as Neisseria gonorrhoeae, Legionella pneumophila and Helicobacter pylori 
(Backert and Meyer, 2006).  
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Figure 1.1: Overview of the major protein secretion systems in Gram-negative bacteria. Some proteins are secreted across both membranes in a single step (Type I, III, IV, and 
VI secretion systems). Other proteins are first transported via the Sec or Tat pathway into the periplasm before being translocated across the outer membrane via the Type II, 
Type V or Type IX secretion system. IM: inner membrane; OM: outer membrane; HM: host membrane; Blue: membrane components; Green: secretion needle; Purple: PoV 
shuttle protein. Adapted from Tseng et al. (2009) and Veith et al. (2017).  
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The Type V secretion system is the second general secretion system which transports proteins 
using a two-step mechanism where secreted substrates rely on a cleavable N-terminal signal 
sequence to be translocated into the periplasm by the Sec-pathway (Van Ulsen et al., 2014). 
Type V secretion systems can be divided into five types and consist of an N-terminal extracellular 
domain (‘passenger domain’) and a C-terminal β-barrel domain in the outer membrane 
(Henderson et al., 2004). Four types have the passenger domain and pore-forming domain 
encoded as a single gene whereas in the two-partner system the pore-forming domain and the 
passenger domain are encoded by two separate genes (Leo et al., 2012). Although it was 
originally proposed that the passenger domain is translocated across the outer membrane 
through a channel formed exclusively by the β-barrel domain, recent experiments suggest that 
translocation of the passenger domain and membrane integration of the β-barrel domain are 
facilitated by the barrel assembly machinery (BAM) complex and therefore that the β-barrel is 
completely assembled before the translocation begins (Bernstein, 2015). Proteins secreted by 
the Type V secretion machinery are mainly virulence factors used by Haemophilus influenzae, 
Vibrio cholerae and Neisseria meningitidis, to name a few (Van Ulsen et al., 2014).  
The Type VI secretion system is composed of 13 conserved proteins together with a variable 
complement of accessory elements and is able to deliver proteins directly into bacterial and 
eukaryotic cell targets (Russell et al., 2014). These effectors have numerous functions, with 
many directed against the bacterial cell wall and membrane, supporting the proposal that this 
secretion machinery has a key role in bacterial competition. It may also play a role in bacterial 
communication due to its ability to transport effector proteins from one bacterium to another 
in a contact-dependent manner (Russell et al., 2014). The Type VI secretion system shares 
structural homology to the tail tubes of some bacteriophages and because of that it has been 
hypothesized that this secretion machinery may have arisen from inverted phage tails that eject 
proteins outside of the bacterial cell rather than injecting them inside the cell (Cianfanelli et al., 
2016). It could be shown that the Type VI secretion system increases the fitness of Vibrio 
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cholerae, Serratia marcescens and Vibrio parahaemolyticus when these bacteria were grown in 
competition with other bacteria under laboratory conditions (Russell et al., 2014).  
The most recently discovered secretion system in Gram-negative bacteria is the Type IX 
secretion system, a novel secretion system which emerged in the Fibrobacteres-Chlorobi-
Bacteroidetes superphylum. It is composed of up to 29 proteins with 18 identified so far 
spreading over 13 distinct loci (Heath et al., 2016; Veith et al., 2017). Substrates secreted by the 
Type IX secretion system rely on an N-terminal signal peptide for the translocation across the 
inner membrane via the Sec-pathway. Additionally, these substrates also contain a C-terminal 
signal which mediates not only the secretion across the outer membrane via the Type IX 
secretion system but also their attachment to the cell surface (Seers et al., 2006; Chen et al., 
2011). For some of the identified proteins a function could be assigned, for example three 
proteins are involved in regulation and four other proteins interact to form the secretion 
apparatus who spans both membranes (Sato et al., 2010; Shrivastava et al., 2013; Veith et al., 
2017). In addition to the secretion apparatus an attachment complex has been identified 
consisting of four proteins. One of these proteins was identified as a sortase which catalyses a 
transpeptidation reaction, anchoring the substrates to the cell wall (Veith et al., 2017).  
 
1.2.3 Protein secretion systems in Gram-positive bacteria 
In contrast to Gram-negative bacteria, which possess two phospholipid membranes separated 
by a periplasmic compartment, Gram-positive bacteria contain only a single lipid bilayer and a 
surrounding cell wall which is mainly composed of peptidoglycan. Covalently attached to the 
peptidoglycan are several macromolecules such as wall teichoic acids, surface proteins and the 
polysaccharide capsule (Navarre and Schneewind, 1999). Despite these differences in their 
architectures, Gram-positive bacteria also use the general Sec- and Tat-pathways. However, 
Gram-positive bacteria also harbour specialised secretion systems for the translocation of 
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proteins into and across the cell wall. Two different kinds of mechanisms can be found in Gram-
positive bacteria: one by which proteins are covalently attached to the cell wall, and one for the 
translocation of proteins into the extracellular milieu (Schneewind and Missiakas, 2012).  
For the attachment of proteins to the cell wall, Gram-positive bacteria encode a variety of 
enzymes, called sortases. In total there are 6 different classes of sortases (class A – F), of which 
class A and class C are the best studied (Spirig et al., 2011; Bradshaw et al., 2015). Enzymes of 
the class A sortases have a general ‘housekeeping’ function and are able to attach more than 40 
different proteins to the cell wall. Most surface proteins attached by class A enzymes contain an 
N-terminal signal peptide, as well as a C-terminal cell wall sorting signal, which is composed of a 
pentapeptide amino acid cleavage site, LPXTG, and a hydrophobic domain. They are first 
targeted to the Sec pathway for translocation across the membrane where subsequently the 
signal peptide is cleaved, while sortase A scans translocated proteins for the LPXTG motif 
sequence. Following cleavage of the translocated protein by sortase A between the threonine 
and glycine of the LPXTG motif, the enzyme catalyses the formation of an amide bond between 
the carboxyl group of threonine and the amino group of a cell wall cross-bridge. 
Transglycosylation and transpeptidation reactions result in the covalent attachment of surface 
proteins to the cell wall (Kline et al., 2009). Class C enzymes are used for the assembly of pili, 
another example of cell surface proteins. Both pili and proteins attached to the surface by class 
A enzymes are found in many bacteria including pathogens such as Staphylococcus aureus and 
Streptococcus pneumoniae and play important roles in virulence, making them potential 
candidates for drug targets (Spirig et al., 2011).  
For the secretion of proteins into the extracellular milieu, Gram-positive bacteria elaborate a 
specialised secretion system, called the Type VII secretion system (T7SS). It was first discovered 
in the Actinobacterial pathogens Mycobacterium tuberculosis and Mycobacterium bovis, where 
it was shown to be essential for virulence and to secrete two small proteins, ESAT-6 (early 
secreted antigenic target – 6 kDa) and CFP-10 (culture filtrate protein – 10 kDa) (Hsu et al., 2003; 
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Pym et al., 2003; Stanley et al., 2003). Since then it was identified in other bacteria such as 
Staphylococcus aureus, Bacillus subtilis and Listeria monocytogenes (Pallen, 2002; Way and 
Wilson, 2005; Burts et al., 2005; Baptista et al., 2013). The T7SS is defined by two characteristics: 
the presence of one or more substrates belonging to the WXG100 family and an ATPase protein 
which belongs to the FtsK/SpoIIIE family (Ates et al., 2016). While the T7SS plays various roles in 
virulence in some bacteria it can also be involved in growth and iron acquisition (Abdallah et al., 
2007).  
 
1.3 The Type VII protein secretion system (T7SS) 
As mentioned above, secretory proteins of Gram-positive bacteria only need to pass through 
the cytoplasmic membrane and peptidoglycan layer to enter the extracellular environment. 
However, members of the Mycobacteriaceae and Corynebacteriaceae contain a plasma 
membrane and a Gram-negative-like outer membrane containing mycolic acids which is 
covalently linked to other (glyco)lipids (Jankute et al., 2015). Additionally, it could be shown that 
both, pathogenic and non-pathogenic mycobacterial species consist of a capsular layer of 
approximately 30 nm thickness present in the cell envelopes (Sani et al., 2010; Ates et al., 2016).  
Staphylococcus aureus, Bacillus subtilis and Listeria monocytogenes belong to the Firmicutes 
(low G+C Gram-positive bacteria) whereas Mycobacterium tuberculosis and Corynebacterium 
diphtheriae belong to the Actinobacteria (high G+C Gram-positive bacteria) and the T7SS has 
been classified into two sub-types: the T7SSa or ESX for Actinobacteria and the T7SSb or ESS for 
Firmicutes (Figure 1.2).  
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Figure 1.2: Comparison of gene clusters encoding T7SSa or T7SSb secretion systems. 
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1.3.1 The Type VII protein secretion system in Actinobacteria 
The archetypal substrates of the T7SSa / ESX secretion system in Actinobacteria are ESAT-6 and 
CFP-10, which have subsequently been renamed EsxA and EsxB (Sørensen et al., 1995; Bitter et 
al., 2009). These proteins belong to the WXG100 protein family (Pallen, 2002), which structurally 
have been shown to form helical hairpins, with the hairpin bend containing the conserved Trp-
X-Gly (WXG) motif. They each have a size of approximately 100 amino acids (Renshaw et al., 
2005; Figure 1.3 A). EsxA and EsxB are encoded at the esx-1 locus and are absent in the 
attenuated vaccine strains Mycobacterium bovis bacilli Calmette-Guérin (BCG) and 
Mycobacterium microti, due to spontaneous deletions of different sizes of the esx-1 locus, each 
of which is known as region of difference 1 (RD1) (Mahairas et al., 1996; Pym et al., 2002; Brodin 
et al., 2002; Pym et al., 2003). EsxA and EsxB form a heterodimer and the complex is an 
antiparallel four-helix bundle, with strong evidence that they are transported as such (Renshaw 
et al., 2005; Sysoeva et al., 2014). Structural analyses of EsxB revealed an elongated C-terminus, 
containing a conserved YxxxD/E secretion motif which is not only crucial for secretion of EsxA 
and EsxB but could also be shown to interact with the membrane component EccC (Renshaw et 
al., 2005; Champion et al., 2006; Daleke et al., 2012a; Figure 1.3 A). EsxA and EsxB play a key 
role in bacterial virulence and they are critical for Mycobacteria to replicate in macrophages and 
suppress the immune response of host cell (Pym et al., 2002; Pym et al., 2003).  
Another major class of T7SS secreted substrates are the so called PE/PPE proteins which to date 
have only been described in members of the Actinobacteria and are most widespread in the 
slow-growing species of Mycobacteria (Gey van Pittius et al., 2006). PE/PPE proteins are named 
after a conserved Pro-Glu and Pro-Pro-Glu motif at the N-terminus and have several 
characteristics in common with the Esx proteins (Ates et al., 2016). For instance PE/PPE proteins 
are transported as heterodimers in an antiparallel four-helix bundle, similar to EsxA and EsxB 
(Strong et al., 2006; Figure 1.3 B). Another conserved characteristic is the flexible tail at the C-
terminus of the PE protein which also harbours the YxxxD/E secretion motif (Daleke et al., 
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2012a). However, contrary to the Esx substrate proteins, secretion of PE/PPE proteins relies on 
an additional soluble protein, called EspG, which was shown to recognise a binding motif 
localised in the extended domain of the PPE proteins (Daleke et al., 2012b; Ekiert and Cox, 2014; 
Korotkova et al., 2014; Phan et al., 2017). Some PE/PPE proteins could be identified as virulence 
factors where they are not only required for survival in macrophages and granulomas but also 
modulate the host immune response by mediating apoptosis and cytokine secretion 
(Ramakrishnan, 2000; Basu et al., 2007).  
 
 
Figure 1.3: Structures of Type VII substrates. A: EsxA-EsxB (Renshaw et al., 2005); B: PE25-PPE41 (Strong 
et al., 2006). WxG motifs are shown in red; secretion signal motifs YxxxD/E are shown in orange; The C-
terminal region of EsxB for interaction with EccC is shown in magenta; it should be noted, that the 
secretion signal is also present in the PE25 sequence but is disordered in the structure. C: EsxA-EsxA dimer 
of S. aureus (Sundaramoorthy et al., 2008). A ribbon diagram with subunit A in blue and subunit B in red 
and labelled helices.  
 
In addition to the two major classes of T7SS substrates, other substrates have also been 
identified, including members of the DUF2563 and DUF2580 protein families. Both, DUF2563 
and DUF2580 family are restricted to Mycobacteria. Little is known about the DUF2563 family, 
while EspC and EspF have been identified as DUF2580 family members which are secreted by 
ESX-1 (Ates et al., 2016). The best studied protein among the Esp substrates is EspB. Structural 
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analyses revealed that this protein not only contains an N-terminal helix-turn-helix motif 
followed by a T7 secretion signal motif, it also shows a very similar fold to PE/PPE dimers, 
indicating that EspB is probably secreted as a monomer (Daleke et al., 2012a; Solomonson et al., 
2015). A lack of EspB secretion is linked to delays in extrapulmonary dissemination of M. 
tuberculosis in mice (Ohol et al., 2010).  
T7SSs are highly versatile secretion systems with up to five different T7SS encoded by pathogenic 
Mycobacteria, termed ESX-1 to ESX-5 with ESX-1, ESX-3 and ESX-5 being essential for full 
virulence (Cole et al., 1998; Bitter et al., 2009; Gröschel et al., 2016; Figure 1.4). The different 
T7SSs each have specific characteristics such as the presence of accessory components and 
different roles in physiology and virulence. However there are conserved core components 
required by all the T7SSs, such as an EsxAB pair, EccC, EccD and mycosin (Abdallah et al., 2009). 
Mycosins belong to the subtilisin protein family and comprise a signal sequence, a protease 
domain and a C-terminal transmembrane region (Brown et al., 2000; Dave et al., 2002). The 
defined role of these proteases in the secretion process remains unclear but they seem to have 
a functional role in various ESX systems, being involved in substrate processing as well as 
negative regulation of the secretion process (Ohol et al., 2010). Moreover, each T7SS also has a 
unique set of substrates. For example, while ESX-1 could be shown to secrete EspA/C and 
EsxA/B, ESX-5 was identified as a major pathway for the translocation of PE/PPE proteins 
(Champion et al., 2006; Abdallah et al., 2009; Champion et al., 2009; Daleke et al., 2011).  
The first T7SS system to be identified was the ESX-1 secretion system and it is therefore the best 
studied. As already mentioned it not only secretes EsxA and EsxB but also some PE/PPE proteins 
and numerous Esp proteins (Champion et al., 2006; Champion et al., 2009; Sani et al., 2010). The 
ESX-1 secretion system plays a major role in virulence. Several cellular events could be shown to 
be related to the activity of a functional ESX-1 system such as disruption of the host cell 
membrane as well as induced apoptosis in macrophages to establish and spread mycobacterial 
infection (Smith et al., 2008; Aguilo et al., 2013; Aguiló et al., 2013). However, in addition to 
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roles in virulence in M. tuberculosis it could also be shown that ESX-1 is essential for DNA transfer 
in M. smegmatis (Coros et al., 2008). 
Immediately next to the ESX-1 locus is the ESX-2 region which harbours genes encoding for the 
complete set of core secretion components, a PE/PPE protein couple as well as two Esp proteins 
(Stoop et al., 2012). However, mutagenesis studies have shown that this system is not required 
for virulence or growth (Sassetti et al., 2003; Sassetti and Rubin, 2003). In fact, genomic analyses 
recently revealed a non-functional ESX-2 system in M. leprae and M. lepromatosis, suggesting 
that this system may not be essential and host-orientated (Singh et al., 2015).  
The genes encoding the ESX-3 system are conserved among pathogenic and non-pathogenic 
Mycobacteria, and the locus encodes a full set of core components, an Esx and a PE/PPE pair as 
well as the Esp protein EspG (Sassetti et al., 2003; Sassetti and Rubin, 2003; Siegrist et al., 2009). 
It is regulated by the iron-dependent transcriptional repressor (IdeR) and the zinc uptake 
repressor (Zur) with the system being involved in zinc and iron homeostasis (Rodriguez et al., 
2002; Maciag et al., 2007; Serafini et al., 2009; Siegrist et al., 2009). Additionally, ESX-3 is 
essential for the growth of M. tuberculosis by secreting soluble factors which are probably 
essential for optimal iron and zinc uptake (Sassetti et al., 2003; Serafini et al., 2009). The Esx 
protein pair EsxG and EsxH play a key role in bacterial virulence by impairing phagosome 
maturation (Tinaztepe et al., 2016). Moreover, a role of the ESX-3 system in host-pathogen 
interactions was suggested as EsxH strongly induces interferon- (IFN) secretion in T cells 
(Tufariello et al., 2016; Portal-Celhay et al., 2016). 
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Figure 1.4: Genetic organisation of the five ESX secretion systems in M. tuberculosis. Adapted from Bitter et al. (2009). 
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ESX-4 is the most archaic T7 secretion system in Mycobacteria with homologues found in other 
Actinobacteria such as Corynebacterium diphtheriae (Gey van Pittius et al., 2006). It is the 
smallest ESX-locus with a minimal set of T7S genes (Figure 1.4). However, genomic analyses 
revealed that M. leprae and M. lepromatosis have lost the esx-4 locus, suggesting that Esx-4, 
similar to ESX-2, is not host-orientated and non-essential (Singh et al., 2015). In fact, secretion 
of the Esx protein pair EsxT and EsxU could not be detected under laboratory conditions in M. 
tuberculosis, supporting this hypothesis (Målen et al., 2007).  
Probably the most recently evolved T7SS in Mycobacteria is the ESX-5 system which is only 
present in slow-growing species (Gey van Pittius et al., 2006). It is one of the most important 
modulators of host-pathogen interaction and crucial for cell wall stability (Di Luca et al., 2012). 
ESX-5 is also essential for mycobacterial growth by exporting cell envelope proteins that are 
essential to acquire nutrients (Ates et al., 2015; Elliott and Tischler, 2016). Additionally it was 
shown to be a major pathway for the secretion of PE and PPE proteins, exporting a large number 
of these proteins of diverse subtypes, many of which are not encoded by the esx-5 locus 
(Abdallah et al., 2006; Abdallah et al., 2009; Daleke et al., 2011; Bottai et al., 2012). In the same 
study Bottai et al. (2012) also demonstrated that M. tuberculosis deletion mutants of esx5 show 
loss of secretion of the esx5-encoded EsxN and PPE41, reduction of cell wall integrity and 
attenuation in macrophages in a mouse infection model.  
 
1.3.1.1 Structural organisation of the Type VII secretion system in M. tuberculosis 
The actinobacterial Type VII secretion system comprises five conserved membrane components, 
EccB, EccC, EccD, EccE and MycP, that are essential for substrate secretion (Stanley et al., 2003; 
Brodin et al., 2006). EccB is a 51 kDa protein with a 40 amino acid (aa) N-terminal domain 
followed by a single membrane spanning helix and a C-terminal fold of ~400 amino acids 
(Wagner et al., 2016). EccE is 44 kDa and has two transmembrane domains and one globular 
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domain (Houben et al., 2012). While EccB and EccE are relatively hydrophilic, EccD is a highly 
hydrophobic protein of 54 kDa with a ubiquitin-like N-terminal domain of ~110 amino acids 
followed by a 30 amino acid linker and 11 TMDs (Wagner et al., 2016). While little is known 
about the function of EccB and EccE, EccD has been proposed to form the membrane pore 
through which substrates are transported, although no evidence for channel activity has yet 
been provided (Stanley et al., 2003). So far only EccC has a predicted function, since this 
membrane protein has three conserved nucleotide binding domains (NBDs) located at the 
cytoplasmic side of the membrane and shows homology to members of the FtsK/SpoIIIE family 
of ATPases. One characteristic for members of this protein family is that they form ring-like 
hexamers which has now also been shown for EccC (Massey et al., 2006; Rosenberg et al., 2015; 
Beckham et al., 2017). The fifth membrane protein, MycP, belongs to the subtilisin protein family 
and is anchored to the membrane with the protease domain facing the extracellular side (Brown 
et al., 2000; Dave et al., 2002).  
Complex formation between the membrane proteins EccB, EccC, EccD and EccE has been shown 
for the mycobacterial ESX-1 and ESX-5 secretion systems. For the ESX-5 secretion system a 
complex of ~1.5 mDa could be isolated with EccB5, EccC5, EccD5 and EccE5 in a ratio of 2:2:2:1 
(Houben et al., 2012). EccE is underrepresented in this complex relative to the other three 
membrane components. EccE is not present in the most archaic ESX-4 secretion system in 
Mycobacteria and was shown to be located on the periphery of the ESX-5 complex suggesting 
that this protein may not be an absolute mechanistic requirement for the function of T7a 
secretion systems (Beckham et al., 2017). The remaining three proteins form the core of the 
ESX-5 secretion machinery and are found as a hexameric arrangement. EccC located at the 
centre, forming the central pore, with EccB forming a collar-like structure around this pore 
(Beckham et al., 2017; Figure 1.5 A). For the ESX-1 secretion system a complex of EccB1, EccC1a, 
EccC1b, EccD1 and EccE1, could be isolated in the ratio 4:9:7:1:4. The only protein that has not 
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been isolated as part of the membrane complex is mycosin MycP, although it was recently 
discovered to be essential for complex stability (Van Winden et al., 2016).  
 
 
Figure 1.5: Possible model for ESX-5 organisation under resting and active conditions. A: In the resting 
state the ATPase protein EccC is in a monomeric state with EccB sealing the translocation channel at the 
periplasmic side. B: Interaction with the C-terminal signal sequence of a heterodimeric substrate protein 
initiates hexamerisation of EccC followed by the translocation of the substrate across the cytoplasmic 
membrane in a folded state. The three P-loop ATPase domains of EccC are each shown with a generic 
bound nucleotide (black circle). Taken from Palmer (2017), with permission. 
 
Assembly of the Type VII secretion system is thought to be driven by interaction of EsxB with 
EccC, the only two components conserved across all T7a and T7b subtypes. Binding of EsxB to 
the C-terminal ATPase domain has been reported to promote the hexamerisation of EccC 
followed by a ‘just-in-time’ post-translational control mechanism in which energy is only used 
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upon the recognition of key substrates by EccC (Rosenberg et al., 2015; Figure 1.5 B). In their 
study, Rosenberg et al. (2015) showed that an EsxB monomer bound to EccC and existed as 
homodimer in isolation, suggesting that EsxB stabilises EccC-multimers by forming 
EccC:EccB:EccB:EccC complexes. However, while EsxB seems to promote assembly and 
activation of EccC, binding of EsxA, another substrate that forms a tight 1:1 complex with EsxB 
but does not directly interact with EccC, leads to disassembly and inhibition of the multimeric 
ATPase. This result suggests that EsxA inactivates EccC by removing the stabilising effect of the 
EsxB:EsxB interaction, presumably by forming EccC:EsxB:EsxA trimers instead of 
EccC:EccB:EccB:EccC tetramers. However, it should be noted that these experiments were 
carried out in vitro using the purified cytosolic part of EccC together with purified EsxB and EsxA 
and more recently substrate-independent hexamerisation of EccC was observed from detergent 
solubilised membranes (Beckham et al., 2017).  
 
1.3.2 The Type VII protein secretion system in Firmicutes 
As discussed above, proteins of the WXG100 family are conserved components that help to 
characterise Type VII secretion systems. Bioinformatic studies comparing the different 
homologues of this family revealed that these proteins were not restricted to the Actinobacteria, 
but were also found in members of the Firmicutes such as Staphylococcus aureus and Bacillus 
subtilis (Pallen, 2002; Baptista et al., 2013). Moreover, Firmicutes also harbour homologues of 
the EccC proteins of Actinobacteria. However, other genes coding for T7a components such as 
EccB and EccD proteins are lacking in the T7b loci, while a variable number of other genes are 
found (Figure 1.2).  
The T7b cluster in B. subtilis is known as the yuk/yue locus, containing the six genes yukAB, yukC, 
yukD, yukE, yueB and yueC. Interestingly, YukE seems to be the only WXG100 family protein 
associated with the Bacillus system (Baptista et al., 2013; Sysoeva et al., 2014; Huppert et al., 
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2014) Its secretion is dependent on YukBA, a FtsK/SpoIIIE family ATPase of which only one of the 
three ATPase domains is required for secretion (Ramsdell et al., 2015). YukD encodes a small 
ubiquitin-like protein with a very short C-terminal tail (Van Den Ent and Löwe, 2005). Another 
interesting finding is that one protein encoded by the yuk/yue regulon of B. subtilis, YueB, is a 
surface-exposed phage receptor that was recently also implicated in conjugative DNA transfer 
(São-José et al., 2004; São-José et al., 2006; Rösch et al., 2014).  
 
1.4 The Type VII protein secretion system in S. aureus 
The ESAT-6 secretion system (Ess) in S. aureus is probably the best characterised Type VII protein 
secretion system outside Mycobacteria, where it is required for virulence in murine abscess, 
pneumonia and skin-infection models (Burts et al., 2005; Kneuper et al., 2014; Wang et al., 
2016). Mutational and bioinformatic analyses have revealed that the Ess machinery consists of 
six core components, of which four are predicted to be membrane-bound proteins, one 
cytoplasmic protein and one extracellular protein (Burts et al., 2005; Kneuper et al., 2014; Warne 
et al., 2016; Figure 1.6). The function of these core components together with the additional 
proteins encoded at the ess locus are described in further detail below.  
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Figure 1.6: The Staphylococcal T7b secretion system. Cartoon showing the membrane components 
(blue); secreted proteins (red); cytoplasmic proteins (orange) and the chaperone EsaE (green).  
 
1.4.1 Substrate proteins of the T7SS in S. aureus 
The first two T7 substrates characterised in S. aureus were EsxA and EsxB, which both belong to 
the WXG100 family and share 21 % and 18 % sequence identity with EsxA and EsxB in M. 
tuberculosis, respectively (Burts et al., 2005). EsxA is proposed to be a core component of the 
Ess machinery in S. aureus. EsxA is required for bacterial virulence and was recently shown to 
suppress host cell apoptosis during intracellular infection (Burts et al., 2005; Kneuper et al., 
2014; Korea et al., 2014). In contrast to the mycobacterial EsxA and EsxB, the S. aureus proteins 
are not secreted as heterodimers in S. aureus; instead x-ray crystallography of EsxA revealed the 
formation of a homodimer (Sundaramoorthy et al., 2008, Figure 1.3 C). However, both EsxA and 
EsxB reportedly play an important role in the pathogenesis of staphylococcal abscesses in mice 
and it was demonstrated that EsxA mediates the release of S. aureus from host cells with the 
help of EsxB (Burts et al., 2005; Korea et al., 2014). 
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EsxC (formerly EsaC) and EsxD (formerly EsaF) are two further proteins identified as T7SS 
substrates (Burts et al., 2008; Anderson et al., 2013). EsxD contains a similar C-terminal YxxxD/E 
secretion signal which is conserved among substrates of the T7SSa secretion system in 
Mycobacteria (Daleke et al., 2012a; Anderson et al., 2013). However, both EsxC and EsxD lack 
the WXG100 motif, nor do they share any sequence features of PE/PPE or Esp protein families. 
EsxC is described as a small protein of ~130 amino acids which is, similar to EsxA and EsxB, 
produced during murine infection by S. aureus and is required for persistence (Burts et al., 2008). 
Genetic and biochemical analyses suggested that EsxA and EsxB form homodimers but do not 
interact with one another. In contrast, EsxC can form a homodimer or heterodimerise with EsxA, 
while EsxD is able to interact with EsxB (Anderson et al., 2013).  
The only secreted protein for which a function has been assigned is EsaD. Initially it was 
described as a membrane protein being displayed on the staphylococcal surface that was 
required for the secretion of EsxA. It was reported to play a role in pathogenesis of the S. aureus 
Newman strain in a mouse abscess model (Anderson et al., 2011). However, a recent study 
revealed EsaD to be a secreted anti-bacterial toxin with a C-terminal nuclease domain which 
targets the DNA of sensitive strains of S. aureus (Cao et al., 2016). Moreover, bioinformatics 
analyses revealed EsaD to be absent from many strains of S. aureus including ST398 and 
MRSA252, making it unlikely to be an essential core component of the T7SS (Warne et al., 2016).  
Two further proteins, EsaE and EsaG, are involved in the biogenesis of EsaD. EsaE, which was 
shown to act as a chaperone, binds to the non-nuclease part of EsaD, and probably targets the 
complex to the membrane bound secretion apparatus, similar to the EspG-chaperone which 
interacts with large PE/PPE proteins in pathogenic Mycobacteria (Daleke et al., 2012b; Ekiert 
and Cox, 2014; Korotkova et al., 2014; Cao et al., 2016; Ohr et al., 2017; Anderson et al., 2017). 
However, in contrast to EspG in Mycobacteria, EsaE was shown not only to interact with the 
ATPase protein, EssC, but also to be secreted together with EsaD (Cao et al., 2016). EsaG was 
initially identified as a protein of unknown function belonging to the DUF600 family. However, 
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in recent studies EsaG was shown to bind to the nuclease domain of EsaD, acting as an anti-toxin 
which prevents the EsaD-producing cell from self-intoxication. Additionally, introduction of EsaG 
into sensitive S. aureus strains showed a significant protection against EsaD-mediated killing 
(Cao et al., 2016; Ohr et al., 2017).  
Very recently, other T7 secreted antibacterial toxins mediating contact-dependent interspecies 
antagonism were identified in Streptococcus intermedius (Whitney et al., 2017). These proteins 
belong to the WXG superfamily harbouring a conserved N-terminal LXG domain, a central 
domain of variable length, and a C-terminal variable toxin domain. These LXG proteins were 
shown to transit the Ess secretion system by interacting with a WXG protein. Interestingly, 
secretion of the WXG interaction partners could not be detected, suggesting that the WXG 
proteins possibly act as analogues to the mycobacterial chaperone EspG, delivering the LXG 
proteins to the secretion apparatus. A further protein carrying the LXG motif was recently 
identified in S. aureus ST398, named EsxX. This protein was shown to be secreted by the Ess 
machinery and deletion analysis indicated that it plays an important role in immune evasion and 
virulence (Dai et al., 2017).  
 
1.4.2 The EsaB protien 
The last remaining soluble protein encoded in the ess cluster is EsaB. EsaB is described as a small 
soluble protein of 80 amino acids, conserved in firmicutes producing the T7SS (Van Den Ent and 
Löwe, 2005; Burts et al., 2005). Studies with the S. aureus Newman strain suggested that EsaB 
was a negative transcriptional regulator of esxC (Burts et al., 2008). By contrast, in the S. aureus 
strain RN6390, EsaB does not regulate esxC or any other genes encoded at the ess locus but 
rather has been shown to be essential for the activity of the Ess secretion system. Deletion of 
esaB resulted in a loss of secretion of EsxA and EsxC but did not have an effect on the production 
of these proteins (Kneuper et al., 2014; Casabona et al., 2017a). Similar results were obtained 
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for the B. subtilis homologue where deletion of yukD abolished the activity of the T7SS and it 
was therefore suggested that EsaB regulates the activity of the secretion machinery post-
translationally (Baptista et al., 2013; Huppert et al., 2014). Moreover, it could be shown that 
esaB-deletion is associated with upregulation of genes involved in iron acquisition. Upregulation 
of the same iron-acquisition genes was also observed in an essC mutant, suggesting that EsaB, 
like EssC, is a core component of the T7SS (Casabona et al., 2017a; Casabona et al., 2017b).  
Structural analyses of EsaB and YukD revealed that the proteins have a ubiquitin-like fold (Van 
Den Ent and Löwe, 2005). However, EsaB lacks the C-terminal tail essential for the activity of 
ubiquitin. It is interesting to note, that a ubiquitin-like domain is also associated with the 
cytoplasmic N-terminus of the mycobacterial T7SS component EccD, suggesting that EsaB-like 
components are essential features of all T7SS (Wagner et al., 2016).  
 
1.4.3 Membrane-bound components of the T7SS in S. aureus 
The T7SS in S. aureus is composed of four membrane proteins: EsaA, EssA, EssB and EssC. EsaA 
is a large protein with six predicted transmembrane domains (TMDs) and a large extracellular 
loop that is known to reach the surface of the cell (Dreisbach et al., 2010). It shows structural 
homology to YueB, a phage receptor in B. subtilis and its requirement in substrate secretion 
appears to be strain-dependent. In fact, it could be shown to be an essential component of the 
Ess machinery in B. subtilis and the S. aureus strain RN6390 but has also been reported to be 
non-essential for the S. aureus Newman strain (Burts et al., 2005; Baptista et al., 2013; Kneuper 
et al., 2014).  
EssA is the smallest of the membrane proteins with a single TMD and a globular domain at the 
extracellular side. It is critical for the secretion of EsxA. However, secretion studies using the 
essA deletion mutant suggested that it may not be completely essential for the secretion of EsxC, 
since low level of EsxC could still be detected in the supernatant (Kneuper et al., 2014).  
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EssB is another small protein with globular domains on both sides of the membrane. EssB-C has 
been predicted to be localised at the trans-side of the membrane and EssB-N in the cytoplasm 
(Chen et al., 2012; Zoltner et al., 2013a; Zoltner et al., 2013b). The cytoplasmic domain harbours 
a pseudokinase fold but lacks the ATP-binding signature motifs and is therefore unable to bind 
ATP-analogues (Zoltner et al., 2013b). Like EssA, EssB is also essential for T7SS activity and was 
shown to be required for the pathogenesis of S. aureus (Burts et al., 2005; Chen et al., 2012; 
Kneuper et al., 2014). Structural analyses of EssB suggest that it dimerises, but at the outset of 
this project no additional interaction partners were identified (Zoltner et al., 2013a).  
The best characterised membrane protein is the FtsK/SpoIIIE family ATPase EssC, the largest of 
all proteins encoded by the ess locus in S. aureus. It has a globular domain at the N-terminus 
that contains two repeats of a fork-head associated domain (FHA) and this is directly followed 
by two TMDs (Zoltner et al., 2016). The FHA domain is a small protein domain identified in a 
number of proteins in different species with a wide range of functions like transcription, 
translation, recognition of phosphothreonine epitopes, DNA repair and protein degradation 
(Tanaka et al., 2007; Li et al., 2013; Xu et al., 2014; Liang et al., 2015). The FHA domain in EssC 
may therefore play a role in interacting with the other proteins in the T7SS. However, so far no 
function could be assigned to the FHA domains in EssC, except for contributing to overall protein 
stability. Since deletion of these domains leads to loss of detectable EssC (Zoltner et al., 2016). 
At its C-terminus EssC possesses three iterations of a P-loop domain, named D1, D2 and D3, 
which are all essential for secretion. Interestingly module D3 does not bind ATP whereas D2 
binds ATP with high affinity. However, deletion of D3 suggests that this module is essential for 
T7SS activity since secretion of EsxA and EsxB could not be detected in this mutant. Similar to 
the FHA domain module D2 is also required for the production of a stable and functional protein, 
since deletion of this module also results in loss of detectable EssC or EsxA and EsxB in the 
supernatant (Zoltner et al., 2016). Structural analyses of EssC suggest that this protein forms 
hexamers with an internal pore of ~30 Å, wide enough to accommodate substrate dimers 
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(Zoltner et al., 2016). A recent study revealed that the 5’ portion of essC is conserved among all 
S. aureus strains, but there are four variants of the 3’-region, which largely covers the final 
ATPase domain (Warne et al., 2016). Together with the observation that the C-terminal domain 
of the mycobacterial EccC is essential for substrate recognition, these data suggest that the 
variable EssC-domains from different S. aureus species might be involved in the recognition of 
different secreted substrates (Rosenberg et al., 2015; Warne et al., 2016).  
 
1.4.4 Genomic analysis of S. aureus strains 
An analysis of 153 S. aureus genome sequences revealed that the ess locus can be grouped into 
four distinct clusters. While the first five ess-encoded genes from esxA to essB are highly 
conserved with a similarity of up to 100 %, three of the four clusters do not encode the described 
substrates EsxB, EsxC, EsxD or EsaD, which are encoded downstream of essC in the S. aureus 
strains RN6390 and Newman (Warne et al., 2016). Instead, each of these groups has a distinct 
set of genes downstream of the core ess genes, indicating discrete repertoires of substrates 
(Figure 1.7). Additionally, the essC genes from these isolates showed high sequence 
conservation in their 5’-regions but variability in their 3’-region, encoding the C-terminal ATPase 
domain. The sequence variability in EssC encoded by the different groupings is thought to be 
responsible for substrate recognition, interaction and secretion (Warne et al., 2016). A possible 
link between this variability and the unique genes encoded downstream of EssC will be discussed 
in Chapter 5.  
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Figure 1.7: Genetic variants of the ess locus found across S. aureus strains. Adapted from Warne et al. 
(2016).  
 
1.6 Aims of this study 
In contrast to the mycobacterial Type VII secretion system little is known about how the core 
Ess machinery is organised or how protein secretion is mediated in S. aureus. Therefore, the aim 
of this thesis was to derive fundamental knowledge about the organisation of the core 
membrane components of the Ess machinery. A further aspect of the thesis work was to shed 
light on the linkage between the different variants of the ATPase protein EssC and the unique 
set of substrates encoded immediately downstream among different S. aureus strains. 
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Materials 
All of the appliances, chemicals, bacterial strains and plasmids used in this study are given below. 
 
2.1 Chemicals 
Table 2.1: Chemicals used in this study 
Chemicals Source of supply 
Acrylamide/Bis-Acrylamide (ProtoFLOWGel) Flowgen Bioscience (Nottingham) 
Agarose Melford Laboratories Ltd. (Suffolk) 
Ammoniumpersulfate (APS) Melford Laboratories Ltd. (Suffolk) 
Anhydrotetracycline Sigma-Aldrich (Suffolk) 
Ampicillin (Amp) Formedium Ltd. (Norfolk) 
2-[Bisamino]-2--1,3-propanediol (bis-TRIS) Melford Laboratories Ltd. (Suffolk) 
Chloramphenicol (Cam) Sigma-Aldrich (Suffolk) 
Coomassie Blue Sigma-Aldrich (Suffolk) 
1,4-Dithiothreitol (DTT) Formedium Ltd. (Norfolk) 
Deoxyribonuclease I from bovine Sigma-Aldrich (Suffolk) 
Digitonin Sigma-Aldrich (Suffolk) 
Dimethyl sulfoxide (DMSO) VWR (Leuven) 
Disuccinimidyl suberate (DSS) Thermo Scientific (Rockford) 
n-Dodecyl-β-D-maltoside Sigma-Aldrich (Suffolk) 
Foscholin-12 Anatrace (Maumee) 
Gel-Red Nucleic Acid Stain Biotium (Hayward) 
HiMarkTM Pre-stained HMW Protein standard Thermo Scientific (Rockford) 
Imidazole Sigma-Aldrich (Suffolk) 
Lauryldimethylamine oxide Sigma-Aldrich (Suffolk) 
Lysostaphin Ambi (Lawrence) 
MOPS-SDS Running Buffer (20x) Formedium Ltd. (Norfolk) 
NativeMarkTM Unstained Protein standard Thermo Scientific (Rockford) 
NuPAGE® Transfer Buffer Thermo Scientific (Rockford) 
NuPAGE® Loading Buffer Thermo Scientific (Rockford) 
Phenylmethanesulfonyl fluoride  Sigma-Aldrich (Suffolk) 
Polyethylene Glycol 6000 (PEG 6000) Duchefa Biochemie (Haarlem) 
Precision Plus ProteinTM Standards (all Blue) Bio-Rad (Hertfordshire) 
Skimmed milk powder (Marvel Original) Chivers Ireland Ltd (Dublin) 
Sodiumdodecylsulfate (SDS) Melford Laboratories Ltd. (Suffolk) 
Sodium Deoxycholate Sigma-Aldrich (Suffolk) 
N,N,N',N'–Tetramethylethylendiamine (TEMED) VWR (Leuven) 
Trichloracetic acid (TCA) Sigma-Aldrich (Suffolk) 
Tricine Sigma-Aldrich (Suffolk) 
Triton – X- 100 Sigma-Aldrich (Suffolk) 
Tween 20 VWR (Leuven) 
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2.2 Appliances 
Table 2.2: Appliances used in this study 
Appliance Model, Producer 
Äkta: Äkta pure (GE Healthcare) 
 Äkta start (GE Healthcare) 
Cell disruptor: Digital Sonifier (Branson) 
 Thermo electron corporation French Press cell disruptor 
 Aminco Pressure Cell 30 000 psi 
Centrifuges: accuSpinTM 1R (Thermo Scientific) 
 Avanti® J-26 XP (Beckman) 
 Biofuge pico (Heraeus) 
 J6-MI Centrifuge (Beckman) 
 OptimaTM L-100 XP Ultracentrifuge (Beckman) 
 OptimaTM TLX Ultracentrifuge (Beckman) 
Electroporator GenePulser XCell (Bio-Rad) 
Incubator: Genlab incubator 
 Infors Multitron (Infors) 
 Innova 2100 platform shaker (New Brunswick Scientific) 
 TC-7 (New Brunswick Scientific) 
Medical Film Processor Model SRX-101A (Konica Minolta) 
Native PAGE gel chamber Mini Gel Tank (Thermo Scientific) 
SDS gel chamber Mini-PROTEAN® Tetra (Bio-Rad) 
Transfer cell: iBlot Dry Blotting System (Thermo Scientific) 
 iBlot 2 Dry Blotting System (Thermo Scientific) 
 Transblot SD Semi-dry transfer cell (Bio-Rad) 
Platereader BioTek ELx808 (Thermo Scientific) 
 
2.3 Columns, Equipment and Kits 
Table 2.3: Columns, Equipment and Kits used in this study 
Material Source of supply 
Chromatography paper 3mm Chr Whatman 
DCTM Protein assay Reagent A + B Bio-Rad 
DNA Clean & Concentrator™-5 Epigenetics company 
HisTrapTM HP 1 ml GE Healthcare 
HybondTM-ECL Nitrocellulose membrane 0.2 µm GE Healthcare 
iBlot® Transfer Stacks PVDF Thermo Scientific 
iBlot® 2 Transfer Stacks nitrocellulose Thermo Scientific 
Immobilon Western Chemiluminescent HRP substrate Millipore 
Immobilon-P Membrane, PVDF, 0.45 µm Millipore 
Medical Film Konica Minolta 
Minisart® Syringe filter, hydrophilic (0.2 µm / 0.45 µm) Sartorius stedim 
NativePAGE™ Novex® 4-16% Bis-Tris Protein Gels, 1.0 mm, 10 well Thermo Scientific 
QIA®prep Spin Miniprep Kit Qiagen 
QIA®quick PCR Purification Kit Qiagen 
rAPid Alkaline Phosphatase Roche 
Superdex 200 10/300 GL GE Healthcare 
T4 DNA Ligase Roche 
Vivaspin 20 (10 kDa / 50 kDa) GE Healthcare 
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2.4 Bacterial Strains 
Table 2.4: Bacterial Strains used in this study 
Strain Resistance Genotype Reference 
E. coli DC10B None dam+ dcm- hsdRMS endA1 recA1 (Monk et al., 2012) 
E. coli JM110 None rpsL (Strr) thr leu thi-1 lacY galK 
galT ara tonA tsx dam dcm supE44 
∆(lac-proAB) [F’ tra∆36 proAB lacIq 
∆M15] 
Stratagene 
E. coli DH5α None 80d ∆(lacZ)M15 recA1 endA1 
gyrA96 thi-1 hsdR17  (rk-mk+) 
supE44 relA1 deoR ∆(lacZYA-
argF)U169 
Promega 
E. coli BL21 DE3 None E. coli B: F-, dcm, ompT, hsdS(rB-, 
mB-), gal, DE3 
(Studier and 
Moffatt, 1986) 
S. aureus RN6390 None NCTC8325 derivative, rbsU, tcaR, 
cured of φ11, φ12, φ13 
(Novick et al., 1993) 
S. aureus RN6390 ∆esaA None esaA deletion (Kneuper et al., 
2014) 
S. aureus RN6390 ∆essA None essA deletion (Kneuper et al., 
2014) 
S. aureus RN6390 ∆essB None essB deletion (Kneuper et al., 
2014) 
S. aureus RN6390 ∆essC None essC deletion (Kneuper et al., 
2014) 
S. aureus RN6390 ∆esxA None esxA deletion (Kneuper et al., 
2014) 
S. aureus RN6390 ∆esxB None esxB deletion (Kneuper et al., 
2014) 
S. aureus RN6390 ∆ess None complete deletion from esxA - esaG (Kneuper et al., 
2014) 
S. aureus RN6390 ∆esaD None esaD deletion (Cao et al., 2016) 
S. aureus RN6390 ∆esaDG None esaDG deletion (Cao et al., 2016) 
S. aureus RN6390 ∆esaE None esaE deletion (Cao et al., 2016) 
S. aureus RN6390 ∆stp1 None stp1 deletion this study 
S. aureus RN6390 
∆stp1_∆pknB 
None stp1 and pknB deletion this study 
S. aureus MRSA252 None S. aureus clinical MRSA isolate (Holden et al., 
2004) 
S. aureus MRSA252 ∆essC None essC deletion lab stock 
S. aureus EMRSA 15 None From Sanger Institute stocks Prof. Sharon 
Peacock 
S. aureus EMRSA 15 ∆essC None essC deletion lab stock 
S. aureus 10.1252.X None Human ST398 isolate Roslin Institute, 
Edinburgh, original 
strain from Scottish 
MRSA Reference 
Lab 
S. aureus 10.1252.X ∆essC None essC deletion lab stock 
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2.5 Plasmids 
Table 2.5: Plasmids used in this study 
Plasmid Vector Resistance Characteristics Reference 
pET15bTEV  Amp Protein overexpression plasmid. Protein 
expressed under the control of the T7 
promoter. Permits fusion of a (His)6- tag 
followed by a TEV protease cleavage site 
to the N-terminus of the overexpressed 
protein, ApR 
Prof. Bill 
Hunter 
pIMAY  Cml, Amp Temperature-sensitive plasmid for gene 
knockouts 
(Monk et al., 
2012) 
pRAB11  Cml, Amp E. coli/S. aureus shuttle vector, inducible 
protein expression, amp
r
, cml
r
 
(Helle, Kull et 
al. 2011) 
pRMC2  Cml, Amp E. coli/S. aureus shuttle vector, inducible 
protein expression, ampr, cmlr 
(Corrigan and 
Foster, 2009) 
pRMC2 h pRMC2 Cml, Amp pRMC2 variant coding for N-terminal 
hexahistidine tag 
(Kneuper et 
al., 2014) 
pRMC2 ch pRMC2 Cml, Amp pRMC2 variant coding for C-terminal 
hexahistidine tag 
(Jäger et al., 
2016) 
pRMC2-yfp pRMC2 Cml, Amp pRMC2 with yfp fragment from pKM3a 
cloned BglII/EcoRI for transcriptional 
and translational yfp fusions, no start 
codon, AGATCT in frame 
(Casabona et 
al., 2017) 
pEsxA pRMC2 Cml, Amp esxA gene from S. aureus RN6390 cloned 
KpnI/EcoRI into pRMC2 
lab stock 
ppEsxA-yfp pRMC2-yfp Cml, Amp esxA gene from S aureus RN6390 with 
own promoter region cloned KpnI/BglII 
into pRMC2-yfp for expression from own 
promoter 
(Casabona et 
al., 2017) 
pEsxA-his pET15bTEV Amp pET15bTEV with esxA gene from S. 
aureus  
Prof. Bill 
Hunter 
EsaA – nhis pRMC2 h Cml, Amp pRMC2h expressing His6-EsaA (Kneuper et 
al., 2014) 
EssA – chis pRMC2 ch Cml, Amp pRMC2ch expressing His6-EssA (Jäger et al., 
2016) 
EssB – nhis pRMC2 h Cml, Amp pRMC2h expressing His6-EssB (Jäger et al., 
2016) 
EssC 11 pRAB 11 Cml, Amp pRAB11 with essC fragment from S 
aureus RN6390 cloned BglII/EcoRI for 
inducible EssC expression 
lab stock 
EssC pRMC2 Cml, Amp pRMC2 with essC fragment from S 
aureus RN6390 cloned BglII/EcoRI for 
inducible essC expression 
lab stock 
EssC / dFHA pRMC2 Cml, Amp pRMC2 with essC fragment coding for aa 
M190-F1479 from S aureus RN6390 
cloned BglII/EcoRI for inducible essC 
expression 
lab stock 
EssC / 
dATP2 
pRMC2 Cml, Amp pRMC2 with essC fragment coding for aa 
M1-P958 from S aureus RN6390 cloned 
BglII/EcoRI for inducible essC expression 
lab stock 
EssC / dCTD pRMC2 Cml, Amp pRMC2 with essC fragment coding for aa 
M1-P1248 from S aureus RN6390 cloned 
BglII/EcoRI for inducible essC expression 
lab stock 
EssC - chis pRMC2 Cml, Amp pRMC2 with essC fragment from S 
aureus RN6390 with added C-terminal 
(Jäger et al., 
2016) 
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His6-tag cloned BglII/EcoRI for inducible 
EssChis expression 
EssCMRSA252 pRAB11 Cml, Amp pRAB11 with essC fragment from S. 
aureus MRSA252 cloned SacI for 
inducible EssC expression 
lab stock 
EssCEMRSA15 pRAB11 Cml, Amp pRAB11 with essC fragment from S. 
aureus EMRSA15 cloned SacI for 
inducible EssC expression 
this study 
EssC10.1252.X 
ST398 
pRAB11 Cml, Amp pRAB11 with essC fragment from S. 
aureus 10.1252.X ST 398 cloned SacI for 
inducible EssC expression 
this study 
EssCATP2-
his 
pET15bTEV Amp pET15bTEV with essC fragment coding 
for the last two ATPase domains from S. 
aureus cloned XhoI / BamHI for inducible 
EssC expression 
this study 
pEsxC-his pET15bTEV Amp pET15bTEV with esxC gene from S. 
aureus  
Prof. Bill 
Hunter 
pEsaE-his pET15b Amp pET15b with esaE gene from S. aureus 
cloned NdeI / XhoI for inducible EsaE 
expression 
lab stock 
EsaD pRAB 11 Cml, Amp pRAB11 with esaD fragment from S. 
aureus RN6390 cloned KpnI / BglII for 
inducible EsaD expression 
this study 
EsaD-yfp pRMC2 Cml, Amp esaD(H528A) from S. aureus RN6390 
cloned into pRMC2-yfp for inducible 
EsaD-yfp expression 
lab stock 
pIMAY stp1 pIMAY Cml stp1 (serine/threonine phosphatase) 
gene flanking regions in pIMAY for single 
gene knockout 
lab stock 
pIMAY stp1-
pknB 
pIMAY Cml stp1/pknB genes flanking regions in 
pIMAY for double gene knockout 
lab stock 
 
2.6 Synthetic oligonucleotides 
Table 2.6: synthetic oligonucleotides used in this study 
Label Sequence (5‘ - 3‘) Restriction 
site 
esaA nhis fw GGAAGATCTAAAAAGAAAAATTGGATTTATG BglII 
esaA nhis rev GGTGAGCTCATTAGATTAATCTCTCTTTCTTAAAG SacI 
essA chis fw GATGGTACCGAAAGAGAGATTAATCTAATGTTG KpnI 
essA chis rev CTAGATCTAATGTTACTTTTACGTGCTGATTCA BglII 
essB nhis fw GATAGATCTGTTAAAAATCATAACCCTAAAAATG BglII 
essB nhis rev CGAGAATTCACTATTTTTTTCTTTCAGCTTCTTGGCGT EcoRI 
essC ATP2 fw GGACTCGAGTGGTCAGATGATGCAAAAGAAG XhoI 
essC ATPase 
rev 
GGTGGATCCTTTAAACCATCTAATTTTTTG BamHI 
esaD rev bgl II GCGCAGATCTCTACTTATTTAATATTCTTCTAATATTTCT BglII 
pRMC2 seq I GACAGGTACCAGGAGGTTTCTACTTATGACAAAAGATATTGAATATCTAAC KpnI 
essCfwdSacI AAAGAGCTCTAGGACTGAGGCAAAGACAATGC SacI 
essCr2EMRSA
15 
CAAATCTCATAGAGCTCTCGTTTTATTCAAATAA SacI 
essCr2ST398 CATAATTGAGCTCCCTATTGAATTAATTTTATTTT SacI 
All synthetic oligonucleotides were obtained from Sigma-Aldrich (Suffolk). Restriction sites are 
marked in red. Ribosome binding sites shaded in grey.  
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Methods 
All growth media used in this study contained the appropriate antibiotics with the final 
concentration as follows: 
 
Chloramphenicol    10 µg/ml 
Ampicillin   125 µg/ml 
 
Components of growth media used in this study: 
 
LB-Medium: 1.0 % Bacto-Tryptone (w/v) TSB-Medium:       1.7   % casein peptone (w/v) 
  0.5 % yeast extract (w/v)         0.3   % soya peptone (w/v) 
  1.0 % NaCl (w/v)          0.25 % glucose (w/w)   
              0.5   % NaCl (w/v) 
              0.25 % K2HPO4 (w/v) 
 
2.7 cell biology methods 
2.7.1 Cell cultivation 
2.7.1.1 for expression tests 
For expression tests the respective plasmids were introduced into S. aureus and transformants 
were incubated on solid TSB-medium with appropriate antibiotics overnight at 37 °C. A single 
colony was used for inoculation of an overnight culture. The following day 10 ml of fresh TSB 
medium was inoculated with an aliquot of the overnight culture to give an OD600 of 0.1. For 
induction of expression of plasmid-encoded proteins, the appropriate concentration of 
Anhydrotetracycline (ATc) was added when the OD600 of the culture reached 0.5 and incubated 
at 37 °C with vigorous shaking until an OD600 of 2.0 was reached. 0.5 ml of the culture was used 
for the preparation of a whole cell sample by centrifuging at 17 000 x g for 2 min and retaining 
the pellet. For the supernatant samples, 5ml of the culture was harvested by centrifugation for 
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15 min at 2 770 x g. To remove cell debris the supernatant was filtered through a 0.45 µm syringe 
filter and stored at -20 °C prior to Trichloracetic acid (TCA) precipitation. 
 
2.7.1.2 for DSS crosslinking 
For in vitro crosslinking experiments, the respective plasmids were introduced into S. aureus 
RN6390 and transformants were incubated on solid TSB medium with appropriate antibiotics 
overnight at 37 °C. A single colony was used for the inoculation of a 5 ml overnight culture. The 
following day 50 ml of fresh TSB-medium was inoculated with an aliquot of the overnight culture 
to give an OD600 of 0.1. For induction of expression of plasmid-encoded proteins, the appropriate 
concentration of ATc was added when the OD600 of the culture reached 0.5, and the culture was 
incubated at 37 °C with vigorous shaking until an OD600 of 2.0 was reached. The culture was 
harvested by centrifugation for 10 min at 2 770 x g.  
 
2.7.1.3 for PFA crosslinking 
For in vivo crosslinking experiments the respective plasmids were introduced into S. aureus 
RN6390 and transformants were incubated on solid TSB medium with appropriate antibiotics 
overnight at 37 °C. A single colony was used for the inoculation of a 5 ml overnight culture. The 
following day 50 ml of fresh TSB-medium was inoculated with overnight culture to give an OD600 
of 0.1. For induction of expression of plasmid-encoded proteins, the appropriate concentration 
of ATc was added when the OD600 of the culture reached 0.5, and the culture was incubated at 
37 °C with vigorous shaking until an OD600 of 1.0 was reached. The culture was harvested by 
centrifugation for 10 min at 2 770 x g. 
 
2.7.1.4 for protein purification 
For protein purification the respective plasmids were introduced into E. coli and transformants 
were incubated on solid LB-medium with appropriate antibiotics overnight at 37 °C. A single 
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colony was used for the inoculation of a culture that was grown for eight hours. 150 µl of this 
was then used for inoculation of a 100 ml of fresh medium and incubated overnight. The 
following day 2 x 500 ml of fresh LB-medium was inoculated with the overnight culture to give 
an OD600 of 0.1 and incubated at 37 °C with vigorous shaking. For induction of expression of 
plasmid-encoded proteins, 1 mM IPTG was added when the OD600 of the culture was between 
0.6 – 0.8 and the culture was then incubated at 25 °C with vigorous shaking overnight. Cells were 
harvested the next day by centrifugation for 30 min at 4 °C at 3 600 x g. 
 
2.7.1.5 for growth curve experiments 
In preparation for growth curve experiments the respective plasmids were introduced into S. 
aureus and transformants were incubated on solid TSB-medium with appropriate antibiotics 
overnight at 37 °C. A single colony was used for inoculation of an overnight culture. The following 
day 10 ml of fresh TSB medium was inoculated with an aliquot of the overnight culture to give 
an OD600 of 0.1. After reaching an OD600 of 0.5, 1 ml of culture was taken to continue the 
experiment. For induction of expression of plasmid-encoded proteins, Anhydrotetracycline 
(ATc) was added to a final concentration of 500 ng/ml. Three times 150 µl of culture was then 
added into a 96 well plate and cell growth and fluorescence monitored over a time 18 hours by 
37 °C. Optical density was measured in 20 min intervals with a shaking step 20 second before 
every read.  
 
2.7.2 Preparation of competent cells 
2.7.2.1 E. coli competent cells prepared with transformation buffer 
To prepare E. coli competent cells 10 ml LB medium was inoculated from a stationary-phase 
culture of the strain of interest at 1:100 dilution. The culture was grown at 37 °C with vigorous 
shaking at 200 rpm until an OD600 0.4 – 0.5 was reached. After chilling on ice for 10 min the cells 
were harvested by centrifugation for 10 min at 2 770 x g. The supernatant was removed and the 
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cell pellet was resuspended in ice-cold transformation buffer (to 1/10th of the original culture 
volume) and chilled on ice for further 20 min before use, or snap frozen and stored at 
 – 80 °C.  
 
Transformation Buffer: 10 g PEG 6000 
     5 ml 1 M MgSO4 
     5 ml DMSO 
    fill up to 100 ml with fresh LB broth  
 
2.7.2.2 S. aureus electro-competent cells 
To prepare electro-competent S. aureus cells, 50 ml of fresh prewarmed TSB-medium was 
inoculated with the host strain to an OD600 = 0.5 and incubated for 30 min at 37 °C with vigorous 
shaking. After chilling on ice for 10 min the cells were harvested by centrifugation for 10 min at 
2 770 x g. The supernatant was removed and the cell pellet was washed in 25 ml sterile, ice cold 
MilliQ water before pelleting again by centrifugation for 10 min at 2 770 x g. This washing step 
was repeated once more. Finally, the cell pellet was resuspended in 5 ml sterile, ice cold 10 % 
(w/v) glycerol and re-pelleted by centrifugation for 10 min at 2 770 x g. After this washing step 
was repeated once more, the cell pellet was resuspended in 1ml sterile, ice cold 10 % (w/v) 
glycerol and centrifuged for 10 min at 2 770 x g. The supernatant was removed again and the 
cell pellet resuspended in 250 µl sterile, ice-cold 10 % (w/v) glycerol before storage at -80 °C in 
50 µl aliquots.  
 
2.7.3 Transformation of competent cells 
2.7.3.1 E. coli competent cells prepared with transformation buffer 
For transformation, 150 µl of E. coli competent cells were mixed with 1 µl of plasmid DNA 
solution and chilled on ice for 30 min. Subsequently the cells were heat-shocked at 42 °C for  
1 min and immediately placed on ice for further 2 min. 800 µl LB-medium without antibiotics 
were added and the cells were incubated at 37 °C for 1 h with vigorous shaking. Afterwards the 
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cells were pelleted at 1 000 x g for 5 min, resuspended in 100 µl LB and plated on LB medium 
containing appropriate antibiotics. The plates were incubated overnight at 37 °C.  
 
2.7.3.2 S. aureus electro-competent cells 
For transformation, a 50 µl aliquot of S. aureus electro-competent cells was used. The cells were 
chilled on ice for 5 min and left at room temperature for a further 5 min. The cells were then 
incubated for 2 min at 56 °C followed by a centrifugation step for 1 min at 5000 x g. The cell 
pellet was resuspended in 50 µl of 10 % glucose / 500 mM sucrose, and up to 5 µg of plasmid-
DNA were added. The sample was transferred to a 0.1 cm electroporation cuvette and treated 
with Pulse 21kV/cm, 100 Ω and 25 µF. 1 ml of 500 mM sucrose / TSB was added immediately 
and the culture incubated at 37 °C for 1.5 h with vigorous shaking. Afterwards the cells were 
centrifuged at 1 000 x g for 5 min, resuspended in 100 µl 500 mM sucrose / TSB and plated onto 
TSB medium containing appropriate antibiotics. The plates were incubated overnight at 37 °C. 
 
2.8 Molecular biology methods 
2.8.1 Polymerase chain reaction 
Each sample contained 50 µl with the following components: 
Table 2.7: Chemical composition of typical PCR samples 
Component volume [µl] 
double-distilled H2O 32.5 - 34.5 
5 x buffer (Rxn Herculase) 10.0 
dNTP-Mix (per 10 mM dATP, dCTP, dGTP, dTTP) 1.0 
Primer 1 [100 µM]   0.5 
Primer 2 [100 µM]   0.5 
DNA-Template [~300 - 500 ng]   3.0 – 5.0 
DNA Polymerase Herculase II 0.5 
 
  
43 
_____________________________________________________________________________________ 
_____________________________________________________________________________________ 
Chapter 2 – Materials and Methods 
The PCR machine was programmed as follows:  
Table 2.8: PCR programme 
Reaction step parameter: 
Preheating 2 min at 95 °C 
Denaturation 30 sec at 95 °C 
Annealing 30 sec at 50 °C - 53 °C 
Elongation 45 sec to 4 min at 72 °C 
Final step 3 – 7 min at 72 °C 
Cycles 29 
 
The time for elongation was varied depending on the size of the template, allowing for 1 kb per 
minute. The final step was 2 – 3 x the elongation time.  
 
2.8.2 Purification of DNA products 
After performing PCR reactions, PCR products were cleaned by following the protocol of the 
QIA®quick PCR Purification Kit (Qiagen). Depending on the amount of DNA, 30 to 50 µl ddH20 
was used for the elution step.  
 
2.8.3 DNA digestion by restriction and preparing for cloning 
1.0 µg of DNA was digested using 15 U of the appropriate restriction enzymes in a buffer 
provided by Agilent in a final volume of 50 µl. For KpnI digestion 0.01 % BSA (v/v) was also 
included. The samples were incubated for 1.5 h at 37 °C.  
 
Following digestion DNA samples were purified (see 2.8.2) and the vectors for cloning were 
dephosphorylated using shrimp alkaline phosphatase (Roche). 3.7 µl 10 x alkaline phosphatase 
buffer and 1.5 µl of alkaline phosphatase were added to each reaction. The samples were 
incubated for 1 h at 37 °C. To stop the reaction the samples were subsequently incubated for  
2 min at 72 °C.  
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2.8.4 DNA ligation 
T4 DNA ligase (Roche) was used to clone inserts into the appropriate vector. Insert DNA was 
mixed with vector DNA in a ratio of 3:1 in 1 x T4 ligase buffer with a final volume of 10 µl. The 
samples were incubated for 2.5 h at room temperature and transformed into the appropriate E. 
coli strain.  
 
2.8.5 Colony PCR 
To check if colonies contained clones of interest, colony PCR was carried out. A single colony 
was resuspended in 60 µl ddH20 and 2 µl was used as template for the PCR reaction. Each sample 
contained 25 µl with the following components: 
 
Table 2.9: Chemical composition of the colony PCR samples 
Component volume [µl] 
5 x Go Taq Buffer       5.0 
Colony       2.0 
Primer (colony PCR pRMC2 primer)       0.5 
dNTPs       0.5 
DMSO       0.5 
MgCl2 [25 mM]       3.0 
Go Taq-Polymerase       0.5 
double-distilled H2O     13.0 
 
The PCR machine was programmed as follows:  
 
Table 2.10: PCR programme 
Reaction step parameter: 
Preheating 2 min at 95 °C 
Denaturation 30 sec at 95 °C 
Annealing 30 sec at 50 °C / 53 °C 
Elongation 45 sec to 4 min at 72 °C 
Final step 3 – 7 min at 72 °C 
Cycles 29 
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The time for elongation was varied depending on the size of the template, allowing for 1 kb per 
minute. The final step was 2 – 3 x the elongation time.  
2.8.6 Agarose gel electrophoresis 
DNA samples were analysed using 1 % (w/v) agarose gels prepared in 1 x TAE buffer containing 
Gel red (Biutium) in a ratio 1:20 000. The samples were mixed with 10 x DNA loading dye and 
loaded on the gel together with DNA size markers (Roche). Gels were run in 1 x TAE buffer for 
30 min at 100 V. After separation all bands were visualised under UV light. 
 
TAE Buffer, pH 8.0:  40 mM Tris 
      1.14 % (v/v) acetic acid 
      1 mM EDTA 
 
2.8.7 Plasmid DNA preparation 
E. coli cells were incubated overnight in 10 ml LB-medium containing the appropriate antibiotics 
at 37 °C with vigorous shaking. The following day cells were harvested by centrifugation for 10 
min at 2 770 x g. Plasmid DNA was isolated by following the protocol of the QIA®prep Spin 
Miniprep Kit (Qiagen) using 50 µl ddH20 for plasmid DNA elution.  
 
2.8.8 DNA Sequencing 
DNA sequencing was performed using the Sanger Sequencing technique based on selective 
incorporation of chain-terminating dideoxynucleotides by DNA polymerase during in vitro DNA 
replication. Sequencing was undertaken by the Sequencing Service at the University of Dundee, 
Dundee, UK and the results analysed using the BioEdit software.  
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2.9 Biochemical methods 
2.9.1 Cell fractionation 
2.9.1.1 for expression tests 
A cell pellet obtained from 0.5 ml of a S. aureus culture grown to an OD600 of 2.0 (as described 
in Section 2.7.1.1.) was washed with 500 µl of 1 x PBS and re-pelleted. The pellet was 
resuspended in 500 µl 1 x PBS and 50 µg/ml Lysostaphin was added. The samples were incubated 
at 37 °C for 30 min before boiling for 5 min at 95 °C and were then stored at -20 °C until further 
use. 
 
For preparing membrane fractions, the cell pellet obtained from the 5 ml aliquot used for the 
preparation of supernatant samples was used, and was resuspended in 1 ml Buffer 1. After 
adding 50 µg Lysostaphin, the sample was incubated for 30 min at 37 °C followed by a 
centrifugation step for 10 min at 10 000 x g. The pellet was then resuspended in 1 ml 1 x PBS 
and disrupted by sonication (three times for 15s with a pulse on an off for 1 second, an amplitude 
of 20 % and a 20 second pause between each step). Subsequently the sonicated sample was 
centrifuged for 30 min at 227 000 x g to pellet the membranes. Membranes were resuspended 
in 100 µl Buffer 2 and stored at - 20 °C for further use.  
 
Buffer 1:   50 mM Tris/HCl, pH 7.5  Buffer 2:   1 x PBS 
  500 mM sucrose       0.5 % Triton 
 
2.9.1.2 for DSS crosslinking experiments 
For in vitro crosslinking experiments, cell pellets were washed in 1 ml M1 buffer followed by 
centrifugation for 10 min at 2 770 x g. The pellet was then resuspended in 1 ml M2 buffer 
containing 100 µg Lysostaphin and was supplemented with 0.1 mM PMSF and a few crystals 
DNAse I. After an incubation time of 30 min at 37 °C, the sample was lysed by sonication (as 
described in Section 2.9.1.1) and centrifuged for 5 min at 17 000 x g to obtain the low speed 
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pellet. The supernatant was centrifuged again for 30 min at 227 000 x g. The high speed pellet 
(containing the membranes) was resuspended in 100 µl M1 Buffer.  
 
M1 Buffer:   20 mM MOPS/NaOH, pH 7.2 M2 Buffer:   20 mM MOPS/NaOH, pH 7.2 
  200 mM NaCl     200 mM NaCl 
          2.5 mM EDTA 
 
2.9.1.3 for PFA crosslinking experiments 
After incubation with paraformaldehyde (PFA), cell suspensions were pelleted by centrifugation 
for 10 min at 2 770 x g. The pellet was resuspended in 1 ml T2 buffer containing 100 µg 
Lysostaphin, 0.1 mM PMSF and a few crystals of DNAse I. After an incubation time of  
30 min at 37 °C, the sample was lysed by sonication (as described in Section 2.9.1.1) and 
centrifuged for 5 min at 17 000 x g to obtain the low speed pellet. The supernatant was 
centrifuged again for 30 min at 227 000 x g. The high speed pellet was resuspended in 100 µl T1 
buffer.  
 
T1 Buffer:   50 mM Tris/HCl, pH 7.5  T2 Buffer: 50 mM Tris/HCl, pH 7.5 
  200 mM NaCl                 200 mM NaCl 
                     2.5 mM EDTA 
 
2.9.1.4 Solubilisation of the membrane extracts 
Membrane fractions were prepared as described above (see Section 2.9.1.2). 400 µg of total 
protein was then used for solubilisation. Firstly, the membrane fraction was centrifuged for  
30 min at 227 000 x g at 4 °C and subsequently resuspended in 40 µl of solubilisation buffer 
containing 1 mM DTT and 0.1 mM PMSF. After adding 2 % (final concentration) of the 
appropriate detergent, the samples were incubated at 25 °C for 2 h with vigorous shaking at 
1000 rpm. To separate the solubilised proteins from remaining membrane fractions the samples 
were subsequently centrifuged for 20 min at 89 000 x g. 
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Solubilisation Buffer:   50 mM Na-PO4, pH 8.0 
   300 mM NaCl 
     10 % Glycerol (v/v) 
       2 % appropriate detergent 
 
2.9.1.5 for protein purification 
Cell pellets were washed in 20 ml Buffer A containing 1 mM DTT and a Mini protease Inhibitor 
tablet (Roche). Samples were lysed by passing through a French press with a pressure of  
12 000 psi. The cytosol was separated from the membrane and unbroken cells by centrifugation 
for 1 h at 160 000 x g at 4 °C. The cytosol was subsequently filtered using a  
0.45 µm syringe filter and supplemented with 25 mM imidazole prior to protein purification.  
 
Buffer A:    50 mM Na-PO4, pH 7.8 
   300 mM NaCl 
     10 % glycerol (v/v) 
 
2.9.2 Lowry protein concentration determination 
To determine the concentration of protein present in membrane fractions, a 1:10 dilution of the 
membrane samples was prepared. 5 µl of this dilution were added, in triplicate, to a microtiter 
plate. 25 µl of Solution A of the DCTM Protein assay from Bio-Rad were added to the samples, 
filled up with 200 µl of Solution B from the Kit and chilled at RT for 15 min. Subsequently the 
Protein concentration was measured at OD750 nm using the BioTek ELx808 plate reader. Bovine 
serum albumin (BSA, Sigma) was used as standard.  
 
2.9.3 TCA precipitation 
1 ml of culture supernatant was mixed with 50 µg of Sodium deoxycholate and 10 % TCA. The 
samples were chilled on ice overnight followed by a centrifugation step for 5 min at 10 000 x g 
at 4 °C. The supernatant was removed and 500 µl ice-cold 80 % ethanol was added to the cell 
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pellet. The samples were centrifuged again for 5 min at 10 000 x g at 4 °C. After removing the 
ethanol, the pellet was allowed to air-dry for 30 min at 37 °C before being resuspended in 30 µl 
50 mM Tris/HCl, pH 8.0 containing 4 % SDS. 
 
2.9.4 bis-Tris polyacrylamide gel electrophoresis 
The gels used in this study contained 6 % acrylamide in the stacking gel. The resolving gel 
contained between 8 % and 15 % acrylamide depending on the size of the protein of interest. 
Supernatant samples were mixed with 4 x NuPAGE® loading buffer, whereas cell samples were 
mixed with 2 x NuPAGE® loading buffer. Before loading into the wells, the samples were 
incubated for 10 min at 95 °C. To determine the relative molecular mass of the protein of 
interest, 5 µl of a Protein ladder (Precision plus ProteinTM All Blue Standards, Bio-Rad) were 
loaded alongside the sample. Proteins were separated in MOPS-SDS running buffer (Formedium) 
at 110 V. Subsequently the gels were incubated in NuPAGE® transfer buffer containing 20 % 
methanol for electroblotting.  
 
MOPS-SDS-Running Buffer: 50.00 mM MOPS       NuPAGE® Transfer Buffer: 25 mM Bicine 
          50.00 mM Tris base                                                  25 mM Bis-Tris base 
            3.47 mM SDS                          1 mM EDTA 
            1.00 mM EDTA 
 
2.9.5 SDS polyacrylamide gel electrophoresis 
Gels used in this study contained 4 % acrylamide in the stacking gel. The resolving gel contained 
between 5 % and 12.5 % acrylamide depending on the size of the protein. Samples were mixed 
with 6x SDS loading buffer prior loading. To determine the relative molecular mass of the protein 
of interest, 7.5 µl of a Protein ladder (HiMarkTM Pre-stained protein standard, Thermo Scientific) 
were loaded alongside the sample. Proteins were separated in Tris-SDS running buffer at 100 V. 
Subsequently gels were incubated in Tris-glycine transfer buffer for electroblotting. 
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Tris-SDS-Running Buffer: 25 mM Tris base  Tris-glycine-Transfer Buffer:  25 mM Tris/HCl, pH 7.5 
   192 mM glycine                192 mM glycine 
   0.1 % SDS (w/v)                   20 % methanol (v/v) 
 
2.9.6 Blue Native polyacrylamide gel electrophoresis 
Blue Native polyacrylamide gel electrophoresis (BN PAGE) was carried out as described by Wittig 
et al. (2006) using precast 4 – 16 % gradient bis-Tris gels (Thermo Scientific). Solubilised 
membrane protein samples were prepared as described above (Section 2.9.1.4) and 
supplemented with a final concentration of 5 % glycerol and 0.2 % Coomassie Blue. To determine 
the relative molecular mass of the protein of interest, 8 µl of a Protein ladder (NativeMarkTM 
Unstained Protein standard, Thermo Scientific) were loaded alongside the sample. Proteins 
were separated at 4 °C and 150 V using an electrophoresis Bolt Mini-gel tank (Novex, Life 
Technologies) containing 25 mM imidazole (Anode Buffer) in the front chamber and Cathode 
Buffer B in the front chamber. Once the solubilised protein samples migrated approximately one 
quarter of the way through the gel, the run was paused to replace Cathode Buffer B with 
Cathode Buffer B/10. The run was then continued at 250 V until the migration front reached the 
bottom of the gel. Gels were immediately used for Western Blotting using a semi-dry transfer 
system (see 2.9.6.2).  
 
Cathode Buffer B:  50.0 mM Tricine  Cathode Buffer B/10: 50.0 mM Tricine 
         7.5 mM imidazole                               7.5 mM imidazole 
            0.2 mM Coomassie Blue                                        0.02 mM Coomassie Blue 
 
2.9.6 Western blotting and immunological detection of proteins 
Following bis-Tris-PAGE (see 2.9.4) or SDS PAGE (see 2.9.5) proteins were transferred to 
nitrocellulose (GE Healthcare) or PVDF (Immobilon) membrane by use of the semi-dry method. 
PVDF membranes were pre-activated in 100 % methanol for 15 sec followed by a 2 min washing 
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step in ddH20. The gel, membrane and filter paper were soaked in NuPAGE Transfer buffer (see 
2.9.4). The transfer was performed at 20 V for 60 min.  
 
For dry transfer the iBlot and iBlot2 devices (Thermo Scientific) were used. Following SDS PAGE 
nitrocellulose membranes were used with customer setting of 20 V for 1 min, 23 V for 4 min and 
25 V for 2.5 min. PVDF membranes were used following BN PAGE with the transfer programme 
P0 (20 V for 7 min).  
 
PVDF membranes after dry transfer from BN PAGE were destained in 25 % methanol / 10 % 
acetic acid solution for 2 h at room temperature with gentle agitation. After a washing step in 
ddH20 membranes were dried, the protein ladder marked and the membrane completely 
destained in 100 % methanol before being washed in TBS/Tween three times for 10 min.  
 
Subsequently membranes were blocked in 5 % skimmed milk suspended in TBS/Tween for 1h at 
room temperature or overnight at 4 °C with shaking. After discarding the blocking buffer the 
membrane was incubated with the primary antibody in 5 % skimmed milk for 1 h at room 
temperature. If the first antibody was not conjugated to horseradish peroxidase (HRP-
conjugated), incubation with a secondary antibody was necessary. In this case the membrane 
was washed three times for 10 min with TBS/Tween at room temperature and incubated for 
further 45 min with the secondary antibody in 5 % skimmed milk at room temperature, followed 
by three washing steps with TBS/Tween each for 10 min. 
 
Finally, the membrane was incubated in 2 ml chemiluminescent HRP substrate. The 
chemiluminescent bands were exposed on medical Film and developed in Medical film 
Processor (Model SRX-101A Konica Minolta).  
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Table 2.11: Antibodies used in this study. 
primary antibody dilution reference 
rabbit anti EssB 1:  5 000 (Kneuper et al., 2014) 
rabbit anti EssA 1:10 000 lab stock 
rabbit anti EssC 1:10 000 (Kneuper et al., 2014) 
rabbit anti EsxC 1:  2 000 (Kneuper et al., 2014) 
rabbit anti EsxA 1:  2 500 (Kneuper et al., 2014) 
rabbit anti EsaA 1:10 000 (Kneuper et al., 2014) 
mouse anti His 1:  2 000 lab stock 
mouse anti His IgG HRP conjugate 1:10 000 Abcam 
rabbit anti TrxA 1:20 000 (Miller et al., 2010) 
secondary antibody dilution reference 
goat anti rabbit IgG HRP conjugate 1:10 000 Bio-Rad 
goat anti mouse IgG HRP conjugate 1:10 000 Bio-Rad 
 
TBS/Tween:    10 mM Tris/HCl, pH 7.5 
   250 mM NaCl 
    0.1 % Tween 20 
 
2.9.7 crosslinking experiments 
2.9.7.1 in vitro crosslinking 
Disuccinimidyl suberate (DSS) crosslinking experiments were carried out with membrane 
fractions containing 30 µg of total protein. The samples were mixed with a final concentration 
of 2 mM DSS or with DMSO only (control sample) and made up to 50 µl with crosslinking buffer. 
After an incubation time of 30 min at room temperature the reaction was quenched by adding 
100 mM Tris/HCl, pH 8.0. Finally all samples were made up to 73.3 µl with 4 x NuPAGE Loading 
Buffer and 1 µg of total protein loaded on a bis-Tris-Gel.  
 
Buffer X1:     20 mM HEPES/NaOH, pH 7.4 
     20 mM KCl 
   250 mM sucrose 
        1 mM EDTA 
 
When crosslinking purified proteins, paraformaldehyde (PFA) was used as a crosslinker. 20 µg of 
the largest protein, EssC, was used for each crosslinking reaction, what resembles a molar 
concentration of 6.7 µmol/L. All other proteins were mixed in a molar ratio of 1:1 and one 
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sample, containing the ATPase protein EssC, treated with 2 mM ATP / 2 mM MgCl2 in addition 
to the crosslinker. PFA was added to a final concentration of 0.6 % and the sample was filled up 
to 50 µl with buffer X2. The reaction was incubated at room temperature for 30 min after which 
it was quenched by adding 100 mM Tris/HCl, pH 7.8. Finally, all samples were made up to 73.3. 
µl with 4 x NuPAGE loading buffer and 5 µl loaded on a bis-Tris-gel. 
 
Buffer X2:     50 mM HEPES/NaOH, pH 7.8 
   100 mM NaCl 
     10 % glycerol (v/v) 
 
2.9.7.2 in vivo crosslinking 
Paraformaldehyde (PFA) crosslinking experiments were carried out in whole cells suspended in 
1 x PBS. Paraformaldehyde was added to the cell suspension to a final concentration of 0.6 % 
and samples incubated for 30 min at room temperature. The reaction was quenched by adding 
100 mM Tris/HCl, pH 8.0. Subsequently membrane fractions were obtained as described in 
Section 2.9.1.3 
 
2.9.8 Protein purification 
Protein purification was carried out using an Äkta start (GE Healthcare). A 1 ml His-Trap HP 
column (GE Healthcare) charged with Ni2+ was calibrated with five column volumes (CV) of buffer 
B1. After the sample was loaded, the column was washed with buffer B1 for 10 CV after which 
fractions were collected over a linear imidazole concentration gradient from 25 mM to 250 mM 
over 18 CV. Fractions containing the protein of interest were pooled and concentrated in a spin 
concentrator (GE Healthcare) exchanging buffer B with buffer A to remove the imidazole.  
Buffer B1:   50 mM Na-PO4, pH 7.8  Buffer B2:   50 mM Na-PO4, pH 7.8 
  300 mM NaCl      300 mM NaCl 
    10 % glycerol (v/v)       10 % glycerol (v/v) 
    25 mM imidazole     250 mM imidazole 
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2.9.9 Size exclusion chromatography 
Size exclusion chromatography (SEC) was performed on EssCATP2-his to check for hexameric 
formation of the protein. SEC was conducted using a Superdex 200 10/300 column (GE 
Healthcare) using an Äkta pure (GE Healthcare). The purified protein (see Section 2.9.8) was 
concentrated to 500 µl using a spin concentrator (GE Healthcare) followed by centrifugation for 
30 min at 4 °C at 10 000 x g to remove any aggregates. Prior to injection of the sample, the 
column was washed with buffer C for 3 CV and equilibrated with the same buffer over 5 CV. A 
500 µl loop was used to load the sample followed by elution of protein in 500 µl aliquots into a 
96 well tray. Samples containing the protein of interest were analysed by SDS PAGE prior to 
pooling and concentrating while changing buffer C against buffer A for future crosslinking 
experiments. 
 
Buffer C:    50 mM Tris/HCl, pH 7.8 
   100 mM NaCl 
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3.1 Introduction 
Prior studies of the ESX-1 and ESX-5 T7SSs from Mycobacteria have shown that the EccB, EccC, 
EccD and EccE components form a complex of ~1.5 mDa, with a likely 6:6:6:6 stoichiometry 
(Houben et al., 2012; van Winden et al., 2016; Beckham et al., 2017). Recent negative stain 
structural analysis of ESX-5 has indicated that the ATPase EccC lies at the centre of this complex 
and probably forms the protein transport channel (Beckham et al., 2017). By analogy it is likely 
that in firmicutes, the homologous protein EssC also acts as the transport channel, in agreement 
with structural and modelling studies on domains of this protein (Rosenberg et al., 2015; Zoltner 
et al., 2016). However, apart from EccC/EssC, none of the other essential membrane 
components of the T7SS are conserved between the two types of T7SS, raising the possibility 
that they may have different architectures. 
As outlined in Chapter 1, the S. aureus T7SS has four critical membrane components: EsaA, EssA, 
EssB and EssC (Burts et al., 2005; Kneuper et al., 2014). The predicted topologies and domain 
structures of these proteins are shown in Fig 3.1.  
 
 
Figure 3.1: Membrane components of the S. aureus T7SS. The sizes and predicted topologies of EsaA, 
EssA, EssB and EssC are shown. Also included is existing structural information for EssB and EssC. The co-
ordinates and structure factor data for EssB-C and EssB-N are deposited in the PDB under code 2YNQ and 
4ANO, respectively. Co-ordinates and structure factor data for EssC-N and EssC-C are deposited in the PDB 
under code 5FWH and 5FV0, respectively.  
57 
_____________________________________________________________________________________ 
_____________________________________________________________________________________ 
Chapter 3 – Detergent extraction and BN PAGE analysis of the essential membrane proteins of the T7SS 
EsaA is a 114 kDa protein with six predicted TMDs and a large extracellular loop that is known 
to reach the surface of the cell (Dreisbach et al., 2010). EssA is a small protein of 17 kDa with a 
single TM and a globular domain at the extracellular side. EssB is another monotopic membrane 
protein with globular domains on both sides of the membrane and a size of 52 kDa (Chen et al., 
2012; Zoltner et al., 2013a). Currently the functions of any of these three proteins are unknown. 
EssC, at 170 kDa, is the largest of the four membrane proteins and consists of a globular domain 
at the N-terminus with two repeats of a fork-head associated domain (FHA), followed by two 
TMDs and three P-loop ATPase domains at the C-terminus (Tanaka et al., 2007; Rosenberg et al., 
2015; Zoltner et al., 2016).  
So far all of the structural analysis of S. aureus T7SS membrane components was undertaken 
following heterologous production of domains of these proteins in E. coli (Chen et al., 2012; 
Zoltner et al., 2013a; Zoltner et al., 2013b; Zoltner et al., 2016). To date there is very little 
published methodology for extraction of membrane proteins directly from the S. aureus 
membrane, and there are likely to be differences in the cytoplasmic membrane lipid 
composition between S. aureus and E. coli. Bacteria are able to adapt to stresses such as changes 
in temperatures and osmolarity or exposure to membrane-damaging compounds by either 
changing the type of fatty acid or the type of polar head group, leading to a different set of 
phospholipids (Zhang and Rock, 2008). While E. coli and S. aureus ensure survival in stationary 
growth phase by increasing the cardiolipin (CL) concentration (Short and White, 1971; Hiraoka 
et al., 1993) it could be shown that S. aureus also uses the same mechanism to adapt to osmotic 
stress (Hayami et al., 1979; Tsai et al., 2011). CL, also called di-phosphatidylglycerol, together 
with phosphatidylglycerol (PG) are the most common bacterial phospholipids. They consist of a 
negatively charged head group giving the membrane anionic properties. However, S. aureus is 
able to modify PG by attaching L-lysine to the PG-head group, resulting in a positive charge of 
the lipid (Gould and Lennarz, 1967). This modification partially neutralises the charge on the S. 
aureus membrane, which increases resistance against cationic antimicrobial peptides but also 
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has an influence on the synthesis of membrane proteins (Peschel et al., 2001; Sievers et al., 
2010; Staubitz et al., 2004).  
Before being able to investigate the architecture of the T7SS membrane components from S. 
aureus it was therefore necessary to first find a detergent which was able to extract these 
membrane proteins. Detergents can be separated into three main groups with different 
characteristics: ionic, non-ionic, and zwitterionic. Ionic detergents consist of a head group which 
is positively or negatively charged followed by a hydrophobic hydrocarbon chain or steroidal 
backbone. Non-ionic detergents in contrast have an uncharged hydrophilic head group, whereas 
zwitterionic detergents combine the properties of the ionic and non-ionic detergents. Also 
belonging to the ionic detergents are the so called bile acid salts. Bile acid salts have a different 
backbone comprising of rigid steroidal groups. As a result they form small kidney-shaped 
aggregates compared to the spherical micelles formed by ionic linear-chain detergents (Seddon 
et al., 2004; Figure 3.2). 
 
 
Figure 3.2: Structures of the detergents used in this study. Detergents shown in A are non-ionic;  
B zwitterionic; and C ionic bile acid salt. 
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3.2 Aim 
The aim of this Chapter was to develop expression systems and membrane extraction protocols 
to facilitate the isolation of complexes containing the Ess membrane components from the 
native organism. 
 
Results 
3.3. Genetic manipulation of the Ess membrane protein-encoding genes 
To facilitate purification of Ess complexes, His-tagged variants of each of the Ess membrane 
proteins, EsaA, EssA, EssB and EssC needed to be constructed to allow inducible production in 
the native host, S. aureus. To achieve this, the backbone vector pRMC2 was used (Corrigan and 
Foster, 2009; Figure 3.3). This vector encodes the TetR repressor protein and the TetR-controlled 
Pxyl/tetO promoter, which is used to induce protein production upon addition of 
Anhydrotetracycline (ATc).  
As S. aureus is known to produce many extracellular proteases, His-tags were introduced onto 
the cytoplasmic-facing termini of each protein. For EsaA and EssB the N-terminus was chosen, 
and for EssA the C-terminus (Figure 3.1). A plasmid-encoded C-terminal His-tagged variant of 
EssC had already been constructed by Dr. Holger Kneuper (Jäger et al., 2016). For construction 
of the N-terminal His-tagged variants of EsaA and EssB a modified pRMC2 vector, pRMC2 h, was 
used, where DNA coding for an N-terminal His-tag had been introduced (Kneuper et al., 2014). 
The gene coding for esaA was introduced using the restriction sites BglII and SacI while the gene 
coding for essB was inserted via the restriction sites BglII and EcoRI. The C-terminal His-tagged 
variant of EssA was produced from a modified pRMC2 vector (pRMC2 ch; Jäger et al., 2016), that 
already contained DNA coding for a C-terminal His-tag, introducing the essA gene using the 
restriction sites KpnI and BglII (see Table 2.6 for the sequence of the primers used in this work).  
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Figure 3.3: Vector used for the genetic manipulation of ess encoding genes. The tetR(B) region regulates 
the protein expression by induction with Anhydrotetracycline (ATc). 
 
3.3.1 Testing expression of the His-tagged proteins 
Before further study of the recombinant His-tagged membrane proteins, it was first important 
to determine whether the added His-tag interfered with the stability and/or functionality of 
each protein. Therefore it was necessary to check for stable production of each membrane 
protein by western blotting, and to find induction levels for each which ensured protein 
production comparable to the native level produced by the S. aureus RN6390 wild type strain. 
The S. aureus RN6390 wild type strain was therefore included as a control, alongside the single 
deletion strains lacking esaA, essA, essB or essC each producing the cognate plasmid-encoded 
protein. Each single deletion strain harbouring the empty pRMC2 vector was used as a negative 
control.  
In the first step, different induction levels were tested by adding between 25 ng/ml and  
200 ng/ml ATc to cultures of these strains. After an OD600 of 2.0 was reached, cells were 
harvested, lysed with Lysostaphin and immunoblotted using polyclonal antisera raised to the 
appropriate protein. In Figure 3.4 it can be seen that while 50 ng/ml ATc was required to give 
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approximately native level expression of EsaA, 25 ng/ml ATc was sufficient to produce native 
levels of the EssB and EssC variants. Detection of the EssA protein via immunoblot was not 
possible due to the poor quality of the antiserum (Data not shown). 
 
 
Figure 3.4: Immunological detection of the plasmid-encoded His-tagged proteins EsaA-His, EssB-His and 
EssC-His. 10 µl of whole cell samples were loaded on a bis-Tris gel containing either 8 % (for EsaA and 
EssC) or 10 % (for EssB) acrylamide. For immunological detection polyclonal antibodies raised against the 
purified proteins were used. 
 
3.3.2 Testing the activity of the ESS machinery after complementation with the His-
tagged proteins 
Once an induction level restoring approximately wild type production of EsaA, EssB and EssC 
was found, it was next tested if the His-tagged proteins retained activity. It should be noted that 
these experiments were also carried out using the essA mutant strain, even though production 
of a stable EssA protein could not be verified by western blotting, as it was reasoned that if the 
plasmid-encoded variant of EssA is able to rescue the activity of the system it would prove that 
the protein is functionally produced. Cells of each of the esaA, essA, essB and essC mutant 
strains, producing the cognate plasmid-encoded His-tagged protein, were grown to an OD600 of 
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2.0 in the presence of ATc and separated into culture supernatant (sn) and cellular fractions (c). 
Samples were then immunoblotted against the T7SS secreted proteins EsxA and EsxC.  
Neither EsxA nor EsxC was detectable in the supernatant of each of the individual deletion 
strains harbouring the empty pRMC2 vector (Figure 3.5). However, reintroducing the plasmid-
encoded His-tagged protein could rescue T7 secretion activity in each case, as the secreted 
proteins EsxA and EsxC could be identified by immunoblot in the supernatants of the 
complemented strains (Figure 3.5). While for EsaA and EssB re-introduction of the plasmid-
encoded protein was sufficient to restore secretion activity (Figure 3.5 A and C), WT levels of 
secretion activity could only be restored for EssC after induction with 25 ng/ml ATc, the same 
amount needed for approximately WT production of the protein (Figure 3.5 D). The secretion 
activity of the system could also be restored after re-introduction of the plasmid-encoded 
variant of EssA although only after induction of the protein production with a final concentration 
of 100 ng/ml ATc (Figure 3.5 B). In each of these experiments the cytosolic protein TrxA was 
used as a negative control and its detection only in the cell samples indicates that there is no 
lysis of the cells and the detection of the proteins EsxA and EsxC in the supernatant is due to 
secretion (Figure 3.5). 
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Figure 3.5: Plasmid-encoded EsaA-His, EssA-
His EssB-His and EssC-His support secretion 
of EsxA and EsxC. The RN6390 WT strain 
together with the isogenic deletion strains 
esaA, essA, essB or essC harbouring the 
empty pRMC2 vector (∆esaA, ∆essA, ∆essB, 
∆essC, respectively) or pRMC2 encoding a 
His-tagged variant of the indicated gene 
(∆esaA pesaA, ∆essA pessA, ∆essB pessB, 
∆essC pessC) were grown in TSB medium. 
After reaching an OD600 = 0.5 cultures 
harbouring the pRMC2 vector encoding a 
His-tagged variant were supplemented with 
ATc to a final concentration of 25 ng/ml for 
EssB and EssC(∆essB pessB++, ∆essC pessC++),  
50 ng/ml for EsaA (∆esaA pesaA++) and  
100 ng/ml for EssA (∆essA pessA++) to induce 
plasmid-encoded protein production. An 
equivalent of 200 µl of culture supernatant 
(sn) and 10 µl of resuspended cell sample (c) 
adjusted to an OD600 = 1.0 were separated on 
a bis-Tris gel containing 15 % acrylamide and 
immunoblotted using the Anti-EsxA or Anti-
EsxC antisera or a control antiserum raised 
against TrxA. 
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3.3.3 Detection of recombinant proteins using anti-His-tag antibodies 
Since the complementation of the essA mutant with the His-tagged EssA protein could restore 
T7 secretion activity, attempts were made to detect the protein using anti-His-tag antisera. Cells 
of the RN6390 WT strain together with essA deletion strain either producing the plasmid-
encoded protein or harbouring the empty pRMC2 vector were grown to an OD600 = 2.0 in the 
presence of 100 ng/ml ATc, harvested and treated with Lysostaphin as described earlier. To also 
confirm the presence of the His-tag for the other membrane components esaA, essB and essC 
deletion strains carrying the plasmid-encoded His-tagged variants were also used, together with 
esaA, essB or essC strains harbouring the empty pRMC2 vector. Cells of these strains were grown 
under the same conditions as described for EssA using the same concentration of ATc required 
to restore protein production to an approximately WT level (Section 3.3.1). Cells were separated 
on bis-Tris gels followed by immunoblotting with anti His-tag antibodies.  
Unfortunately none of the whole cell fractions gave obvious cross-reacting bands with the anti 
His-tag antiserum (data not shown). Therefore membrane fractions of each strain were 
prepared, separated on bis-Tris gels and immunoblotted. As seen in Figure 3.6 the presence of 
the His-tag could only be confirmed on the EssB protein (Figure 3.6 C). However, the signal was 
not as strong as that detected using the native EssB antiserum (compare upper and lower 
panels). For EssC only a faint band could be detected when blotting against the His-tag, barely 
visible above the background (Figure 3.6 D). For EsaA detection of the His-tag was not possible 
while for EssA neither the protein itself nor the His-tag could be detected by immunoblot (Figure 
3.6 A and B). 
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Figure 3.6: Immunological detection of the His-tagged Ess proteins. Membrane fractions were prepared 
from strain RN6390 WT or the isogenic esaA, essA, essB or essC deletion strains, either harbouring the 
empty pRMC2 vector (lanes labelled ∆esaA, ∆essA, ∆essB, ∆essC, respectively) or pRMC2 overproducing 
a His-tagged variant of the indicated gene (∆esaA pesaA++, ∆essA pessA++, ∆essB pessB++, ∆essC pessC++). 
10 µg of total membrane protein was loaded on a bis-Tris gel containing 8 %, 10 % or  
15 % acrylamide for the detection of EsaA and EssC, EssB or EssA, respectively. The upper panels are 
Western blots using polyclonal antisera raised against the specific protein. The lower panels are Western 
Blots using a monoclonal anti His antibody (Abcam).  
 
3.4 solubilisation of the Ess membrane proteins 
3.4.1 Identification of detergents able to extract Ess proteins from the membrane of 
S. aureus 
Initial analysis of the ESX-5 secretion system membrane complex used BN PAGE analysis of 
membrane fractions of M. marinum and M. bovis BCG (Houben et al., 2012). BN PAGE analysis 
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is widely used when studying membrane complexes as it is possible to maintain the native 
protein conformation. In standard SDS gels SDS denatures and binds to the proteins, conferring 
a negative charge which allows the proteins to migrate towards the positively charged electrode. 
In BN PAGE coomassie blue dye is used instead of SDS. This also binds to the proteins, resulting 
in a negative charge, but contrary to SDS keeps the proteins in their native state. The absence 
of SDS in the gels and running buffer makes it necessary to solubilise the bacterial membrane in 
advance. The first step was therefore to identify a detergent that would effectively solubilise the 
ESS membrane proteins. To this end, membrane fractions of the RN6390 WT strain were 
prepared and solubilised using six different detergents. The results are shown in Figure 3.7.  
 
 
Figure 3.7: Detergent solubilisation of S. aureus membrane proteins. The six indicated detergents were 
tested for the efficiency to solubilise total membrane protein. 400 µg of total protein were solubilised 
using 2 % of the indicated detergent by incubation for 2 h at RT with vigorous stirring. To remove insoluble 
material the samples were centrifuged at 89 000 x g for 20 min at 4 °C. 10 µl of the supernatant (sn) 
together with 10 µl of the resuspended high-speed-pellet (HSP) were then separated on bis-Tris gels 
containing 12 % acrylamide. LDAO: Lauryldimethylamine oxide; DDM: n-dodecyl-β-D-maltoside. 
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Deoxycholate and Triton-X-100 are detergents that have already been used in other experiments 
when working with S. aureus (Burts et al., 2008). As shown in Figure 3.7 A, these detergents, 
together with Digitonin, were partly successful at solubilising proteins from the S. aureus 
membrane. Approximately half of the total membrane proteins could be extracted by these 
detergents as the amount of protein in the detergent extracted supernatant was roughly the 
same as in the unextracted membrane (high-speed pellet). Comparing these three detergents 
showed that Triton-X-100 was most successful in solubilisation of the membrane proteins as 
more proteins could be found in the supernatant than when solubilising with Deoxycholate or 
Digitonin. N-Dodecyl β-D-maltoside (DDM) and Lauryldimethylamine oxide (LDAO) apparently 
failed to efficiently extract any protein from the membrane, since almost no distinguishable 
protein bands were found in the supernatant following detergent treatment (Figure 3.7 B), 
instead large smears were observed. However, comparing these two detergents with Digitonin, 
Triton-X-100 and Deoxycholate it was noticeable that the amount of protein found in the high-
speed pellet was lower after solubilisation with LDAO or DDM than after the partial solubilisation 
with Digitonin, Triton-X-100 or Deoxycholate (Figure 3.7 A and B). Usually smeary gels are an 
indicator for overloading or degradation of the protein. Since the samples were not boiled prior 
loading it is possible that a problem in handling the samples resulted in the smearing observed 
with these detergents. The sixth detergent, Fos-Choline 12, appeared to be the most successful 
detergent since no protein was found in the high-speed pellet after the solubilisation and all of 
the protein appeared in the supernatant (Figure 3.7 C).  
 
3.4.2 Identification of detergents able to solubilise the target proteins EsaA, EssB and 
EssC 
Since Digitonin, Triton-X-100, Deoxycholate and Fos-Choline-12 were able to cleanly solubilise 
proteins from the S. aureus RN6390 membrane, it was next tested whether these detergents 
were able to extract the target proteins EsaA, EssB and EssC. DDM was also included in these 
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experiments even though it had resulted in smearing previously. 5 µg of solubilised protein (sn) 
and an equal amount of insoluble fraction (HSP) were separated on bis-Tris gels followed by 
immunoblotting against antisera raised against EsaA, EssB and EssC. Figure 3.8 shows the results 
for the solubilisation of EsaA.  
 
 
Figure 3.8: Detergent extraction of EsaA. Membrane fractions were treated with 2 % of the indicated 
detergent followed by centrifugation for 20 min at 89 000 x g to remove solubilised (sn) and insoluble 
material (HSP). 5 µg of total protein were loaded on a bis-Tris gel containing 8 % acrylamide and 
subsequently transferred on a nitrocellulose membrane followed by immunological detection of EsaA.  
 
Given that Digitonin, Triton-X-100 and Deoxycholate were able to successfully solubilise a range 
of S. aureus membrane proteins (Figure 3.7), it is perhaps not surprising that each of these 
detergents could also solubilise EsaA, since the antigen could be detected in the supernatant as 
well as in the high-speed pellet after treatment with each of these (Figure 3.8 A – C). The 
coomassie-stained gels in Fig 3.7 suggested that Triton-X-100 was the most successful detergent 
among these three as more proteins could be detected in the supernatant than in the high-
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speed pellet. However, looking at the Western blots for EsaA, Triton-X-100 seems to be the least 
successful detergent as less EsaA could be detected in the soluble fraction after treatment of 
the membrane with this detergent compared to the amount of EsaA in the supernatant when 
treated with Digitonin or Deoxycholate. Surprisingly DDM was able to extract all of EsaA from 
the membrane (Figure 3.8 D) even though the coomassie stained gel in Fig 3.7 did not show any 
discrete protein bands in the soluble fraction. Fos-Choline-12 was deemed to be the most 
promising detergent following coomassie staining for total extracted protein (Figure 3.7), and it 
was clearly able to extract most of the EsaA protein from the membrane (Figure 3.8 E).  
Similar results were also seen when immunoblotting for detection of EssB. Digitonin, Triton-X-
100 and Deoxycholate were partially successful in solubilising this protein as approximately half 
of the EssB was detected in the soluble fraction (Figure 3.9 A – C). Contrary to EsaA, Triton-X-
100 seemed to be the most successful among these three detergents as more EssB protein could 
be detected in the supernatant than in the high-speed pellet (Figure 3.9 B). Fos-Choline-12 
proved even better at extracting EssB, and most of the protein was found in the soluble fraction 
with almost no EssB left in the unextracted membrane (Figure 3.9 E). Again, however, the best 
result was observed for using the detergent DDM, which was able to extract all of EssB (Figure 
3.9 D).  
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Figure 3.9: Detergent extraction of EssB. Membrane fractions were treated with 2 % of the indicated 
detergent followed by centrifugation for 20 min at 89 000 x g to remove solubilised (sn) and insoluble 
material (HSP). 5 µg of total protein were loaded on a bis-Tris gel containing 10 % acrylamide and 
subsequently transferred on a nitrocellulose membrane followed by immunological detection of EssB. 
 
Different behaviour of these detergents was seen, however, when immunoblotting for EssC. 
While Digitonin, Triton-X-100 and Deoxycholate were able to solubilise at least 50 % of EsaA and 
EssB, none of the detergents were able to solubilise comparable amounts of EssC (Figure 3.10 A 
– C). In fact, EssC could only be detected in the soluble fraction when the membrane was treated 
with Digitonin while none of the protein could be extracted from the membrane by using either 
Triton-X-100 or Deoxycholate. Also in contrast to EsaA and EssB, are the results obtained using 
DDM. While DDM was able to solubilise 100 % of EsaA and EssB, all of EssC remained in the 
membrane (Figure 3.10 D). The best result for EssC extraction was achieved when using Fos-
Choline-12 as it was able to extract between 50 and 100 % of the EssC present in the membrane 
(Figure 3.10 E).  
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Figure 3.10: Detergent extraction of EssC. Membrane fractions were treated with 2 % of the indicated 
detergent followed by centrifugation for 20 min at 89 000 x g to remove solubilised (sn) and insoluble 
material (HSP). 5 µg of total protein were loaded on a bis-Tris gel containing 8 % acrylamide and 
subsequently transferred on a nitrocellulose membrane followed by immunological detection of EssC. In 
E. two separate experimental extractions with Fos-Choline-12 are shown. 
 
3.5 complex formation under native conditions 
With Fos-Choline-12 being the only detergent able to extract reasonable levels of all three 
proteins from the membrane, the next step was to test whether they are part of the same 
complex by carrying out BN PAGE. Samples were solubilised with 2 % Fos-Choline-12 followed 
by a centrifugation step to separate the soluble from the insoluble material. Extracted protein 
was then separated on gels containing a gradient of 4 – 16 % acrylamide and blotted using 
antibodies raised against EsaA, EssB and EssC.  
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Figure 3.11: Blue native PAGE analysis of EsaA-, EssB- and EssC-containing complexes. Membrane 
fractions from the RN6390 WT strain or the indicated deletion mutant were prepared and solubilised using 
2 % Fos-Choline-12. An equivalent of 5 µg of total membrane protein of the solubilised material was 
loaded on a BN gel containing a gradient of 4 – 16 % acrylamide. Subsequently the proteins were 
transferred on a PVDF membrane followed by immunological detection of the membrane proteins EsaA, 
EssB and EssC. 
 
Figure 3.11 A shows that two separate complexes could be detected that contained EsaA. One 
of these migrates close to the 150 kDa marker and one just above the 200 kDa marker. These 
same complexes are still detected when any of essA, essB or essC are deleted and therefore 
most likely do not contain any of the other ESS membrane proteins. Since the size of EsaA is 114 
kDa, these two bands could potentially correspond to monomers and dimers of EsaA.  
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Contrary to analysis of EsaA, only a single band was detected for EssB that migrated between 
the 66 kDa and 150 kDa marker (Figure 3.11 B). This band did not migrate at the same position 
as the complexes containing EsaA and it therefore seems unlikely that the two proteins are in 
the same complex following Fos-Choline-12 extraction. Moreover the same EssB-containing 
complex could be identified from strains lacking esaA, essA or essC indicating that none of the 
encoded proteins are found within this EssB complex. With a calculated size of 52 kDa for an 
EssB monomer, this band could correspond to an EssB dimer which would be consistent with 
the literature, where EssB from Geobacillus thermodenitrificans is able to form homo-dimers 
(Zoltner et al., 2013a; Zoltner et al., 2013b).  
For EssC only one band could be detected, running just above the 150 kDa marker (Figure 3.11 
C). The same complex could be detected when analysed from cells lacking EsaA, EssA or EssB. 
EssC has a size of 170 kDa so this band could correspond to an EssC monomer. However, a fainter 
band of similar size was also detectable in membranes extracted from the essC deletion strain 
which leads to the conclusion that the signal may not correspond to EssC.  
 
3.6 Discussion 
3.6.1 EsaA, EssA, EssB and EssC are essential for T7SS activity. 
In this Chapter, His-tagged variants of the core T7SS membrane proteins EsaA, EssA, EssB and 
EssC have been constructed. To prevent potential proteolysis by extracellular proteases, the tag 
was introduced onto a cytoplasmic facing terminus of each protein. It was shown that the 
plasmid-encoded tagged variants retained activity because they restored T7 secretion to a strain 
lacking the native copy of each protein. The findings presented here are in accordance with the 
prior literature where it was shown that EssA, EssB and EssC are essential for secretion in the S. 
aureus Newman strain and EsaA additionally also for the secretion in the RN6390 strain of S. 
aureus (Burts et al., 2005; Kneuper et al., 2014).  
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Surprisingly, despite confirming by DNA sequencing of the constructed plasmids that the tag 
sequence should be present on each protein, it was only possible to confirm the presence of the 
His-tag on EssB by Western blot (Figure 3.6). The reason for this is not clear. One explanation 
could be that the tags are cleaved off after protein production by cytoplasmic proteases. 
Previous work from Dr Holger Kneuper involved adding different tags at different positions of 
EssC, including His-, and also single or double Strep-tags onto the N-terminus as well as the C-
terminus of the protein. In agreement with the work presented here, none of those tags could 
be detected immunologically, again for reasons that are unclear. 
 
3.6.2 EsaA, EssA, EssB and EssC are not part of the same complex following Fos-
Choline-12 membrane extraction 
As a pre-requisite to purifying ESS membrane complexes, it was necessary to solubilise the S. 
aureus membrane. Six detergents were tested for this purpose, of which three were non-ionic 
(DDM, Triton-X-100 and Digitonin), two zwitterionic (LDAO and Fos-Choline-12) and one was 
ionic (Deoxycholate). EsaA and EssB could be partially membrane extracted with Deoxycholate, 
whereas this detergent did not solubilise EssC. From the three non-ionic detergents used, Triton-
X-100 and Digitonin were able to extract approximately 50 % of the total EsaA and EssB protein 
while there was 100 % extraction of each of these using DDM. All three of these detergents 
failed to solubilise the third membrane protein, EssC. This is particularly striking since DDM was 
used to isolate the 1.5 mDa complex of the distantly related ESX-5 secretion system of M. 
marinum which consists of four membrane proteins, including the EssC homologue EccC 
(Houben et al., 2012; Beckham et al., 2017). The zwitterionic detergents LDAO and Fos-Choline-
12 showed very different abilities to extract the Ess proteins although sharing a high similarity 
in their structure (Figure 3.2). While LDAO failed to solubilise any proteins from the S. aureus 
membrane, Fos-Choline-12 was the only detergent able to successfully solubilise 50 % - 100 % 
of each of the target membrane proteins. In contrast to LDAO Fos-Choline-12 contains a 
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phosphate group (Figure 3.12) which could have a more stabilising effect on the protein during 
the solubilisation process making this detergent more successful compared to LDAO. The ability 
of S. aureus to produce lysyl-phosphatidylglycerol (Lys-PG) could also have an effect on the 
efficiency of detergents. Properties of membrane proteins are usually modulated by interactions 
with the head groups of membrane lipids. Lys-PG partially neutralises the membrane surface 
charge with an impact on the protein-lipid head group interaction (Sievers et al., 2010) which 
could also explain why only the zwitterionic Fos-Choline-12 is able to extract all target 
membrane proteins while DDM was sufficient to solubilise proteins from M. marinum.  
That no interaction could be seen in between the different proteins may potentially lie in the 
detergent used. Fos-Choline-12 is a zwitterionic detergent and these detergents are known to 
be more deactivating than non-ionic detergents. It should be noted that demonstration of 
complex formation for the ESX-5 secretion system in M. marinum employed DDM for 
solubilisation of the membrane proteins (Houben et al., 2012; Beckham et al., 2017).  
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4.1 Introduction 
As discussed in Chapter 3, no heteromeric interactions between the Ess membrane proteins 
could be detected following their extraction from the membrane with detergent. One possible 
explanation for this could be that Fos-Choline-12, the only detergent identified that was able to 
solubilise the EsaA, EssB and EssC membrane components, may disrupt interactions between 
the proteins. Chemical crosslinking has long been used as a tool for studying protein complexes. 
Chemical crosslinkers induce the formation of a covalent bond between two nearby residues 
within one or more polypeptide chains (Back et al., 2003; Leavell et al., 2004). The covalent bond 
is formed as the result of the attachment of a functional group onto the target protein by the 
reactive group of the crosslinking reagent.  
Several features have to be considered when choosing a suitable crosslinking reagent. Most 
important are the spacer arm length, water-solubility, and cell membrane permeability. The 
spacer arm length may provide some information about the proximity between conjugated 
proteins. For example, if the conjugation of two proteins is successful with the use of a 
crosslinking reagent having a long spacer arm but not with a shorter crosslinking reagent the 
proteins might be located in the same part of the membrane but not directly interacting. Only a 
successful conjugation of two proteins with a crosslinking reagent containing a short spacer arm 
provides evidence about intimate contact between the proteins. The spacer arm length also 
gives information about water-solubility and consequently about the cell membrane 
permeability. The spacer region is often comprised of alkyl chains which means the longer the 
spacer the more hydrophobic and therefore water-insoluble and membrane permeable the 
crosslinking reagent (Leitner et al., 2010). For the investigation of integral membrane proteins a 
water-insoluble crosslinker is therefore more suitable as it is able to penetrate the cell 
membrane. Another important aspect in the choice of a suitable crosslinking reagent is the 
reactive group of the targeted proteins, as only a small number contains selectable targets for 
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chemical crosslinking. Table 4.1 gives an overview over protein targets which are suitable for the 
majority of crosslinking reagents.  
 
Table 4.1: Reactive groups for protein conjugation.  
Group target functional group occurrence 
Primary amines -NH2 at the N-terminus of each polypeptide chain; in the side 
chain of lysine residues 
Carboxyls -COOH at the C-terminus of each polypeptide chain; in the side 
chain of aspartic acid and glutamic acid 
Sulfhydryls -SH in the side chain of cysteine 
Carbonyls -CHO created by oxidising carbohydrate groups in 
glycoproteins 
 
Crosslinking reagents targeting sulfhydryls are very specific with the need for two cysteines 
located within close proximity on the protein surface. Therefore disulphide crosslinkers are 
mainly used for detailed studies of protein interaction in complexes that have already been 
identified by other methods (Kneuper et al., 2012; Rollauer et al., 2012; Cléon et al., 2015; Huang 
et al., 2017).  
More suitable for the investigation of a possible interaction between less well studied proteins 
are crosslinking reagents targeting primary amines. Primary amines are present in each 
polypeptide chain and are often outward facing which makes them more accessible for 
conjugation (Back et al., 2003). Candidates for crosslinking reagents targeting primary amines 
are bis(sulfosuccinimidyl)suberate (BS3), dithiobis(succinimidyl propionate) (DSP) and 
disuccinimidyl suberate (DSS). All three products belong to the so called NHS esters and have a 
spacer arm length of 11.4 – 12 Å. BS3 contains a hydrophilic sulfonyl component, whereas DSP 
and DSS are water-insoluble and therefore cell membrane permeable. The covalent bond is 
generated as the N-hydroxysuccinimide (NHS) group of the crosslinking reagent reacts with 
primary amines of the target protein. The reaction is shown in Figure 4.1.  
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Figure 4.1: Reaction Scheme for chemical conjugation of a NHS ester to a primary amine. (R): crosslinking 
reagent having the NHS ester reactive group; (P): Protein containing the primary amine group. 
 
Another crosslinking reagent targeting primary amines is formaldehyde. It is the smallest 
aldehyde which reacts with proteins in a two-step mechanism. In the first step the nucleophilic 
group of an amino acid forms a covalent bond with formaldehyde which results in a methylol 
adduct converting into a Schiffs base. In the second step this Schiffs base stabilises crosslink 
formation by binding another functional group of an additional protein through a methylene 
bridge (Hoffman et al., 2015). The small size and its ability to permeate biological membranes 
without the use of chemical solvents makes formaldehyde a preferred crosslinking reagent for 
investigating interaction between proteins in vivo (Sutherland et al., 2008). Additionally 
formaldehyde is known to ‘freeze’ protein complexes in a native state which makes it possible 
to crosslink dynamic complexes (Vasilescu et al., 2004; Sutherland et al., 2008) 
 
4.1.1 Dynamic complex formation in protein secretion systems 
Protein secretion systems are often dynamic and only adopt their active configuration upon 
interaction with a substrate. A good example of this can be seen with the twin-arginine 
translocation (Tat) protein export system. In E. coli the Tat machinery consists of three main 
components: TatA, TatB and TatC (Bogsch et al., 1998; Sargent et al., 1998; Weiner et al., 1998; 
Sargent et al., 1999). TatB and TatC are known to form a hetero-oligomeric membrane-bound 
complex that acts as the receptor for substrate proteins, which are targeted to the pathway with 
the aid of specific N-terminal signal peptides. Tat signal peptides contain a conserved ‘S-R-R-x-
80 
_____________________________________________________________________________________ 
_____________________________________________________________________________________ 
Chapter 4 – Probing interactions between the Ess membrane components by chemical crosslinking 
F-L-K twin-arginine’ motif, giving the transport system its name, that is specifically recognised 
by TatC (Alami et al., 2003). The translocation pore is formed by the third protein, TatA. It could 
be shown that substrate binding to the TatBC complex results in the association of TatA with the 
complex, where it subsequently multimerises to form channel-like structures (Mori and Cline, 
2002; Alami et al., 2002; Alcock et al., 2013). Crosslinking of TatA to the TatBC complex is 
dependent on the pmf and the presence of a bound substrate, and only persists until the 
substrate is translocated across the membrane (Mori and Cline, 2002; Alami et al., 2003; 
Dabney-Smith and Cline, 2009). Following substrate translocation TatA disassembles and the Tat 
system returns to the resting state. A full model of the Tat transport cycle is shown in Figure 4.2. 
 
 
Figure 4.2: The Tat protein transport cycle. Top: The TatBC complex and dispersed protomers of TatA 
form separated assemblies under resting conditions. 1: Binding of a substrate to the TatBC complex via 
its twin arginine signal peptide. 2: pmf-dependent interaction of the TatA protomers with the substrate-
bound TatBC complex to form a transport channel. 3: Translocation of the substrate across the membrane 
through the transport channel formed by TatA. It is not clear whether the pmf is also required at this step. 
4: The transported substrate is released and the signal peptide cleaved off. The TatBC complex and TatA 
multimers dissociate back into the resting state. Adapted from Palmer et al. (2010) and Palmer and Berks 
(2012).  
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4.2 Aim 
The results presented in Chapter 3 indicate that EsaA and EssB form homomeric complexes 
following detergent extraction but interactions with other components of the Ess machinery 
could not be shown. The aim of this chapter was to investigate interactions between the Ess 
membrane components in the native environment, both in vitro and in vivo, using chemical 
crosslinking. 
 
Results 
4.3 In vitro crosslinking studies using DSS 
Firstly, experiments were carried out in vitro using isolated membranes, and crosslinking was 
carried out using DSS, which crosslinks exposed primary amine-containing residues with a 
preference for lysine. Membrane fractions were prepared from the RN6390 WT strain, from the 
esaA, essA, essB and essC isogenic deletion strains and from the isogenic deletion strains that 
had been complemented with a plasmid-encoded copy of the missing gene (see Section 2.9.7.1). 
For each sample, 30 µg of total membrane protein were incubated with a final concentration of 
2 mM DSS for 30 min after which the reactions were quenched with Tris-HCl and then analysed 
by immunoblot using antibodies raised against the membrane proteins EsaA, EssB and EssC. An 
untreated membrane sample from each strain/plasmid combination was also loaded as a 
negative control (Figure 4.3). 
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Figure 4.3: DSS crosslinking of the Ess membrane components in vitro. Membrane fractions of the 
RN6390 WT strain together with the isogenic deletion strains harbouring the empty pRMC2 vector (∆esaA, 
∆essA, ∆essB, ∆essC) or pRMC2 overproducing a His-tagged variant (∆esaA pesaA++, ∆essA pessA++, ∆essB 
pessB++, ∆essC pessC++) were prepared and treated with DSS as described in Section 2.9.7.1. After 
incubating with 2 mM DSS crosslinker for 30 min at RT the reaction was quenched by adding Tris/HCl, pH 
8.0 (final concentration of 100 mM). 1 µg of total membrane protein was loaded on a bis-Tris gel 
containing 8 % acrylamide when blotting against EsaA or EssB (A and B, respectively) or SDS gel containing 
5 % acrylamide when blotting against EssC (C). For immunological detection polyclonal antibodies raised 
against the proteins were used. Crosslinked products are indicated with an asterisk; nonspecific bands 
detected with the EsaA antiserum are marked with an open triangle.  
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It can be seen in Fig 4.3 A that native EsaA was detected in membranes derived from the WT 
strain as well as each of the essA, essB and essC deletion strain backgrounds, indicating that it is 
stably produced in the absence of each of these Ess components. No higher molecular weight 
bands could be detected in the presence of the DSS crosslinker in membrane fractions from any 
of these strains, or when EssA, EssB or EssC was overproduced. Only a dark smear of EsaA-
containing material was visible in the crosslinked sample containing overproduced EsaA (Figure 
4.3 A).  
Similar findings were obtained when blotting against EssB (Fig 4.3 B). Monomeric EssB could be 
detected in the WT strain as well as in the strains lacking either esaA, essA or essC showing that 
the protein is stably produced in the absence of other Ess membrane components. No higher 
molecular weight crosslinked products could be detected from membranes of any of these 
strains, or these strains overproduced plasmid-encoded variants of EsaA, EssA or EssC. 
Crosslinking of membranes containing overproduced EssB also did not result in any higher 
molecular weight crosslinked products, contrary to the dimerization observed on BN PAGE. It 
may be that EssB lacks suitably juxtaposed lysine residues that can crosslink with DSS. Indeed, 
the only notable difference for this sample is that the plasmid encoded variant of EssB migrates 
slightly higher on SDS PAGE than in the other samples, due to the added His-tag.  
Fig 4.3 C shows that it was possible to detect EssC monomers in membranes of the RN6390 WT 
strain and in membranes of the isogenic deletion strains of esaA, essA and essB or the strains 
encoding a His-tagged variant of EsaA or EssB. Contrary to the observations with EsaA and EssB, 
the monomer of EssC disappeared in the DSS treated samples and a higher molecular weight 
band was generated that cross-reacted with the EssC antibody. The crosslinked band migrates 
above the 460 kDa marker in membrane fractions of the WT as well as the esaA, essA and essB 
deletion strains indicating that EssC forms homomeric complexes and does not appear to 
interact with any of the other membrane components of the Ess machinery (Figure 4.3 C). 
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4.4 In vivo crosslinking studies using PFA 
The in vitro crosslinking analysis using DSS revealed very few detectable interactions. However, 
in these experiments, the proton-motive force, ATP and soluble proteins are lacking, and any of 
these factors may influence the behaviour of the Ess components. Therefore similar 
experiments were next carried out under in vivo conditions, in whole cells using 
paraformaldehyde (PFA) as a crosslinker, which also crosslinks amine residues (but with a much 
shorter spacer arm). Cultures of the RN6390 WT strain, the esaA, essA, essB and essC isogenic 
deletion strains and the isogenic deletion strains that had been complemented with a plasmid-
encoded copy of the missing gene were grown to an OD600 = 1.0. Cells were harvested, washed 
in 1 x PBS and incubated with a final concentration of 0.6 % PFA for 30 min. After quenching the 
reaction with 100 mM Tris/HCl, pH 8.0, membrane fractions were prepared as described in 
Section 2.9.1.3 and immunoblotted using antibodies raised against EsaA, EssB and EssC. Once 
again, an untreated sample of each strain/plasmid combination sample was kept as a negative 
control.  
Interestingly, in vivo crosslinking with PFA gave different results for EsaA than the in vitro 
incubation with DSS. Fig 4.4 A shows that four or five discrete EsaA-containing bands at or above 
the 250 kDa marker could be detected for the WT strain. Similar high molecular weight 
crosslinked bands could be also detected in the samples where EssA, EssB or EssC is absent, 
indicating that the crosslinked products are unlikely to contain any of these proteins (Figure 4.4 
A).  
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Figure 4.4: PFA crosslinking of the Ess membrane proteins in vivo. The RN6390 WT strain together with 
the isogenic deletion strains harbouring the empty pRMC2 vector (∆esaA, ∆essA, ∆essB, ∆essC) or pRMC2 
overproducing a His-tagged variant (∆esaA pesaA++, ∆essA pessA++, ∆essB pessB++, ∆essC pessC++) were 
treated with PFA as described in Section 2.9.7.2. Following quenching, cells were lysed and membrane 
fractions prepared. 1 µg of total membrane protein was loaded on a bis-Tris gel containing  
8 % acrylamide when blotting against EsaA or EssB (A and B, respectively) or 2 µg on a SDS gel containing 
5 % acrylamide when blotting against EssC (C). For immunological detection polyclonal antibodies raised 
against the proteins were used. Crosslinked products are indicated with an asterisk; nonspecific bands 
detected with the EsaA antiserum are marked with an open triangle. 
 
86 
_____________________________________________________________________________________ 
_____________________________________________________________________________________ 
Chapter 4 – Probing interactions between the Ess membrane components by chemical crosslinking 
In vivo crosslinking of EssB yielded similar results to the in vitro crosslinking experiments, with 
only monomers of EssB being detected. Only the sample in which EssB is overproduced showed 
a very faint crosslinked product running at the approximate size of an EssB dimer, which would 
be in agreement with the findings from BN PAGE (Figure 4.4 B). Similar to the in vitro crosslinking 
analysis, crosslinking in vivo also resulted in high molecular weight products for EssC. However, 
while in vitro there was only one major crosslinked product seen, the in vivo crosslinking resulted 
in at least two distinct high molecular weight bands, both of them migrating above the 460 kDa 
molecular weight marker. Notably, these bands also appeared in the absence of EsaA, EssA or 
EssB indicating that neither of the two crosslinking products arise from interaction of EssC with 
any of the other core components of the Ess system, and therefore likely represent homo-
multimeric forms of EssC (Figure 4.4 C).  
 
4.4.1 Crosslinking of EssC in the absence of Ess substrates 
The multimerisation of EssC seen here by crosslinking is in accordance with findings reported in 
the literature where hexamerisation could be shown for S. aureus EssC (Zoltner et al., 2016) as 
well as for the homologue in Actinobacteria, EccC (Rosenberg et al., 2015), with the latter study 
indicating that multimerisation occurs upon binding of a substrate. Thus, Rosenberg et al. (2015) 
showed that the interaction of purified EccC with the small substrate protein EsxB induces the 
formation of EccC multimers, whereas interaction of EsxA with the EccC-EsxB complex resulted 
in disassembly of EccC. 
To determine whether the multimerisation of EssC observed in the in vitro and in vivo 
crosslinking experiments was also a result of the presence of EsxA and/or EsxB, the in vivo 
crosslinking reactions were repeated in whole cells of the RN6390 WT strain alongside a strain 
deleted for all 12 genes encoded at the ess locus, including esxA and esxB, either carrying the 
empty pRMC2 vector or the plasmid encoded His-tagged variant of EssC. As a control, the 
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isogenic deletion strain of essC and its plasmid-complemented derivative was also used. Fig 4.5 
shows that, as observed previously, higher molecular weight bands of crosslinked EssC were 
detected in the RN6390 WT strain as well as in the essC deletion strain overproducing the 
plasmid encoded His-tagged variant. Interestingly, the same pattern of bands was also 
detectable when EssC was overproduced in absence of any other Ess component. These results 
indicate that the multimerisation of EssC is independent of any previously identified Ess 
components.  
 
 
Figure 4.5: PFA-mediated crosslinking of EssC in the presence and absence of other Ess components. 
Whole cells of the RN6390 WT strain together with the isogenic ∆esxA – esaG deletion or the isogenic 
essC deletion variant of EssC strain harbouring the empty pRMC2 vector (∆ess and ∆essC, respectively) or 
pRMC2 overproducing a His-tagged variant of EssC (∆ess pessC++ or ∆essC pessC++) were treated with PFA 
as described under 2.9.7.2. After quenching the reaction cells were lysed and membrane fractions 
prepared. 2 µg of total membrane protein was loaded on a SDS gel containing 5 % acrylamide followed by 
immunological detection of EssC. Crosslinked products are indicated with an asterisk. 
 
4.5 Crosslinking studies after overproduction of Ess substrates and soluble 
components  
So far the results have shown that EsaA and EssC form homo-multimeric complexes, with no 
indication of interaction with one another or any other components of the Ess machinery. 
However, as discussed in Section 4.1, for many secretion systems, interactions between 
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components can be transient and may depend on the presence of a substrate protein. If complex 
formation between the Ess membrane components is dependent upon the translocation of a 
substrate it might be possible that under the conditions tested it was not possible to trap a 
translocating complex. In order to maximise the formation of putative assembled complexes, 
crosslinking experiments were repeated in the presence of overproduced substrates.  
 
4.5.1 Probing interaction of EsxA and EsxA-YFP with membrane components of the Ess 
machinery 
As discussed in Chapter 1, EsxA is considered a core component of the Ess machinery that is 
secreted in a T7SS-dependent manner, and therefore is highly likely to interact with one or more 
of the Ess membrane proteins. Purified EsxA crystallises as a homo-dimer (Sundaramoorthy et 
al., 2008), and secreted homo-dimers of the B. subtilis EsxA homologue have been observed 
(Sysoeva et al., 2014).  
Before testing possible interaction of EsxA with the membrane components of the Ess 
machinery, crosslinking experiments were first undertaken to confirm the dimerization of EsxA 
in vivo. Cells of the RN6390 WT strain and strains lacking either esxA or all 12 genes encoded at 
the ess locus harbouring the empty pRMC2 vector or plasmid encoded EsxA were grown to an 
OD600 of 1.0. Supernatant and cells were separated and collected, with the cells being 
subsequently washed in 1 x PBS. Supernatant and cells were then incubated with a final 
concentration of 0.6 % PFA for 30 min. After quenching the reaction, cells were lysed and 
membrane fractions prepared as described in Section 2.9.1.3 this time retaining the cytosol. 
Supernatant and cytosol samples were loaded on a bis-Tris gel followed by immunological 
detection of EsxA.  
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Figure 4.6: in vivo dimerization of EsxA detected by PFA crosslinking. Whole cells of strain RN6390 WT, 
the isogenic ∆esxA – esaG deletion strain (∆ess) together with the isogenic ∆esxA deletion strain, either 
harbouring the empty pRMC2 vector or pEsxA were treated with PFA. Following quenching, cells were 
lysed and membrane fractions prepared. 10 µl of cytosol was loaded on a bis-Tris gel containing 15 % 
acrylamide. Samples were transferred to nitrocellulose membrane and proteins detected using polyclonal 
antibodies raised against EsxA. The apparent EsxA dimer detected in the untreated ∆ess/pesxA sample is 
marked with an asterisk; nonspecific bands detected with the EsxA antiserum are marked with an open 
triangle. 
 
Unfortunately only a faint band was detectable for EsxA in the untreated supernatant samples 
whereas no signal could be detected in the supernatant samples treated with PFA probably due 
to the TCA precipitation after the crosslinking step (data not shown). In the cytosol samples 
strong bands of EsxA could be detected from the WT strain as well as from the strains carrying 
the plasmid encoded variant (Figure 4.6). Much fainter bands at a similar but slightly lower 
apparent mass were also detected from strains lacking esxA, and most likely result from cross-
reaction of the antibody with an unrelated protein. Interestingly, in the ∆ess strain 
overproducing plasmid-encoded EsxA, in the absence of PFA crosslinker, a strong cross-reacting 
band could be detected migrating just above the 20 kDa marker, at the expected size for an EsxA 
dimer. It has been observed previously that some proteins are able to form non-covalent dimers 
that are partially resistant to SDS denaturation (e.g. the membrane-extrinsic domain of TatB (De 
Leeuw et al., 2001)). This EsxA ‘dimer’ band is not detected to the same degree in the wild type 
or ∆esxA strain backgrounds suggesting that a component encoded at the ess locus may be 
involved in modulating the formation of this dimer.  
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Following treatment with PFA, a higher molecular weight band containing EsxA was visible in 
samples of the WT strain or the strains carrying the plasmid-encoded EsxA (Fig 4.6). This band 
migrated slightly below the 20 kDa marker. However, since the same band is detectable in the 
treated sample of the complete ess knockout strain harbouring plasmid encoded EsxA, it is 
unlikely to represent a crosslink of EsxA with another Ess component, and most likely represents 
a covalently crosslinked EsxA dimer. This crosslink migrates slightly faster than the putative EsxA 
dimer species seen in the non-crosslinked sample from the ∆ess/pEsxA strain suggesting that 
crosslinking results in a more compact form of the EsxA dimer.  
After dimerization of EsxA in solution was confirmed, membrane fractions were tested for 
interaction of EsxA with one of the membrane components of the Ess machinery. Membrane 
fractions of the same strains and plasmid combinations used in Fig 4.6 were loaded on a bis-Tris 
gel followed by immunological detection of EsxA and the membrane components EsaA, EssB and 
EssC. When blotting against EsxA only a black smear could be detected in the crosslinked 
samples making it difficult to distinguish between unspecific and cross-reacting bands. Blotting 
against the membrane components EsaA, EssB and EssC resulted in the same crosslinking 
pattern as already described in Figure 4.4. Due to the small size of EsxA it was not possible to 
detect any changes in this crosslinking pattern when crosslinking was carried out in presence or 
absence of EsxA (data not shown). 
Previously, Dr Holger Kneuper constructed a fusion of YFP to the C-terminus of EsxA as a high 
throughput tool to monitor T7 secretion activity. He found that the YFP-tag on EsxA appeared 
to block T7 activity by preventing the secretion of untagged EsxA (Kneuper and Palmer, 
unpublished). These findings imply that EsxA-YFP may negatively interact with the Ess 
machinery, and therefore might be a potentially useful tool to trap complexes of the Ess 
membrane components. 
91 
_____________________________________________________________________________________ 
_____________________________________________________________________________________ 
Chapter 4 – Probing interactions between the Ess membrane components by chemical crosslinking 
Firstly, the initial findings of Dr Kneuper were repeated and extended to examine the secretion 
of the T7 substrate protein EsxC. The RN6390 WT strain carrying the empty pRMC2-YFP vector, 
the untagged EsxA or the YFP-tagged variant of EsxA was utilised, alongside the esxA deletion 
strain carrying EsxA or EsxA-YFP constructs. The ∆ess strain (lacking all 12 genes of the ess locus) 
harbouring the empty vector was used as a negative control. Cultures were grown to an OD600 = 
2.0 and separated into culture supernatant (sn) and cellular fractions (c). An equivalent of 10 µl 
cells adjusted to an OD600 of 1.0 and an equivalent of 200 µl TCA precipitated supernatant were 
separated on a bis-Tris gel and subsequently immunoblotted against EsxA and EsxC (Figure 4.7).  
Wild type EsxA was stably produced in all strains but was absent in the negative control, as 
expected. However, secretion of EsxA was only detectable in the strains not producing the EsxA-
YFP variant (Figure 4.7 A; lower panel), very little was found in the supernatant when cells also 
contained EsxA-YFP. The EsxA-YFP fusion protein also appeared to be secreted (Figure 4.7 A; 
upper panel, Fig 4.7 B). EsxC could also be detected in the cell samples of most of the strains, 
but was absent from the negative control, as expected. Very little EsxC was also seen when the 
cells produced EsxA-YFP as the only EsxA variant. It has been reported that EsxA and EsxC 
interact (Anderson et al., 2013), and it is possible that the YFP tag might block such an interaction 
which could destabilise EsxC. Interestingly, although EsxA-YFP could be secreted, in the presence 
of EsxA-YFP secretion of EsxC appeared to be almost completely blocked (Figure 4.7 C). In these 
experiments TrxA was used as a cytosolic control protein to confirm that detection of proteins 
in the supernatant is due to secretion and not lysis (Figure 4.7 D). 
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Figure 4.7: Overproduction of EsxA-YFP negatively affects T7 secretion. Whole cells of RN6390 WT or the 
isogenic ∆esxA or ess deletion strains harbouring either the empty pRMC2 vector or pRMC2 encoding 
the indicated variants of EsxA were grown in TSB. Cell and supernatant samples were prepared as 
described earlier and separated on bis-Tris gels containing 15 % acrylamide followed by immunological 
detection of (A): EsxA; (B): YFP; (C): EsxC or (D): TrxA. Crosslinking products of EsxA-YFP are marked with 
an asterisk. 
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The blocking of EsxA and EsxC secretion by EsxA-YFP is consistent with this fusion protein 
interacting with the Ess machinery, and slowing down or impeding transport potentially by 
complexing with one or more of the Ess membrane components. To explore this, in vivo 
crosslinking experiments were carried out using the RN6390 WT strain and the isogenic ∆ess and 
∆esxA deletion strains harbouring either the empty pRMC2 vector or the same vector producing 
the YFP-tagged EsxA variant. Whole cells were treated with PFA and membrane fractions 
prepared as described earlier. Proteins were transferred onto a nitrocellulose membrane 
followed by immunoblotting against antibodies to the membrane proteins EsaA, EssB and EssC 
(Figure 4.8). Only a black smear could be detected for EsaA in the PFA treated samples and it is 
difficult to identify possible higher molecular weight bands (Figure 4.8 A). Interestingly, the EssB 
monomer appears to be weaker in the treated samples of the esxA deletion strain compared to 
the WT but again no higher molecular weight bands could be detected in these samples (Figure 
4.8 B). However, considering that the monomer is also weaker following PFA treatment of the 
same strain harbouring the empty pRMC2 vector, this suggests that the YFP-tagged variant of 
EsxA was not the cause of this. Higher molecular weight bands are detectable in the RN6390 WT 
sample and variants of the esxA deletion strain for EssC (Figure 4.8 C). The bands migrate well 
above the 250 kDa marker making it difficult to distinguish between bands only representing the 
previous observed multimerisation of EssC and bands showing a possible interaction with the 
YFP-tagged variant of EsxA.  
To follow up this question the same samples were also blotted against EsxA and the YFP-tag to 
test if the same higher molecular weight bands can be picked up. As it can be seen in Figure 4.9 
higher molecular weight bands running at the approximately same size as in the EssC blot are 
detectable when blotting against EsxA as well as GFP. However, the same band is also detectable 
in the strain deleted of the 12 genes encoded at the ess locus, indicating that this higher 
molecular weight band most likely represents oligomerisation of EsxA rather than an interaction 
with any of the membrane components (Figure 4.9 A + B). 
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Figure 4.8: Formaldehyde mediated crosslinking of EsaA, EssB and EssC in the presence of EsxA-YFP in 
whole cells. Whole cells of strain RN6390 WT, the isogenic ∆esxA – esaG deletion strain (ess) or the 
isogenic esxA deletion strain, either harbouring the empty pRMC2 vector or pEsxA-YFP were treated with 
PFA. Following quenching, cells were lysed and membrane fractions prepared. 1 µg of total membrane 
protein were loaded on a SDS gel containing 10 % acrylamide for the immunological detection of the 
membrane proteins EsaA (A), EssB (B) or EssC (C).  
 
95 
_____________________________________________________________________________________ 
_____________________________________________________________________________________ 
Chapter 4 – Probing interactions between the Ess membrane components by chemical crosslinking 
 
Figure 4.9: Immunological detection of EsxA-YFP. Whole cells of strain RN6390 WT, the isogenic ∆esxA – 
esaG deletion strain or the isogenic esxA deletion strain, either harbouring the empty pRMC2 vector or 
pesxA-YFP were treated with PFA. Following quenching, cells were lysed and membrane fractions 
prepared. 1 µg of total membrane protein were loaded on a SDS gel containing 12.5 % acrylamide for the 
immunological detection of EsxA (A) and YFP (B).Marked with an asterisk is free YFP. 
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4.5.2 Probing interaction of EsaD-YFP with membrane components of the Ess 
machinery 
Previous unpublished work in the Palmer group indicated that producing an inactive variant of 
the soluble T7 substrate protein EsaD (harbouring a point mutation in the nuclease active site) 
with YFP fused at its C-terminus caused S. aureus cells to die (Cao and Palmer, unpublished). This 
observation led to the idea that YFP-tagged EsaD may be too large for the T7 translocation 
channel, potentially resulting in blockage of the system and cell death by ion leakage or futile 
hydrolysis of ATP. If this were the case, then such a ‘suicide substrate’ might be an ideal tool to 
trap active complexes of Ess membrane components. 
To explore this further, it was first necessary to ascertain the threshold of EsaD-YFP after which 
cell death occurs. To this end, the S. aureus RN6390 WT strain was cultured alongside the esaD 
deletion strain and the esaD strain harbouring the plasmid-encoded YFP-tagged variant. Once 
the cultures reached an OD600 = 0.5, those cultures harbouring the plasmid encoded YFP-tagged 
variants of EsaD were supplemented with different concentrations of ATc to induce EsaD-YFP 
production and growth was followed (Figure 4.10).  
As shown in Fig 4.10, the S. aureus RN6390 strain exhibited normal grow behaviour, reaching an 
OD600 = 2.2 after 3 hours. A similar pattern of growth could be seen for both the S. aureus strain 
lacking EsaD, and for the ∆esaD strain harbouring a plasmid encoding esaD-yfp in the absence 
of any inducer. However, upon induction of EsaD-YFP production, a change in growth behaviour 
was seen. Even the lowest concentration of inducer tested (50 ng/ml ATc) caused a slowdown 
in cell growth, with the cells reaching an OD600 = 2.0 after 3.5 hours. When incubated with a 
higher concentration of ATc, cultures only reached an OD600 of 1.3 or 1.4 after 3 hours which 
decreased to OD600 = 1.1 or 1.0 within the next hour. The decline in growth after 3 hours strongly 
suggests that at these levels of induction EsaD-YFP causes cell death. 
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Figure 4.10: Growth of S. aureus producing different levels of EsaD-YFP. Cultures of the indicated strains 
were grown until an OD600 = 0.5 was reached before inducing the production of EsaD-YFP using either 50, 
100, 150 or 200 nm/ml ATc as indicated. Cell growth was monitored over a time of 4 hours and cells 
harvested as soon as they reached an OD600 = 2.0. 
 
To get an idea of the relative amounts of EsaD-YFP in the cells following the different induction 
levels, membrane fractions were prepared and the cytosol retained. Cytosol samples were 
loaded on a bis-Tris gel followed by immunological detection of the YFP-tag. However, no signal 
for EsaD-YFP could be obtained in the cytosol samples (data not shown). To determine whether 
EsaD-YFP was associated with the membranes, membrane fractions were also blotted against 
the YFP-tag using an anti GFP antibody (Figure 4.11). The blot revealed that in samples treated 
with an ATc-concentration of 100 ng/ml or higher a GFP cross-reacting band was detectable 
running at ~100 kDa, close to the expected size for EsaD-YFP. As the induction level was 
increased, additional higher bands were also detected. At the highest concentration of ATc used, 
only a black smear was detectable following western blotting of membranes. Therefore, for 
further experiments a concentration of 150 ng/ml ATc, which gave clearly detectable EsaD-YFP, 
was chosen.  
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Figure 4.11: Detection of EsaD-YFP in membrane samples following different levels of induction. Cells 
were grown and harvested as described in figure 4.10. Membrane fractions were prepared from 5ml 
cultures of cells as described in Section 2.9.1.1 and 10 µg of total membrane protein run on a bis-Tris gel 
containing 10 % acrylamide. Proteins were subsequently transferred onto a nitrocellulose membrane and 
blotted using an anti GFP antibody. Degradation products are marked with an asterisk. 
 
Since the EsaD-YFP fusion protein could be detected in membrane fractions it supported the 
idea that EsaD-YFP might get stuck in the transport channel, causing a blockage of the system 
leading cell death. To investigate this further, and to try and identify which Ess membrane 
protein/s EsaD-YFP might interact with, membrane fractions were prepared from strains lacking 
genes for each one of the membrane components EsaA, EssA, EssB or EssC. Strains deleted for 
chromosomal esaD or all 12 genes of the ess locus were simultaneously used as controls. In each 
case experiments were run in duplicate, with strains carrying either plasmid-encoded YFP alone, 
or pRMC2-EsaD-YFP, in the absence of any chemical crosslinker. The results are shown in Figure 
4.12.  
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Figure 4.12: Analysis of EsaA, EssB and EssC in membranes from strains overproducing EsaD-YFP. 
Membrane fractions of RN6390 WT together with the ∆esaA, ∆essA, ∆essB, ∆essC, ∆esaD and ∆ess 
deletion strains harbouring either pRMC2-YFP or pRMC2-EsaD-YFP were prepared as described in Section 
2.9.1.1 and 5 µg of total protein loaded on a bis-Tris gel containing 10 % acrylamide. Proteins were 
subsequently transferred onto a nitrocellulose membrane followed by immunological detection of the 
membrane components EsaA (A), EssB (B) and EssC (C). Nonspecific bands detected with the EsaA 
antiserum are marked with an open triangle. 
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Western blot analysis for EsaA shows that monomers of EsaA migrating just above the 100 kDa 
marker can be detected in all samples except for the ∆esaA and ∆ess deletion strains (Figure 
4.12 A). Curiously, a strongly cross-reacting band migrating below the 100 kDa marker is 
detected in many of the lanes containing samples overproducing EsaD-YFP. This band is very 
similar in mass to that detected with the GFP antibody in Fig 4.11 and may therefore be this 
fusion being picked up by the polyclonal EsaA antibody for unknown reasons. A faint signal is 
detected running above the 250 kDa marker for samples overproducing the YFP-tagged EsaD 
lacking either EssB or EssC. However, the same signal can be detected in the strain 
overproducing EsaD-YFP lacking EsaA, indicating that this band does not correspond to a 
potential interaction between these two proteins (Figure 4.12 A).  
Western blot analysis for EssB revealed that the EssB monomer is stably produced in all strains 
except for the ∆essB and ∆ess strains, but no higher molecular weight bands were generated in 
the presence of overproduced EsaD-YFP (Figure 4.12 B). Blotting the samples for EssC showed a 
similar result as that seen for EsaA, i.e. a faint signal was detected running above the 250 kDa 
marker in samples derived from strains overproducing EsaD-YFP while lacking either EssA or 
EssB. Again, however, this signal is also detectable in the ∆essC strain indicating that it cannot 
correspond to an interaction between EsaD-YFP and EssC (Figure 4.12 C).  
Since testing the membrane fractions for higher molecular complexes using antibodies raised 
against the Ess membrane components did not give indication of EsaD-YFP interaction with any 
of the membrane proteins, the same samples were re-run and blotted with anti-GFP to detect 
EsaD-YFP. It can be seen in Figure 4.13 that there are several bands detectable in strains 
harbouring EsaD-YFP. The highest band runs above the 250 kDa size marker. However, as this 
band is detectable in all strains individually lacking EsaA, EssA, EssB or EssC, it is unlikely to 
represent EsaD-YFP interacting with any of the Ess membrane proteins. In samples derived from 
strains lacking chromosomally-encoded EsaD or deleted for all 12 genes at the ess locus, bands 
were only detected close to the 50 kDa marker, which is too small for an EsaD-YFP monomer 
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and may correspond to S. aureus protein A (which binds antibodies). No other bands could be 
detected in these samples, suggesting a lack of EsaD-YFP production. It should also be noted 
that these two strains also showed strong growth after induction of EsaD-YFP production, 
whereas the other strains producing plasmid-encoded EsaD-YFP variant grew poorly following 
ATc addition. This raised the possibility that EsaD-YFP was either not being produced or was 
highly unstable in these strain backgrounds. 
 
 
Figure 4.13: Analysis of EsaD-YFP in membranes derived from S. aureus T7 mutant backgrounds. 
Membrane fractions of RN6390 WT together with esaA, essA, essB, essC, esaD and ess deletion 
strains harbouring either pRMC2-YFP or pRMC2-EsaD-YFP were prepared as described in Section 2.9.1.1 
and 5 µg of total protein loaded on a bis-Tris gel containing 10 % acrylamide. Proteins were subsequently 
transferred onto a nitrocellulose membrane followed by immunological detection of EsaD-YFP using an 
anti-GFP antibody. Cross-reaction of the GFP antibody with Protein A is marked with an asterisk. 
 
To investigate this further, each of the strains lacking individual ess genes and harbouring either 
the plasmid-encoded EsaD-YFP variant or a control plasmid encoding YFP alone (pRMC2-YFP), 
were monitored for cell growth and fluorescence over a period of 18 hours. In these 
experiments, cells were grown in 10 ml TSB to an OD600 = 0.5 after which 1 ml of each sample 
was withdrawn. Initiation of EsaD-YFP production was induced by adding 500 ng/ml ATc, 
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whereas no ATc was added to strains harbouring pRMC2-YFP and 150 µl of each sample was 
aliquoted into a 96 well plate to allow simultaneous monitoring of OD600 and fluorescence.  
 
 
 
 
B 
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Figure 4.14: OD600 and YFP fluorescence measurements for the indicated S. aureus strains harbouring 
plasmids encoding YFP or EsaD-YFP. RN6390 WT and strains lacking the individual Ess membrane proteins 
EsaA, EssA, EssB or EssC harbouring either pRMC2-YFP or pRMC2-EsaD-YFP. Cells were grown at 37 °C for 
18 h with regular measurement of OD600 and fluorescence (excitation at 485 nm/ emission at 528 nm) in 
20 min intervals. Culture was shaken for 20 seconds before every read. 
 
Figure 4.14 shows the growth and fluorescence measurements for cultures of the RN6390 WT 
strain and of strains individually lacking one of the membrane components EsaA, EssA, EssB and 
EssC in presence of overproduced EsaD-YFP. Strains harbouring the control pRMC2-YFP vector 
show an increase of cell density over a time of ~16 hours after which they start to reach the 
stationary phase. Strains producing EsaD-YFP showed similar growth as the control strains over 
the first 1.0 - 1.5 hours, after which a pronounced growth lag was seen before growth rate was 
restored after ~9.5 hours. Although strains producing EsaD-YFP also reached stationary phase 
after ~16 hours they did not reach the same final OD600 as strains harbouring pRMC2-YFP. 
Looking at the fluorescence of theses strains it can be seen that all samples tested show an initial 
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level of ~100 000 RFU which decreased to 40 000 RFU within the first hour for strains harbouring 
the vector encoding YFP alone (Figure 4.14 right panel). The WT strain producing pEsaD-YFP 
shows the highest fluorescence of all the strains tested, peaking at ~86 000 RFU after 4.5 to 5.0 
hours (Figure 4.14 B). This strain is also the only one to show a decline in OD600 at that time 
(Figure 4.14 A). 
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Figure 4.15: OD600 and YFP fluorescence measurements for the indicated S. aureus strains harbouring 
plasmids encoding YFP or EsaD-YFP. Cells lacking either of EsaE, EsaD or EsxB, both EsaD and EsaG, or all 
12 genes of the ess locus were grown at 37 °C for 18 h with regular measurement of the relative 
fluorescence unit (RFU) in 20 min intervals. Culture was shaken for 20 seconds before every read. 
 
Next strains lacking individual soluble components encoded at the ess locus were investigated 
in a similar way. Here the strain growth behaviour fell into two distinct patterns (Figure 4.15). 
Strains lacking either of EsaE or EsxB showed a similar slowing of growth upon production of 
EsaD-YFP as the wild type strain or the strains lacking EsaA, EssA, EssB or EssC, and also produced 
very similar fluorescence profiles. By contrast, strains deleted for esaD, esaDG or all 12 genes 
from the ess locus did not show the slowdown of cell growth when EsaD-YFP production was 
induced (Figure 4.15 E, G and I). Instead growth of these strains was very similar to the same 
strains harbouring the pRMC2-YFP control. Moreover, these strains showed a much lower level 
of fluorescence than all of the other strains analysed (Figure 4.15 F, H and J). In fact, fluorescence 
of these strains is more comparable with the fluorescence of the strains harbouring the empty 
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pRMC2-YFP vector and therefore suggests that they indeed do not carry the plasmid or are not 
expressing the plasmid-encoded construct.  
 
4.6 Discussion 
4.6.1 EsaA and EssC form homomeric complexes  
As outlined in Chapter 3, EsaA and EssB form homomeric complexes in detergent extracts. In 
this chapter complex formation between the membrane components was addressed in the 
native membrane environment, both in vitro and in vivo, using chemical crosslinking reagents. 
In vitro experiments with isolated membrane fractions were undertaken using DSS as a 
crosslinker, which crosslinks amine residues of proteins with a preference for the side chain of 
lysine. Results obtained with this method revealed multimeric complex formation for EssC, but 
homo-oligomerisation of EsaA, which was observed in BN PAGE analysis, was not seen (Figure 
4.3), potentially due to a lack of appropriately positioned lysine residues. No dimerization of 
EssB was detected in any of these crosslinking experiments, which is surprising as it was 
previously demonstrated that EssB crystallises as a dimer (Zoltner et al., 2013a; Zoltner et al., 
2013b). Again, this may reflect a lack of appropriately positioned reactive side chains. 
Different results for EsaA were seen when crosslinking was undertaken in whole cells using PFA 
as a crosslinking reagent, compared to in vitro crosslinking with DSS. Under in vivo conditions  
4 - 5 EsaA-cross-reacting bands could be detected migrating around 250 kDa. Since these bands 
were also detected in strains lacking each of the other Ess membrane components, they cannot 
represent crosslinks to known membrane proteins of the T7SS. They may potentially reflect 
crosslinks to other unknown proteins, or more likely (given that they are approximately twice 
the size of an EsaA monomer) they may be different conformers of an EsaA homo-dimer. In this 
context it should be noted that the Bacillus subtilis homologue of EsaA is known to form a high 
elongated homo-dimer (São-José et al., 2006).  
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Crosslinking analysis of EssC in vivo with PFA also revealed differences to the in vitro analysis 
with DSS. Whereas the DSS crosslinking gave only one higher molecular weight EssC-reacting 
band, migrating well above the 460 kDa marker, the in vivo crosslinking revealed two EssC-
reacting bands that both migrate above the 460 kDa marker. The EssC monomer has a calculated 
mass of 170,930 Da, although it migrates above the 171 kDa marker on SDS PAGE analysis (e.g. 
Fig 4.4). Aberrant migration of membrane proteins on SDS PAGE is a common phenomenon for 
membrane proteins (De Leeuw et al., 2001). However, both of the crosslinked products detected 
are too large to represent a homo-dimer (which would be expected to migrate below the 460 
kDa marker), and, assuming they are homomeric EssC complexes, they must correspond to at 
least homo-trimers. EssC belongs to the FtsK/SpoIIIE ATPase family which is known to form 
hexameric complexes (Massey et al., 2006; Rosenberg et al., 2015; Beckham et al., 2017), and 
purified, recombinant EssC isolated from E. coli membranes has an apparent molecular mass of 
1 mDa, consistent with hexamer formation (which has a calculated mass of 1.026 mDa; Zoltner 
et al., 2016)). It is highly unusual that no EssC dimers were detected here by crosslinking as the 
crosslinker is bifunctional, so dimeric complexes should always be an intermediate. Repeating 
the crosslinking at lower temperatures or for shorter times may allow dimeric intermediates of 
EssC to be observed.   
Multimerisation of the purified C-terminal domain of the actinobacterial EccC has also been 
observed by crosslinking (Rosenberg et al., 2015). In that study, glutaraldehyde was used as a 
crosslinker, and both dimeric and multimeric EccC species were detected. It was shown that 
multimerisation was apparently controlled by the presence of the small substrate proteins EsxA 
and EsxB. However, Fig 4.5 shows that in vivo crosslinking of a plasmid-encoded variant of EssC 
in a strain lacking all 12 genes at the ess locus can still be detected. This indicates that for the S. 
aureus Type VII secretion system multimerisation is not dependent upon any of the known 
substrates. In this context, a very recent study has also shown substrate-independent 
hexamerisation of M. xenopi EccC under native conditions (Beckham et al., 2017).  
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Differences between the patterns of crosslinking seen in vivo and in vitro may have several 
potential explanations. As already mentioned the presence of substrates, ATP and the proton 
motive force in whole cells could play an important role, but the crosslinkers and the conditions 
in which they were used could also have an effect. DSS and PFA both belong to the NHS ester 
family, which preferably crosslink amine-residues of amino acids. With a spacer arm length of 
11.4 Å for DSS compared to a spacer arm length of only 2.3 – 2.7 Å for PFA it might be expected 
that more crosslinks would be detected in the in vitro experiments since proteins under in vivo 
conditions using PFA would need to be in closer proximity to each other for crosslinking to 
happen. However, one explanation for less crosslinking seen with DSS could be that there are 
no suitable lysine residues exposed for an interaction with neighbouring proteins. Another 
reason for less interaction under in vitro conditions could be that NHS esters are known to be 
subject to rapid hydrolysis in aqueous solution giving them a half-life of only a couple of minutes 
under the reaction conditions used (Leitner et al., 2010).  
It is interesting to note that to detect complex formation for the distantly related Esx-5 secretion 
system in M. marinum DSP was used as a crosslinker under in vitro conditions (Houben et al., 
2012). DSP is a DSS homologue with the only difference that the spacer arm contains a disulphide 
bond allowing crosslinks to be reversibly formed. At present it is not clear why heteromeric 
complexes of the Ess membrane components cannot be detected, although it should be noted, 
that the S. aureus strain RN6390 used in this study is known to have a rather low T7 secretion 
activity under laboratory conditions (Kneuper et al., 2014) which could also contribute to the 
fact that no interaction between the membrane components could be detected. In future it 
might be interesting to repeat this analysis in more actively secreting S. aureus strains. 
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4.6.2 Interaction of the membrane components is not dependent on EsxA and EsaD 
For the Twin arginine transport system it is known that the membrane protein TatA only 
interacts with TatBC upon binding of a substrate (Gohlke et al., 2005; Leake et al., 2008). 
Therefore experiments were undertaken to determine whether substrate overproduction could 
allow Ess complexes to be detected by crosslinking. It was noted that adding a C-terminal YFP-
tag onto the secreted protein EsxA prevented this variant from being efficiently secreted and it 
also showed dominant negative activity as it blocked the secretion of native EsxA and EsxC 
(Figure 4.7). These findings suggested that EsxA-YFP interacts with Ess machinery, blocking it at 
one step in the transport pathway and therefore offering a potential opportunity to catch a 
‘snapshot’ of Ess complex formation. Unfortunately in vivo crosslinking studies in the presence 
and absence of the YFP-tagged EsxA-variant did not result in a noticeable difference in the 
crosslinking pattern, making it difficult to identify a potential interaction of the membrane 
components with each other or with EsxA-YFP. Even when samples were blotted with an anti-
EsxA or anti-GFP antibody the same crosslinking products were detected in presence and 
absence of the membrane components indicating that EsxA-YFP oligomerises but does not 
appear to interact with the secretion machinery (Figure 4.9).  
An even more drastic effect was observed when a YFP-tag was fused to a nuclease-inactive 
variant of the EsaD substrate, as overproduction of this construct caused cell death. The initial 
conclusion was that EsaD-YFP may become jammed in the Ess transport channel, blocking the 
system. In support of this, EsaD-YFP was detected in membrane fractions as both monomeric 
and high molecular weight forms. However, no corresponding high molecular weight bands 
could be detected when blotting for the membrane components EsaA, EssB and EssC (Figure 
4.12) indicating that EsaD-YFP probably does not interact with the machinery.  
When blotting against the YFP-tag it was noted that strains lacking chromosomally-encoded 
EsaD or all 12 genes of the ess locus did not show a YFP signal, indicating that these strains did 
not contain EsaD-YFP. This was also confirmed by monitoring growth curves and levels of 
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fluorescence of different strains in the presence and absence of the plasmid-encoded YFP-
tagged EsaD-variant. Here it was discovered that strains lacking all twelve genes at the entire 
ess locus, the esaD gene or the esaDG genes displayed reduced fluorescence together with 
unaffected cell growth, whereas strains encoding chromosomal esaD showed a high 
fluorescence with a significant decrease in cell growth over the time.  
EsaD was recently discovered to be a secreted nuclease toxin killing competitive bacteria (Cao 
et al., 2016). EsaG, another cytosolic protein, works as an antitoxin by interacting with the 
predicted nuclease-domain of EsaD and therefore protecting S. aureus. The YFP-tagged variant 
of plasmid-encoded EsaD carries a codon substitution (H528A) at the predicted nuclease active 
site since it was not possible to clone the wild type esaD due to the toxic activity (Cao et al., 
2016). A potential explanation for the toxicity of plasmid-encoded EsaD-YFP could be that the 
non-toxic pEsaD-YFP variant titrates away the cellular EsaG leaving the chromosomally-
produced, nuclease-active EsaD free of toxin and therefore able to kill the producing cell. This 
toxicity would clearly be alleviated in any cells that lack chromosomal esaD which would account 
for the almost normal growth of esaD- strains producing EsaD-YFP. It is, however, harder to 
explain why the EsaD-YFP fusion protein is not detected in these strain backgrounds unless the 
EsaD-YFP fusion protein requires interaction with native, untagged EsaD for stability. 
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5.1 Introduction 
As discussed in Chapter 1, EsaD is a secreted nuclease toxin which forms a heterodimer prior to 
secretion with its antitoxin partner EsaG (Cao et al., 2016). In the same study it could be shown 
that this heterodimer pair additionally interacts with a further protein EsaE. Moreover, PFA 
crosslinking in whole cells revealed an interaction of EsaE with the T7 membrane component 
EssC (Cao et al., 2016), suggesting that EsaE functions as a chaperone delivering EsaD to the 
transport channel. Similar results were also obtained by Anderson et al. (2017) where pull down 
experiments revealed that not only do EsaE, EsaD, EsaG and EssC co-purify, but that a further 
substrate protein EsxC also co-purifies with EsaE. EsxC has been identified as a secreted protein, 
playing an important role in abscess formation in a mouse infection model (Burts et al., 2008; 
Kneuper et al., 2014). EsxC, like the other known T7SS substrates EsxB, EsxD and EsaD are 
encoded downstream of essC in the ess loci of S. aureus strains such as RN6390, USA300, 
Newman and COL (Burts et al., 2005; Kneuper et al., 2014; Warne et al., 2016). 
The dependence of substrates on chaperones for secretion by the T7SS is also described in 
Mycobacteria, where EspG was shown to bind PE/PPE dimers (Daleke et al., 2012b). PE and PPE 
proteins are secreted proteins, named after highly conserved proline-glutamic acid (PE) and 
proline-proline-glutamic acid (PPE) motifs that are found in these protein families (Cole et al., 
1998). EspG proteins are only encoded in esx gene clusters that also encode PE and PPE proteins 
indicating that EspG proteins from one cluster specifically interact with PE and PPE proteins from 
the same cluster. Indeed it was demonstrated that the chaperone of the Esx-3 secretion system, 
EspG3, binds to PPE69 while EspG5 of the Esx-5 secretion system binds to PPE14, PPE17 and 
PPE60 (Ekiert and Cox, 2014). The recognition of the PE/PPE complex by EspG takes place 
through binding to a specific binding domain located at the N-termini of the PPE proteins (Ekiert 
and Cox, 2014; Korotkova et al., 2014), building a complex with the PE/PPE dimer in a ratio of 
1:1:1 (Daleke et al., 2012b). 
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Similar to EspG, genomic analysis revealed that EsaE in S. aureus is only present in strains also 
coding for esaD and esxC, supporting the idea that EsaE functions as a specific chaperone for 
strain-specific proteins. EsaE, as well as EsaG and EsaD are encoded downstream of essC, a part 
of the ess locus which is highly diverse among the different S. aureus strains (Warne et al., 2016; 
Figure 5.1). Warne et al. (2016) divided the S. aureus ess loci into four modules. The first module 
contains the first five genes of the ess locus, namely esxA, esaA, essA, esaB and essB, which are 
known to encode core components of the secretion system (Burts et al., 2005; Burts et al., 2008; 
Kneuper et al., 2014). The 5’ end of the second module covers the essC gene coding for the 
ATPase protein as well as the five genes encoded immediately downstream of essC with which 
they are co-transcribed, at least in strain RN6390 (Kneuper et al., 2014). Four of these five genes 
code for the substrate proteins EsxBCD and EsaD, while the remaining gene codes for EsaE. 
Within the second module it was also discovered that although the 5’ portion of essC is highly 
conserved, there are four variants of the essC 3’ region (Figure 5.1). Each essC variant was 
associated with a unique set of downstream genes encoded within Module 2 suggesting that 
the C-terminus of EssC is linked with a distinct repertoire of secreted and accessory proteins. 
The first EssC variant, EssC1, is encoded in S. aureus strains such as Newman, COL, USA300 and 
RN6390 while variant two (EssC2) is encoded in the ST398 strain. Variant essC3 was found in 
strains including MRSA252 and ST239 while the final variant, essC4, was found in the S. aureus 
strain EMRSA15. Modules 3 and 4 of the ess loci contained a variable number of hypothetical 
membrane proteins and genes coding for DUF600–domain proteins, which are EsaG-like anti-
toxins (Cao et al., 2016).  
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Figure 5.1: Schematic representation of the four genetic variants of the ess locus found across S. aureus strains. Adapted from Warne et al. (2016). 
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5.2 Aim 
The genetic diversity in the 3’ region of the different essC variants together with the genes 
encoded immediately downstream suggest that these genes code for strain specific substrates 
only recognised and secreted by the specific EssC. The aim of this chapter was to specifically test 
this hypothesis.  
 
Results 
5.3 Strain specific T7 substrate secretion 
A sequence alignment of the three C-terminal ATPase domains of the different EssC variants 
shows that the first ATPase domain (residues 626 - 931) is highly conserved. (Figure 5.2) Towards 
the second half of ATPase Domain 2 (residues 932 - 1219) it can be seen that EssC from RN6390 
begins to exhibit sequence variation relative to the EssC proteins from the other strains. The 
EssC variants from MRSA252 and ST398 are the most similar to each other, and only start to 
diverge in sequence towards the middle of ATPase Domain 3 (Figure 5.2). This variability is also 
shown on the crystal structure of the C-terminal ATPase domains of EssC from G. 
thermodenitrificans (Figure 5.3).  
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Figure 5.2: Sequence alignment of EssC sequences encoded by RN6390, EMRSA15, MRSA252 and ST398. 
Only the sequences of the last three ATPase domains are shown which are indicated with colour coding 
red for ATP1, green for ATP2 and blue for ATP3. The alignment was generated using the programme 
Clustal W and shaded with Boxshade.  
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Figure 5.3: Crystal structure of the C-terminal region of EssC. Shown in blue is the extent of the conserved 
and in red the variable regions identified between essC1 and essC2 on the x-ray structure of the ATPase 
domains of G. thermodenitrificans EssC. Taken from Warne et al. (2016), with permission. 
 
In order to test the hypothesis that the C-terminal, variable domain of EssC is involved in strain 
specific substrate recognition, firstly the four essC variants needed to be cloned. The laboratory 
strain RN6390 was chosen as representative of variant EssC1, ST398 for EssC2, MRSA252 for 
EssC3 and EMRSA15 for EssC4. A construct encoding RN6390 and MRSA252 essC in pRAB11 had 
already been made by Dr Holger Kneuper (Chapters 3 and 4), and constructs of the other two 
variants in the same vector were also generated, using the oligonucleotides listed in Table 2.6. 
Dr Holger Kneuper had previously constructed in frame deletions of essC in each of these four 
strain backgrounds (Kneuper et al., 2014; Kneuper and Palmer, unpublished). The plasmid-
encoded EssC-variants of each group were then introduced into each of these essC deletion 
strains.  
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5.3.1 Testing production of EssC-variants in the different strain backgrounds 
Before undertaking any secretion assays, it was first necessary to confirm stable production of 
each of the EssC variants in the four different strain backgrounds. To this end, the wild type 
strains RN6390, ST398, MRSA252 and EMRSA15, the four essC deletion strains harbouring empty 
pRAB11 vector and the four essC deletion strains harbouring each of pRAB11-EssCV1, -EssCV2, -
EssCV3 and -EssCV4 were grown to an OD600 of 2.0 in the presence of ATc. Whole cell samples 
were then immunoblotted using an antibody raised against purified RN6390 EssC (Figure 5.4).  
For S. aureus RN6390 it can be seen that native EssC is stably produced from the chromosome 
and it is also stably produced in the essC strain carrying the plasmid-encoded RN6390 variant 
of EssC (Figure 5.4 A). The plasmid-encoded EssC variants derived from MRSA252, EMRSA15 and 
ST398 can also be detected when produced in the RN6390 essC deletion strain, although the 
signals for these proteins are weaker than for the cognate EssC1 variant. This is because the 
antibody used in this study is raised against C-terminal 60kDa portion of EssC from RN6390, 
covering the conserved second P-loop ATPase domain and the sequence variable third P-loop 
domain. Immunological detection of EssC2, EssC3 and EssC4 is therefore weaker because there 
are fewer epitopes recognised by the antiserum. Each of the plasmid-encoded EssC variants 
were also stably produced in the essC mutants derived from strains MRSA252, EMRSA15 and 
ST398 (Figure 5.4 B – D). 
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Figure 5.4: Immunological detection of EssC in different strain backgrounds WT strains of (A) RN6390, 
(B) MRSA252, (C) EMRSA15 and (D) ST398 were grown together with the individual essC deletion strains 
either harbouring the empty pRAB11 vector or pRAB11 encoding the indicated EssC variants and 
harvested once they reached an OD600 of 2.0. 10 µl of whole cell samples adjusted to an OD600 = 1.0 were 
loaded on a bis-Tris gel containing 8 % acrylamide and subsequently transferred onto a PVDF membrane 
for immunological detection of EssC.  
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5.3.2 Testing T7 secretion after complementation of S. aureus strains with non-
cognate essC genes 
Once stable production of all four plasmid-encoded EssC-variants was confirmed in each strain 
background, it was next tested whether they were able to functionally complement and restore 
T7 secretion. As discussed in Chapter 1, the secreted protein EsxA is a core component of the 
Ess machinery and Figure 5.5 shows that the EsxA proteins from the four S. aureus strains are 
almost 100% identical. It was therefore hypothesized that secretion of this protein was likely to 
be independent of the EssC subtype. Cells of each of the RN6390, MRSA252, EMRSA15 and 
ST398 essC mutant strains carrying the plasmid-encoded EssC variant of groups 1 – 4 were grown 
to an OD600 = 2.0. Samples were then separated into culture supernatant and cellular fractions, 
transferred onto nitrocellulose membrane and immunoblotted using anti-EsxA antibodies. 
Blotted samples were also probed with antibodies to the cytosolic protein TrxA as a negative 
control.  
 
 
Figure 5.5: Sequence alignment of EsxA from RN6390, EMRSA15, MRSA252 and ST398. The alignment 
was generated using the programme Clustal W and shaded with Boxshade.  
 
Figure 5.6 A shows that EsxA is detectable in the supernatant of the RN6390 WT strain but not 
in the essC deletion strain, as expected. Re-introducing plasmid-encoded RN6390 EssC protein 
restored secretion activity. Moreover, plasmid-encoded variants of EssC2, EssC3 and EssC4 each 
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restored EsxA secretion to the essC mutant of RN6390 indicating that they retained function 
when produced in the heterologous background.  
Slightly different results were obtained with the MRSA252 strains (Figure 5.6. B). EsxA was not 
detectable in the supernatant of either the WT or the essC deletion strain. Even re-introducing 
and overproducing MRSA252 EssC from a plasmid did not lead to EsxA secretion. These 
observations indicate that the T7SS of strain MRSA252 is not active under laboratory conditions. 
As expected, introduction of any of the other EssC variants into the MRSA252 essC strain did 
not lead to EsxA secretion. 
EsxA could be clearly detected in the supernatants of the EMRSA15 and ST398 strains but not in 
the essC derivatives (Figure 5.6 C and D). Re-introducing the cognate plasmid-encoded EssC 
variant restored EsxA secretion to both strains as did all other plasmid-encoded EssC variants 
tested. However, it should be noted that TrxA can be detected in the supernatant sample of the 
EMRSA15 WT strain, indicating that the strong signal detected for EsxA in the supernatant of 
this strains might not solely be due to secretion, but may also be attributable to cell lysis (Figure 
5.6 C).  
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Figure 5.6: EsxA secretion is not dependent on the origin of EssC. WT strains of (A) RN6390, (B) MRSA252, 
(C) EMRSA15 and (D) ST398 were grown together with the individual essC deletion strains either 
harbouring the empty pRAB11 vector or pRAB11 encoding the indicated EssC variants and harvested once 
they reached an OD600 of 2.0. An equivalent of 200 µl of culture supernatant (sn) and 10 µl of resuspended 
cell sample (c) adjusted to an OD600 = 1.0 were separated on a bis-Tris-gel containing 15 % acrylamide and 
immunoblotted using the antiserum raised against EsxA or the control TrxA.  
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5.3.3 Secretion of EsxC is dependent on the EssC variant  
Since variant EssC proteins from different S. aureus strains all supported the secretion of the 
core component EsxA in different strain backgrounds the next step was to test whether they 
could also mediate secretion of strain-specific substrates. EsxC is a small substrate protein 
encoded downstream of essC in RN6390 but is not found in MRSA252, ST398 or EMRSA15. The 
RN6390 WT strain together with the isogenic essC deletion strain either harbouring the empty 
pRAB11 vector or pRAB11 encoding for each of the EssC variants was grown to an OD600 = 2.0, 
samples separated into culture supernatant and whole cells followed by immunoblotting against 
EsxC or the cytosolic control TrxA.  
It can be seen (Figure 5.7) that native EsxC was detected in the supernatant of the WT but 
remained in the cells of the essC deletion strain harbouring the empty vector. Re-introducing 
the cognate plasmid-encoded EssC protein restored EsxC secretion. However, plasmid-encoded 
variants of EssC2, EssC3 or EssC4 did not support secretion of EsxC and the protein was only 
detectable in the cell samples of the strains harbouring EssC from MRSA252, EMRSA15 or ST398 
(Figure 5.7). These findings are in accordance with the hypothesis that genes located 
downstream of essC encode for strain-specific substrates and that these substrates are 
recognised by the C-terminal domain of EssC. However, since all four EssC proteins can recognise 
‘non-cognate’ EsxA proteins it strongly suggests that EsxA interacts elsewhere on EssC. 
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Figure 5.7: EsxC secretion is supported only by the EssC variant from RN6390. RN6390 or the essC mutant 
derivative harbouring either empty pRAB11 or pRAB11 encoding the indicated EssC variant were cultured 
and harvested once they reached an OD600 of 2.0. An equivalent of 200 µl of culture supernatant (sn) and 
10 µl of resuspended cell sample (c) adjusted to an OD600 = 1.0 were separated on a bis-Tris-gel containing 
15 % acrylamide and immunoblotted using the antiserum raised against EsxC or the control TrxA.  
 
5.4 Crosslinking studies using purified proteins.  
The results obtained above support the idea that genes downstream of essC code for strain-
specific substrates that are recognised by the most C-terminal domain of the ATPase protein. As 
discussed previously, Cao et al. (2016) showed that the nuclease toxin EsaD binds to the soluble 
protein EsaE which then interacts with EssC upon secretion. Both EsaD and EsaE proteins are 
encoded downstream of essC at the ess locus of RN6390 and therefore EsaE might also interact 
with the C-terminal domain of EssC. To test this hypothesis, the proteins of interest were 
overproduced and purified for interaction studies. To this end, a His-tagged variant of the last 
two ATPase domains of EssC was purified, as well as His-tagged versions of the soluble proteins 
EsaE and EsxC. EsxA was shown to be secreted by all EssC-variants and is therefore thought to 
bind to a conserved region of the EssC protein, either the first ATPase-domain or the N-terminus 
of the protein. EsxA was therefore also purified for use in interaction studies as a potential 
negative control.  
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5.4.1 Purification of EsxA, EsxC, EsaE and EssCATP2 
To facilitate purification it was first necessary to generate plasmid-encoded His-tagged variants 
of the proteins to allow for heterologous production and purification from E. coli. To achieve 
this, the backbone vector pET15bTEV was chosen which codes for an N-terminal His-tag followed 
by a Tobacco etch virus (TEV) cleavage site. Plasmid-encoded His-tagged variants of the soluble 
proteins EsxA and EsxC as well as EsaE were already generated by Dr Martin Zoltner and Dr 
Zhenping Cao, respectively. The gene coding for essCATP2 was introduced into this vector using 
the restriction sites XhoI and BamHI.  
Proteins were overproduced in E. coli BL21 DE3 and purified using a His-trap column. Following 
purification, elution fractions were analysed by SDS PAGE to check purity of the protein, after 
which fractions containing the protein of interest were pooled, concentrated and the imidazole 
removed. Figure 5.8 shows the concentrated protein fractions together with the mass 
spectrometry analyses for each of the purified proteins.  
Figure 5.8 A shows that EsxA could be purified in very large amounts. Low levels of a dimeric 
form were also detected on SDS PAGE. Several EsxC-containing bands could be detected 
following coomassie staining, with the highest one running at 25 kDa followed by two strong 
bands between 10 and 15 kDa. Mass spectrometry analyses revealed that all three bands 
contained EsxC with the lowest molecular weight band probably containing one or more 
degradation products of the protein. The faint band at 25 kDa probably corresponds to a dimeric 
form of EsxC (Figure 5.8 B). Similar to EsxA and EsxC it was possible to purify EsaE to almost 
complete homogeneity (Figure 5.8 C). Two bands were detectable with a size of ~25 kDa, of 
which both corresponded to EsaE by mass spectrometry analyses. Purification of EssCATP2 was 
not as successful as purification of the other proteins. As it can be seen in Figure 5.8 D there 
were still many bands detectable on SDS PAGE after purification of the protein. Four strong 
bands could be detected between 25 and 75 kDa. Mass spectrometry analyses revealed the 
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lower three bands containing EssCATP2 while the highest band contained solely proteins of E. coli 
origin.  
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Figure 5.8: Purification of EsxA, EsxC, EsaE and EssCATP2. Proteins were purified using a His-Trap column. 
Following purification eluted fractions were pooled and concentrated using a vivaspin concentrator. 
Concentrated proteins and flow through (FT) were loaded onto an SDS gel containing 15 % acrylamide for 
EsxA and EsxC, 12 % acrylamide for EsaE and 10 % acrylamide for EssCATP2. The left panel shows the 
peptide coverage for the indicated bands generated by mass spectrometry with matching peptides in bold 
red. For EssCATP2 the second and third ATPase domains are highlighted in grey and yellow, respectively.  
 
To obtain cleaner protein, the His-Trap purified and concentrated sample of EssCATP2 was 
subsequently run over size exclusion chromatography in an attempt to remove unspecific bands. 
During this step it was possible to remove some of the contaminating E. coli proteins that 
migrate around 75 kDa although a small amount was still co-purified with EssCATP2 (Figure 5.9). 
Elution fractions B12 – C2 were subsequently pooled, concentrated and used for crosslinking 
experiments.  
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Figure 5.9: Size exclusion chromatography of EssCATP2. EssCATP2-containing fractions from three separate 
His-Trap purification experiments were pooled and concentrated to 500 µl before being loaded onto a 
Superdex 200 300/10 GL column. 10 µl was retained as the input sample (‘before’) and was loaded onto 
an SDS gel containing 10 % acrylamide together with 10 µl of each indicated elution fraction.  
 
Before starting crosslinking analyses it was next confirmed that the His-tag was still present in 
each of the purified proteins. Western Blot analysis using an anti-His-tag antibody was in 
agreement with the SDS PAGE and mass spectrometry results, revealing the dimer and monomer 
bands for EsxA and EsxC (Figure 5.10 left panel). It could also be shown that the degradation 
product obtained following EsxC purification contained a His-tag since the signal for this smaller 
band is as strong as for the monomeric form of the protein. An additional faint band could also 
be detected for EsxC-His which was not seen in the coomassie-stained gel. Considering that the 
size of EsxC is ~17 kDa this band could correspond to a protein-trimer. The purification of His-
tagged EssCATP2 and EsaE could also be verified with the His-tag antibody.  
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Figure 5.10: Immunological detection of the purified His-tagged proteins. Purified and concentrated 
protein were loaded onto an SDS gel containing 15 %, 12 % and 10 % acrylamide for the detection of EsxA 
and EsxC, EsaE and EssCATP2, respectively. Proteins were detected using a monoclonal anti His-Tag 
antibody (Abcam).  
 
5.4.2 Probing interaction of EsaE with the last two ATPase domains of EssC 
Since it is already known from PFA crosslinking analysis that EsaE interacts with EssC in vivo (Cao 
et al., 2016) the first experiments aimed to test whether an interaction between purified EsaE 
and the last two ATPase domains of EssC could be detected after PFA treatment. Following 
crosslinking, samples were subsequently immunoblotted using anti-EssC and anti-His antibodies 
(Figure 5.11).  
EssCATP2 could be detected in the treated and untreated samples when blotting against EssC, 
running at an approximate size of 50 kDa (Figure 5.11 A). Following PFA-treatment, higher 
molecular weight bands containing EssC could be detected in samples containing EssCATP2 alone. 
In total four different crosslinking products could be identified with the lowest one running just 
below the 100 kDa marker and the biggest product detectable well above  
250 kDa. The same bands were detectable when EssCATP2 was crosslinked in the presence of 
EsaE, indicating that these bands probably represent different oligomerisation stages of EssC. 
Unfortunately no additional bands were detected when EssCATP2 was mixed with purified EsaE 
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which leads to the conclusion that these two proteins do not detectably interact in these 
experiments. 
 
 
Figure 5.11: PFA crosslinking of EsaE with the last two ATPase domains of EssC. Purified EssC and EsaE 
were mixed in a 1:1 molar ratio of in the presence of 0.6 % PFA for 30 min after which the reaction was 
quenched with 100 mM Tris/HCl, pH 8.0. A 5 µl aliquot of sample was loaded on a bis-Tris gel containing 
8 % acrylamide when blotting against EssC (A) and 10 % acrylamide when blotting against the His-tag (B). 
Homomeric rrosslinking products are marked with an asterisk; nonspecific bands detected with the EssC 
antiserum are marked with an open triangle.  
 
Since there is currently no antibody available against EsaE, detection of this protein was only 
possible by blotting against the His-tag. Unfortunately, as all of the proteins used in this study 
contain a His-tag it was difficult to unequivocally identify samples containing EsaE. However, 
monomeric EsaE could be recognized running just above 25 kDa in the treated and untreated 
samples (Figure 5.11 B). A higher molecular weight band, running between 50 and 75 kDa was 
detectable in the treated sample of EsaE alone which could be a possible multimer of this 
protein. Bands of a similar size were also detectable in the treated and untreated sample of EsaE 
when mixed with EssCATP2, and at least one of these should be the monomeric form of His-tagged 
EssCATP2. Two cross-reacting bands running between 100 and 150 kDa and well above the 250 
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kDa marker were also detectable when EsaE was incubated EssCATP2. These bands likely 
correspond to the oligomerisation of EssCATP2 observed in Figure 5.11 A. It is not possible to 
deduce whether this crosslink also contains EsaE.  
 
5.4.3 Probing interaction of EsxC with EssC and EsaE 
As already mentioned in the introduction Anderson et al. (2017) were able to co-purify EsxC 
together with EsaE and EssC. Given that EsaE also interacts with EsaD (Cao et al., 2016) it is 
possible that EsaE is a chaperone for EssC1-secreted T7 substrate proteins. Initially, therefore, it 
was tested whether EsaE and EsxC interact under purified conditions following PFA treatment. 
Samples were crosslinked, followed by immunoblotting using anti-EsxC and anti-His antibodies 
(Figure 5.12).  
When testing for EsxC the monomer as well as the degradation product can be detected in the 
treated and untreated samples for EsxC alone and when mixed with EsaE (Figure 5.12 A). Faint 
bands for the homo-dimer and homo-trimer of EsxC could also be detected in the untreated 
samples, which showed a stronger signal after incubation with the crosslinker. Two additional 
bands were detected in the treated sample of EsxC when mixed with EsaE running just below 25 
and 37 kDa (Figure 5.12 A right panel). However, the same bands were detected when EsxC was 
treated alone and therefore probably represent homo-oligomeric states of EsxC.  
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Figure 5.12: Probing interaction of EsxC with the chaperone EsaE. Purified EsaE and EsxC were mixed 
together in a molar ratio of 1:1 and incubated with a final concentration of 0.6 % PFA for 30 min after 
which the reaction was quenched with a final concentration of 100 mM Tris/HCl, pH 8.0. 5 µl of sample 
was loaded on a bis-Tris gel containing 13 % acrylamide when blotting against EsxC (A) and 10 % 
acrylamide when blotting against the His-tag (B). Homomeric crosslinking products are marked with an 
asterisk.  
 
Blotting against the His-tag showed the monomeric forms of EsaE (Figure 5.12 B) as well as the 
EsxC monomer and degradation product (Figure 5.12 B right panel). When incubated with the 
crosslinking reagent no additional bands could be detected when EsaE was treated alone. 
However, two higher molecular weight bands could be seen in the crosslinked sample when EsaE 
and EsxC were mixed in a molar ratio of 1:1. The lower of these two bands was migrating just 
below the 37 kDa marker, most likely corresponding to EsxC since the same band could be 
detected when blotting directly against the substrate (Figure 5.12 A+B). However, the second 
band, running just above the 37 kDa marker, could neither be detected in the treated sample of 
EsaE alone nor when EsxC was crosslinked in presence or absence of the chaperone.  
Since no interaction of the substrate EsxC with the chaperone EsaE could be identified under 
purified conditions it was questioned whether EsxC might interact directly with domains of the 
membrane component, EssC. To test this hypothesis EsxC and EssCATP2 were mixed in a molar 
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ratio of 1:1 and treated with PFA as a crosslinker. Samples were subsequently immunoblotted 
using anti-EsxC and anti-EssC antibodies.  
 
 
Figure 5.13: Probing interaction of EsxC with the C-terminal ATPase domains of EssC. Purified EssCATP2 
and EsxC were mixed in a molar ratio of 1:1 and incubated with a final concentration of 0.6 % PFA for 30 
min after which the reaction was quenched with a final concentration of 100 mM Tris/HCl, pH 8.0. 5 µl of 
sample was loaded on a bis-Tris gel containing 13 % acrylamide when blotting against EsxC (A) and 8 % 
acrylamide when blotting against EssC (B). Homomeric crosslinking products are marked with an asterisk; 
Potential heteromeric crosslinking products are marked with a diamond; nonspecific bands detected with 
the EssC antiserum are marked with an open triangle. 
 
In these experiments, a higher molecular weight band was detected in the treated sample of 
EsxC when incubated together with EssCATP2 running at 250 kDa. There is no band this size 
detectable when EsxC is treated alone and therefore it may correspond to an EssC-EsxC-hetero-
multimer (Figure 5.13 A). However, when blotting against EssC there was no difference 
detectable between crosslinking the protein in presence or absence of the substrate EsxC and 
the same higher molecular weight bands were detectable in the treated samples of EssC alone 
or when incubated together with EsxC (Figure 5.13 B). It should be borne in mind, however, that 
EsxC is a small protein, and the level of resolution in the high molecular weight area of the gel is 
134 
_____________________________________________________________________________________ 
_____________________________________________________________________________________ 
Chapter 5 – EssC is a specificity determinant for T7 secretion in S. aureus 
poor, so a complex of hexameric EssC crosslinked to EsxC may not differ in migration to the EssC 
multimer alone. It is tentatively concluded that EsxC may directly interact with EssC. 
As already discussed in Chapter 4, interaction of the membrane components of the T7SS may 
require binding of a substrate and energisation (for example by the pmf or ATP hydrolysis). Since 
no convincing interaction between purified EssC and EsaE could be observed, it may be that EsaE 
needs to interact with a client protein before binding to EssC. To investigate this further, purified 
EssCATP2 and EsaE were also mixed with EsxC in a molar ratio of 1:1:1 followed by immunological 
detection of EssC and EsxC using polyclonal antisera raised to the purified proteins, and by 
detection of all three proteins using an anti-His-tag antibody (Figure 5.14).  
 
 
Figure 5.14: Immunological detection of EsxC following PFA crosslinking in the presence and absence of 
EssC and EsaE. Purified EsxC was mixed with either EsaE or EssC in a molar ratio of 1:1:1 and incubated 
with a final concentration of 0.6 % PFA for 30 min after which the reaction was quenched with a final 
concentration of 100 mM Tris/HCl, pH 8.0. 5 µl of sample were loaded on a bis-Tris gel containing 8 % 
acrylamide when blotting against EssC (A), 13 % acrylamide when blotting against EsxC (B) and 10 % 
acrylamide when blotting against the His-tag (C). Homomeric crosslinking products are marked with an 
asterisk; Potential heteromeric crosslinking products are marked with a diamond; nonspecific bands 
detected with the EssC antiserum are marked with an open triangle. 
 
As it can be seen in Figure 5.14 A there is no change in the crosslinking pattern for EssCATP2 when 
the protein is crosslinked in the presence or absence of proteins EsaE and EsxC. When blotting 
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against the substrate EsxC, additional to the higher molecular weight bands already detected in 
the previous experiments a further crosslinking product could be identified migrating between 
75 and 100 kDa (Figure 5.14 B right panel). According to the size and the fact that this band was 
not detected when the substrate was crosslinked with either EssCATP2 or EsaE alone it may be a 
hetero-multimeric state of all three proteins in a ratio of 1:1:1. Bands of similar size could also 
be detected when blotting against EssC and with the anti His-tag antiserum (Figure 5.14 C), 
supporting this idea.  
 
5.4.4 Interaction of EsxA with the membrane component EssC 
EsxA is a core component of the Ess machinery and was seen to be secreted by almost all S. 
aureus strains tested in this study, independent of the origin of EssC. These results suggested 
that EsxA may bind to a conserved region of the ATPase protein, either the first ATPase domain 
or the N-terminus, rather than to the last two ATPase domains of EssC. To test this, purified EsxA 
was incubated with EssCATP2 in the presence of PFA. The results are shown in Figure 5.15.  
Incubation of EssC with PFA with or without EsxA gives an identical crosslinking pattern (Figure 
5.15 A). When analysing EsxA, monomeric EsxA is detectable in the treated and untreated 
sample of EsxA alone running at a size of ~15 kDa (Figure 5.15 B). Five higher molecular weight 
bands are detectable in the treated sample, four with a size of ~20 to 50 kDa and one with a 
molecular weight of 250 kDa. These bands most likely represent oligomeric states of EsxA. 
Incubating EsxA and EssC resulted in an additional band detectable at the size of 75 kDa cross-
reacting with the EsxA antiserum. However this band was also detected in the untreated sample 
and therefore represents some unspecific cross-reaction with the EsxA antibody rather than an 
interaction between EsxA and EssCATP2.  
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Figure 5.15: PFA crosslinking of EsxA in presence and absence of the membrane component EssC. 
Purified EssC and EsxA were mixed in a molar ratio of 1:1 and incubated with a final concentration of  
0.6 % PFA for 30 min after which the reaction was quenched with a final concentration of 100 mM Tris/HCl, 
pH 8.0. 5 µl of sample was loaded on a bis-Tris gel containing 8 % acrylamide when blotting against EssC 
(A) and 13 % acrylamide when blotting against EsxA (B). Homomeric crosslinking products are marked 
with an asterisk; nonspecific bands detected with the EssC and EsxA antiserum are marked with an open 
triangle. 
 
5.5 Discussion 
5.5.1 Genes immediately downstream of essC code for strain specific substrates 
S. aureus strains can be grouped according to unique clusters of downstream genes associated 
with different variants of the gene coding for the ATPase protein EssC (Warne et al., 2016). In 
this Chapter the hypothesis was tested whether the C-terminal variation in the different S. 
aureus EssC proteins can be linked to substrate specificity. It was shown that the four different 
EssC variants were stably produced in strain backgrounds of S. aureus representing the different 
groups described by Warne et al. (2016). Moreover, secretion of the core component EsxA could 
be confirmed for strains RN6390, EMRSA15 and ST398 after essC mutants of each strain were 
successfully complemented for EsxA secretion with plasmid-encoded EssC-variants of each 
group (Figure 5.6). This finding indicates that all four EssC variants must retain the ability to 
137 
_____________________________________________________________________________________ 
_____________________________________________________________________________________ 
Chapter 5 – EssC is a specificity determinant for T7 secretion in S. aureus 
interact with the other core components of the T7SS and strongly suggests that the C-terminal 
variable region of EssC is not involved in any of these core interactions.  
Interestingly, of all of the plasmid-encoded EssC-variants only the cognate RN6390 EssC protein 
was able to support secretion of EsxC in the RN6390 strain background (Figure 5.7), and none of 
the other EssC proteins facilitated secretion of EsxC. These findings support the hypothesis that 
the C-terminal variable domain is a specificity determinant for T7 substrate secretion in S. 
aureus. It has been reported in the literature that the mycobacterial EsxB protein binds to a 
pocket located at the final ATPase domain of EccC and that this facilitates assembly of the EccC 
hexamer (Rosenberg et al., 2015). It is interesting to note that within module 2, downstream of 
each essC variant, is a variant-specific gene coding for a protein of the WXG100 superfamily in 
group 1 represented by EsxB (Warne et al., 2016). This raises the possibility that each of these 
specific WXG100 proteins may be involved in modulating assembly and/or activity of their 
cognate EssCs. 
 
5.5.2 Interaction of EsxC with the membrane component EssC is not dependent on 
EsaE under purified conditions.  
According to literature some of the strain specific substrates of the T7SS rely on the chaperones 
for their secretion (Cao et al., 2016; Anderson et al., 2017). Indeed, pulldown experiments 
revealed that EsxC was co-purified not only with EsaE but also with the membrane component 
EssC (Anderson et al., 2017). Crosslinking experiments using purified proteins were undertaken 
to investigate the interaction of the secretion substrate EsxC, the chaperone EsaE, and the final 
two ATPase domains of the membrane component EssC. Although the work here was somewhat 
hampered by the lack of a specific anti-EsaE antibody it did not appear that there were any 
detectable interactions of EsaE with ATPase domains of EssC (Figure 5.11).  
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As already discussed in Chapter four it is known for the Twin arginine transport system that the 
membrane protein TatA only interacts with the TatBC complex upon binding of a substrate 
(Alcock et al., 2013). It was therefore tested whether further addition of purified EsxC to the 
crosslinking mixture would result in crosslinks between EsaE and EssC. Surprisingly, under these 
conditions, an additional signal running just above the 37 kDa could be detected when blotting 
against the His-tag antibody which could not be confirmed when blotting against either EssC or 
EsxC (Figure 5.12). When testing interaction of EsxC separately with EsaE and EssC it was found 
that EsxC does not interact with the chaperone but directly with the membrane component EssC 
under purified conditions (Figure 5.13). These findings have some support from the 
mycobacterial T7SS, where EsxB was shown to directly interact with the membrane component 
EccC (Rosenberg et al., 2015). It should also be noted that in the mycobacterial T7SS, large 
secreted substrates such as the PE/PPE proteins require the participation of EspG chaperones, 
whereas small substrates do not (Daleke et al., 2012b). This is somewhat analogous to the 
situation in S. aureus as EsaD is much larger than EsxC and was shown to absolutely require EsaE 
for secretion whereas some EsxC could be secreted in the absence of EsaE (Cao et al., 2016). 
In these experiments, crosslinking between EsxA and the EssC ATPase domains was tested as a 
negative control since it was anticipated that this highly-conserved component should interact 
with a highly conserved region of EssC, either the first ATPase domain or the N-terminal domain, 
both of which were missing from the purified protein. No crosslinks were detected between the 
two purified proteins, as expected, although there could be other explanations for a negative 
result. Intriguingly, however, it was noted that homomeric crosslinks for EsxA could be detected, 
including at least one of very high molecular weight. This raises the possibility that EsxA could 
potentially exist in a higher order oligomer. There is no published evidence to support the 
suggestion that EsxA forms a polymer, but unpublished results from the Palmer and Hunter 
groups have shown that EsxA from Geobacillus thermodentrificans crystallises as an octamer 
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(Ng, Zoltner, Palmer and Hunter, unpublished). Whether multimeric forms of EsxA are essential 
for T7 secretion might be an interesting avenue for future study. 
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6.1 Homo-oligomeric complexes of Ess membrane components 
The main objective of this project was to probe the organisation of the S. aureus Ess machinery 
by examining complexes of the Ess membrane-bound proteins using crosslinking and BN PAGE 
analysis. One of the key findings from this study is that EsaA, EssB and EssC proteins were shown 
to form homomeric complexes, but under the conditions tested there was no evidence that 
these components interact with one another.  
For extraction of the proteins from S. aureus membranes, six different detergents were tested. 
Contrary to previous findings where DDM was successfully used to isolate a complex of the 
distantly related ESX-5 secretion system of M. marinum (Houben et al., 2012) only the 
zwitterionic detergent Fos-Choline-12 was able to extract reasonable quantities of all three of 
the EsaA, EssB and EssC membrane proteins. The subsequent use of this detergent might be a 
potential reason why interaction between the different membrane components could not be 
observed in BN PAGE analyses since zwitterionic detergents are known to have a more 
deactivating effect than the non-ionic detergent DDM. Subsequent analysis of the detergent-
extracted material by BN PAGE revealed self-interaction of EsaA and EssB. These findings are 
supported by other literature reports where the dimerization of the B. subtilis homologue of 
EsaA, YueB (São-José et al., 2006) and EssB (Zoltner et al., 2013a; Zoltner et al., 2013b;) were 
described. As a future prospective it would be interesting to further investigate the role of the 
detergent on the complex formation of the membrane component. With 2 % the final 
concentration of detergent used in this study is high above the critical micelle concentration of 
each detergent used which could have an effect on the interaction of the membrane proteins. 
Testing lower detergent concentrations might be gentler, ensuring the solubilisation of the 
proteins without breaking possible complex formations. 
Complex formation between the Ess membrane components was further addressed in the 
native membrane environment, both in vitro and in vivo, using chemical crosslinking reagents. 
Results obtained from experiments using isolated membranes under in vitro conditions revealed 
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multimeric complex formation for EssC. Since the same pattern of multimerisation was seen in 
the absence of the other Ess membrane proteins, it most likely represents an EssC homo-
multimer. This is in accordance with the literature where hexamerisation of the ATPase protein 
EssC as well as its mycobacterial homologue EccC could be shown (Rosenberg et al., 2015; 
Zoltner et al., 2016). Structural and functional analysis of EccC has shown that stable 
multimerisation occurs upon interaction with the EsxB substrate protein (Rosenberg et al., 
2015). However, the same multimeric crosslinking pattern for EssC was observed in a strain 
background where esxB and all known substrate protein-encoding genes were deleted 
indicating that the multimerisation of EssC may be independent of substrate binding.  
In this study, no evidence was obtained for heteromeric complex formation between any of the 
Ess membrane components, even in whole cells where T7 substrates, ATP and the protonmotive 
force should all be present. The reason for this is not clear, but it should be noted that the S. 
aureus strain RN6390 used in this study has low T7 secretion activity under laboratory 
conditions. As a future prospective it would be interesting to repeat these experiments in a more 
actively secreting S. aureus strain. It is not clear how T7 secretion activity is regulated. Study of 
other bacterial secretion systems has shown that they are often regulated at a post-translational 
level. For example the Type III secretion system of Shigella interacts with bile salts to drive 
formation of an active tip complex, and secretion by the Yersinia T3SS is activated by low calcium 
ion concentration (which mimics the eukaryotic cytosol) (Torruellas et al., 2005; Olive et al., 
2007). The T6SS is also controlled at a posttranslational level by protein phosphorylation. A 
threonine kinase, PpkA, phosphorylates the FHA component of the T6SS and/or TssL 
component, regulating activity of the baseplate complex (Mougous et al., 2007; Lin et al., 2014).  
It is possible that a posttranslational modification of one of the T7SS components, for example 
EssC, controls secretion activity and complex formation at least in S. aureus. Intriguingly, S. 
aureus and M. tuberculosis are known to harbour a membrane bound proline-directed 
serine/threonine kinase, PknB, with which the N-terminal domain of EssB shares structural 
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homology (Young et al., 2003; Zoltner et al., 2013a). Analysis of firmicute EssC sequences reveals 
a conserved sequence where a serine (or threonine in B. subtilis EssC) directly precedes a proline 
residue (Figure 6.1).  
 
 
Figure 6.1: Sequence alignment of EssC sequences encoded by RN6390, MRSA252, EMRSA15, ST398, B. 
subtilis, L. monocytogenes and S. agalactiae. Only the sequence covering the conserved candidate 
phosphorylation motif is shown. The alignment was generated with Clustal Omega and shaded with 
Boxshade.  
 
The serine is located at position 204 of the S. aureus EssC proteins, in a potential hinge region 
between the second FHA domain and the first transmembrane helix. A potential hypothesis is 
that PknB phosphorylates this position of EssC altering its conformation and modulating 
interaction with EssB and subsequently the formation of an active membrane complex. As part 
of the work in this thesis, attempts were made to test this hypothesis through the use of 
Phosphate Affinity SDS PAGE using an acrylamide-pendant Phos-tag, as well as through mass 
spec analysis of trypsin-treated samples enriched for EssC. Unfortunately the results obtained 
were inconclusive, and therefore further work will be required to determine whether and how 
T7 secretion activity is regulated in S. aureus.  
 
6.2 S. aureus shows substrate specificity among different strains 
Bioinformatic analyses identified a unique set of genes located immediately downstream of essC 
among different S. aureus strains. This variation was linked with sequence diversity of the C-
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terminal domain of EssC (Warne et al., 2016). A further aim of this thesis was to identify a link 
between this diversity and the unique set of genes encoded downstream of the ATPase protein. 
It could be shown that plasmid-encoded EssC variants of different S. aureus strains were cross-
functional and that all four variants could support secretion of the core component EsxA, which 
is highly conserved across all strains. However, secretion of EsxC, a substrate specific for S. 
aureus RN6390, was only supported by its cognate EssC variant. These findings strongly suggest 
that strain-specific substrates are only recognised by their cognate T7SSs, and more precisely by 
the C-terminal domain of EssC.  
Further crosslinking experiments using purified proteins revealed that EsxC directly interacts 
with the ATPase domain of EssC and does not require a chaperone, in contrast to findings for 
the much larger substrate protein EsaD, that is probably targeted for secretion by EsaE (Cao et 
al., 2016). These findings have some support from the mycobacterial T7SS where large secreted 
substrates such as PE/PPE proteins need the participation of EspG chaperones to be secreted 
whereas small substrates do not (Daleke et al., 2012b). Interestingly, previous work has shown 
that secretion of EsxC is abolished in an esaE background and it has been suggested that EsaE 
acts as an assembly platform for T7 substrates in EssC1 strain variants (Cao et al., 2016; Anderson 
et al., 2017). However it should be noted that the total cellular level of EsxC was greatly 
decreased in the esaE mutant background and that overproduction of EsxC in this strain resulted 
in secretion (Cao et al., 2016). Further work will be required to determine whether EsaE is a 
chaperone specific for the EsaD substrate or for all substrates in EssC1 strains. 
Crosslinking between purified EsxA and the last two ATPase domains of EssC was also tested as 
a negative control since it was thought that EsxA interacts elsewhere on the ATPase protein at 
the much more highly conserved N-terminus or the first ATPase domain. As expected the results 
showed no interaction of the secreted core component with this region of EssC, but did reveal 
oligomerisation of EsxA. These findings are in conformity with in vivo crosslinking experiments 
in this thesis where oligomerisation could be observed for YFP-tagged EsxA (see chapter 4). 
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Moreover, it was previously seen that EsxA crystallises as an octamer (Ng, Zoltner, Palmer and 
Hunter, unpublished) and is significantly overexpressed compared to other ess genes (Cao and 
Palmer, unpublished). An interesting future prospective could therefore be the investigation 
whether multimeric forms of EsxA are essential for T7 secretion.  
On a final note the bioinformatic analysis undertaken by Warne et al. (2016) suggested that 
although there was variability in the genes downstream of essC, each variant encoded a protein 
of the WXG100 family, EsxB in RN6390. An interesting path for future studies could lie in 
investigating whether these proteins are involved in modulating activity of their cognate EssCs.  
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The Ess/Type VII protein secretion system, essential for virulence of patho-
genic Staphylococcus aureus, is dependent upon the four core membrane pro-
teins EssA, EssB, EssC and EsaA. Here, we use crosslinking and blue native
PAGE analysis to show that the EssB, EssC and EsaA proteins individually
form homomeric complexes. Surprisingly, these components appear unable to
interact with each other, or with the EssA protein. We further show that two
high molecular weight multimers of EssC detected in whole cells are not
dependent upon the presence of EsxA, EsxB or any other Ess component for
their assembly.
Keywords: membrane protein complex; protein secretion; Staphylococcus
aureus; Type VII secretion
Protein secretion systems allow bacteria to interact
with and manipulate their environments, and in patho-
gens, they play critical roles in host colonisation and
disease [1]. The Gram-positive bacterium Staphylococ-
cus aureus produces a Type VII protein secretion sys-
tem, also known as Ess (ESAT-6 secretion system),
that is required for pathogenesis in murine models of
infection [2,3]. Substrates of the S. aureus Ess machin-
ery include two small proteins, EsxA and EsxB, of the
WXG100 superfamily, and two additional proteins,
EsxC and EsxD, which lack the W-X-G motif [2,4,5].
Mutational and bioinformatic analyses have revealed
six core components of the S. aureus Ess machinery,
of which four (EsaA, EssA, EssB and EssC) are pre-
dicted to be membrane-bound proteins, one (EsaB) to
be cytoplasmic and one (EsxA) extracellular [2,3,6;
Fig 1]. Little is known about how the core Ess
machinery is organised or how protein secretion is
mediated.
The S. aureus Ess system is distantly related to the
ESX/type VII secretion system of actinobacteria, shar-
ing EsxA/B-like and EssC-like components. EssC pro-
teins (termed EccC in actinobacteria) are membrane-
bound ATPases of the FtsK/SpoIIIE family that form
hexameric membrane-spanning pores which traffic
macromolecules [7]. Very recently, the structure of
EccC from the thermophilic actinobacterium Ther-
momonospora curvata was reported. The protein has
three interlocking ATPase domains at its C terminus
and its multimerisation was unexpectedly shown to
depend upon the binding of EsxB to a pocket on the
most C-terminal ATPase domain [8]. In the same
study, the structure of the two C-terminal domains of
EssC from Geobacillus thermodenitrificans, a ther-
mophilic relative of S. aureus was also described,
although it is not clear whether multimerisation of
this protein is also controlled by interaction with EsxB
(or EsxA) [8]. Analysis of more than 150 S. aureus
Abbreviations
ATC, anhydrotetracycline; DDM, ndodecyl-b-D-maltoside; DSS, disuccinimidyl suberate.
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genome sequences has shown that the C-terminal
ATPase domain of EssC falls into one of four different
sequence variants that cluster with genes coding cog-
nate suites of candidate substrate proteins, implicating
this domain in substrate recognition [6].
The EccC protein of pathogenic Mycobacteria has
been shown to form a large (1.5 MDa) complex with
three additional membrane proteins, EccB, EccD and
EccE [9]. However, these accessory proteins are found
only in actinobacteria and it is not known whether
S. aureus EssC forms part of a larger membrane-
bound complex containing additional components. To
investigate this question, we probed the organisation
of the essential membrane components of the S. aureus
Ess system. Our results are consistent with three of the
proteins, EsaA, EssB and EssC forming homo-oligo-
meric complexes; however, we find no evidence for het-
ero-oligomeric assemblies between any of these
proteins or even with a fourth membrane-bound
protein, EssA, under the conditions we examined.
Methods
Plasmids and strains
Staphylococcus aureus strain RN6390 (WT; ess+) [10] along
with a series of isogenic strains lacking individual genes
coded at the ess locus, or a deletion of all 12 of the coex-
pressed ess genes [3] were used for all experiments in this
study. A plasmid construct producing N-terminally hex-
ahistidine-tagged EsaA has been described previously [3].
Plasmid pEssB-nhis encodes N-terminally hexahistidine-
tagged EssB was constructed as follows: the essB coding
region was amplified from RN6390 genomic DNA using
primers: 50-GATAGATCTGTTAAAAATCATAACCCTA
AAAATG-30 and 50-CGAGAATTCACTATTTTTTT. CT
TTCAGCTTCTTGGCGT-30, digested with BglII–EcoRI
and cloned into the expression vector pRMC2h [3]. A vari-
ant of plasmid pRMC2 [11] coding for a C-terminal hex-
ahistidine tag (pRMC2ch) was generated by amplification
across the multiple cloning site of pRMC2 using primers
pRMC2seq1 (50-ATTTGGATCCCCTCGAGTTCATG-30)
and Chisins (50-TTGAATTCATTAATGATGATGATGAT
GATGGAGCTCAGATCTGTTACC-30), digestion of the
product with XhoI and EcoRI and cloning into similarly
digested pRMC2. Plasmid pEssA-chis encodes C-terminally
hexahistidine-tagged EssA and was constructed following
amplification of the essA coding region from RN6390 geno-
mic DNA using primers: 50-CTAGATCTAATGT-
TACTTTTACGTGCTGATTCA-30 was digested with KpnI
and BglII and cloned into pRMC2ch. Plasmid pEssC-chis
encodes C-terminally hexahistidine-tagged EssC and was
constructed by amplification of the essC coding region
from RN6390 genomic DNA primers: 50-AAATAGATC-
TAGGACTGAGGCAAAG-3 and 50-TGAATTCATTAAT
GATGATGATGATGAT. GACTACCAGATTTAAACCA
TCTAATCTTTTG-30 was digested with BglII and EcoRI
and cloned into vector pRMC2.
Biochemical methods
For in vitro crosslinking experiments with disuccinimidyl
suberate (DSS), 50 mL of TSB medium was inoculated
from an overnight culture of the strain of interest to give
an OD600 of 0.1. For induction of expression of plasmid-
encoded proteins, the indicated concentration of anhydrote-
tracycline (ATC) was added when the OD600 of the culture
reached 0.5, and the culture was incubated at 37 °C with
vigorous shaking until an OD600 of 2.0 was reached. Cells
were pelleted by centrifugation for 10 min at 2770 9 g,
washed once with 1 mL 20 mM MOPS/NaOH, pH 7.2,
200 mM NaCl (M1 buffer), and resuspended in 1 mL M1
buffer containing 2.5 mM EDTA. The resuspended sample
was supplemented with 200 lg lysostaphin and incubated
for 30 min at 37 °C to digest the cell wall, after which
sphaeroplasts were lysed by sonication and centrifuged for
5 min at 17 000 9 g to remove unbroken cells. The clari-
N
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CN
EssA (17 kDa) EssB (52 kDa)
N
EssC (170 kDa)
N
EsaB
C
Fig. 1. The membrane components of the
Staphylococcus aureus Ess/Type VII
protein secretion system. The sizes and
predicted topologies of EsaA, EssA, EssB
and EssC are shown. The other two
essential components, EsxA and EsaB, are
also shown, along with their known or
predicted subcellular location.
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fied supernatant (containing the cytoplasm and membranes)
was centrifuged again for 30 min at 227 000 9 g at 4 °C to
pellet the membranes. The membrane fraction was resus-
pended in 100 lL M1 buffer. For DSS crosslinking, mem-
branes (30 lg of protein) were supplemented with either
DSS (to a final concentration of 2 mM) or an equivalent
volume of DMSO (control sample) and made up to 50 lL
final volume with 20 mM HEPES/NaOH, pH 7.4, 20 mM
KCl, 250 mM sucrose, 1 mM EDTA. After incubation for
30 min at room temperature, the reaction was quenched by
addition of Tris/HCl, pH 8.0 to a final concentration of
100 mM. For analysis of EsaA or EssB crosslinks, samples
were made up to 73 lL with 4 9 NuPAGE loading buffer
prior to separation on Bis-Tris gels. For analysis of EssC
crosslinks, samples were made up to 66 lL with 6 9 SDS
sample buffer prior to separation by SDS PAGE.
Formaldehyde (PFA) crosslinking experiments were car-
ried out using whole cell samples. About 50 mL of TSB
medium was inoculated from an overnight culture of the
strain of interest to give an OD600 of 0.1. For induction of
expression of plasmid-encoded proteins, anhydrotetracy-
cline (ATC; 50 ngmL1 for EsaA production,
100 ngmL1 for EssA production and 25 ngmL1 for
EssB and EssC production) was added when the OD600 of
the culture reached 0.5. Once an OD600 of 1.0 was reached,
cells were pelleted by centrifugation for 10 min at 2770 9 g
and resuspended in 1 mL 1 9 PBS. Paraformaldehyde was
added to the cell suspension to a final concentration of
0.6% and samples incubated for 30 min at room tempera-
ture before the reaction was quenched by addition of Tris/
HCl, pH 8.0 to a final concentration of 100 mM. Cells were
pelleted by centrifugation for 10 min at 2770 9 g, resus-
pended in 1 mL 50 mM Tris/HCl, pH 7.5, 200 mM NaCl,
2.5 mM EDTA and treated as described above to obtain
the isolated membrane fraction. Membranes were resus-
pended in 100 lL 50 mM Tris/HCl, pH 7.5, 200 mM NaCl
prior to separation on Bis-Tris gels (for analysis of EsaA
or EssB crosslinks) or SDS gels (for analysis of EssC cross-
links).
Growth of cells and preparation of cell and supernatant
samples for secretion experiments were performed as
described previously [3]. The same cell samples were also
used to analyse the level of production of EsaA. To analyse
the level of EssB and EssC, membrane fractions were pre-
pared from whole cell samples as described above.
For detergent solubilisation tests, cells were harvested at
OD600 of 2.0, following supplementation with ATC when
the OD600 of the culture reached 0.5, conditions where the
T7SS is active (Fig. S1). Membrane fractions were prepared
as described above, and samples containing 400 lg of total
protein were used for solubilisation. Membrane fractions
were pelleted by centrifugation for 30 min at 227 000 9 g
at 4 °C and resuspended in solubilisation buffer (50 mM
sodium phosphate, pH 8.0, 300 mM NaCl, 10% glycerol) to
a final protein concentration of 10 lglL1. Samples were
supplemented with the appropriate detergent to a final con-
centration of 2%, and incubated at 25 °C for 2 h with
shaking. To separate the solubilised protein from the insol-
uble material, samples were centrifuged for 20 min at
89 000 9 g at 4 °C. The supernatant was taken as the solu-
bilised membrane protein and the pellet as the insoluble
material. For blue native polyacrylamide gel electrophoresis
(BN PAGE), solubilised membrane protein samples were
supplemented with 5% glycerol and 0.2% Coomassie Blue
(final concentration) and BN PAGE was performed as
described by Wittig et al. [12] using precast 4–16% gradient
gels (Novex).
SDS PAGE was carried out using Bis-Tris gels as
described previously [3], and western blotting was per-
formed following standard protocols with the following
antibody dilutions: a-EsxA [3] 1 : 2500, a-EsxC [3]
1 : 2000, a-EsaA [3] 1 : 10 000, a-EssB [3] 1 : 10 000, a-
EssC [3] 1 : 10 000 and a-TrxA [13] 1 : 10 000.
Results
Currently little is known about the organisation of the
membrane components of the S. aureus Ess machin-
ery. A previous study has reported a membrane
location for EssB in S. aureus [14] and when heterolo-
gously expressed in E. coli EssB behaves as a dimer
[15,16], but interactions with other components of the
Ess machinery have not yet been described. We firstly
used chemical crosslinking on isolated membrane frac-
tions to probe the organisation of the essential mem-
brane components EsaA, EssB and EssC, using the
bifunctional crosslinker disuccinimidyl suberate (DSS),
which crosslinks exposed primary amine-containing
residues. To maximise the possibility of detecting inter-
actions, we also undertook these experiments with the
overproduction or absence of individual Ess membrane
components. Figure S1 confirms the lack of EsxA and
EsxC secretion in each of the esaA, essA, essB and
essC deletion strains and the complementation by the
missing gene expressed in trans and Fig. S2 shows the
level of plasmid-encoded EsaA, EssB and EssC pro-
duction.
As shown in Fig. 2(A), native EsaA could be
detected in membranes derived from the wild-type
strain and each of the essA, essB and essC deletion
strain backgrounds, indicating that it is stably pro-
duced in the absence of each of these Ess components.
No additional EsaA-specific bands were generated in
the presence of the DSS crosslinker in membrane frac-
tions from any of these strains, or when any of EssA,
EssB or EssC was overproduced, although a dark
smear of EsaA-containing material was visible when
crosslinking was carried out in the presence of over-
3FEBS Letters (2016) ª 2016 Federation of European Biochemical Societies
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produced EsaA. Figure 2(B) shows that likewise, EssB
was stably produced and found in the membrane frac-
tion in the absence of any of EsaA, EssA or EssC, but
did not yield any crosslinked products, even when it
was overproduced.
By contrast, crosslinked products were detected for
EssC following incubation with DSS (Fig. 2C). A very
similar high molecular weight band migrating well
above the 460 kDa molecular weight marker was
detected in membrane fractions of the wild-type and
the esaA, essA and essB deletion strains. It is likely
that this represents a homo-multimer of EssC, an
observation consistent with previous reports [8]. The
mass of crosslinked product appears to be too large
for a homo-dimeric species (which would be expected
to migrate below the 460 kDa marker) and therefore it
is likely to represent at least a homo-trimer. Note that
we were unable to directly assess crosslinking of EssA
as we do not have a functional antibody.
These initial crosslinking experiments, which
revealed few detectable interactions, were carried out
in vitro, where factors such as the proton-motive force,
ATP and soluble proteins are absent. Therefore, we
next undertook similar crosslinking experiments in
whole cells, using formaldehyde as a cell-permeable
crosslinker that also crosslinks amino groups. As
shown in Fig. 3A, incubation with formaldehyde
resulted in EsaA-specific crosslinks in whole cells of
the wild-type strain. A series of 4–5 discrete bands
could be detected, migrating around 250 kDa. Interest-
ingly, essentially the same pattern of EsaA crosslinks
was seen whether EssA, EssB or EssC were absent,
suggesting that the crosslinked products did not con-
tain any of these proteins. It has been reported that
the long extracellular domain of YueB, the Bacil-
lus subtilis homologue of EsaA, forms a highly
elongated homo-dimer [17] and it is therefore likely
that the crosslinks seen here correspond to different
conformers of a crosslinked EsaA dimer.
In vivo crosslinking analysis of EssB resulted in no
detectable EssB crosslinks unless the protein was over-
produced, in which case a very faint crosslinked pro-
duct running at the approximate size of an EssB
homo-dimer could be detected (Fig 3B). As homo-
dimerisation of EssB has been reported previously,
[15,16] it is likely that this crosslink is a homo-dimeric
form of EssB.
Crosslinking of EssC in vivo also yielded high
molecular weight products, as was observed in vitro
(Fig 3C). However, in contrast to the in vitro analysis,
where one major crosslinked product was seen, in this
instance at least two distinct high molecular weight
species were detected, both of which migrated above
the 460 kDa molecular weight marker. The differences
between the pattern of crosslinks seen in vivo and
in vitro may reflect the difference in size between DSS
which was used as a crosslinker in vitro and formalde-
hyde which was used in vivo. Alternatively they may
arise due to the presence of ATP, proton-motive force
or other factors that are present in whole cells. It
should be noted that as similar crosslinks were seen in
the absence of any of EsaA, EssA or EssB, neither of
the two crosslinks arise from interactions of EssC with
any of the other core membrane components of the
Ess system, and probably represent homo-multimeric
forms of EssC.
It has been reported that multimerisation of EccC,
the homologue of EssC found in actinobacteria, is
controlled by interaction with the two small WXG100
proteins, EsxA and EsxB. Rosenberg et al. [8] showed
that the interaction of purified EccC with EsxB drives
the formation of high-order multimers, whereas inter-
action of EsxA with the EccC–EsxB complex resulted
in cooperative disassembly of EccC and the accumula-
tion of dimeric and monomeric species. To determine
whether the high molecular weight EssC crosslinks
were detected in vivo as a result of the presence of
EsxA or EsxB, we repeated the formaldehyde
crosslinking in whole cells of a strain deleted for all 12
genes encoded at the ess locus, including esxA and
esxB [3]. Figure 3D shows that the pattern of EssC
crosslinks was not affected by the absence of EsxA,
EsxB or any other protein encoded at this locus. We
conclude that oligomerisation of EssC is independent
of any previously identified Ess component.
The results presented to date suggest that there is
likely homo-oligomeric interactions for three of the
membrane components of the Ess machinery, but
provide no evidence for interactions between the
components. One possible explanation for this is that
there are no suitably juxtaposed lysine residues in
neighbouring proteins to allow crosslinking to occur.
Therefore, we next attempted to extract the Ess mem-
brane proteins to examine interactions in detergent
solution. We conducted solubilisation tests using the
nonionic detergents Triton X-100, ndodecyl-b-D-mal-
toside (DDM) and digitonin, and the zwitterionic
detergent Fos-choline-12, on membranes isolated from
the S. aureus wild-type strain. As shown in Figure 4,
the EsaA, EssB and EssC proteins differed in their
behaviour with the four detergents tested. DDM was
able to successfully extract all of the EsaA and EssB
from the membrane, but did not solubilise full length
EssC. EsaA and EssB were also partially extracted
with Triton X-100 and digitonin, whereas only a very
small fraction of EssC was extracted with digitonin
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Fig. 2. DSS-mediated crosslinking of EsaA, EssB and EssC in isolated membrane fractions. Membrane fractions were prepared from strain
RN6390 (WT) or the isogenic esaA, essA, essB or essC deletion strains, either harbouring the empty pRMC2 vector (lanes labelled ΔesaA,
ΔessA, ΔessB, ΔessC respectively) or pRMC2 overproducing a his-tagged variant of the indicated gene (ΔesaA pesaA++, ΔessA pessA++,
ΔessB pessB++, ΔessC pessC++) and treated with DSS as described under Experimental Procedures. After the reaction was quenched,
aliquots (1 lg of total membrane protein for EsaA, EssB; or 2 lg of total membrane protein for EssC) were loaded on a Bis-Tris gel
containing 8% acrylamide (A and B) or SDS gel containing 5% acrylamide (C), samples were transferred to nitrocellulose membrane and
proteins detected using polyclonal antibodies raised against A. EsaA, B. EssB or C. EssC, as indicated. Crosslinked products are indicated to
the right with an asterisk; the open triangle indicates a nonspecific band that is detected with the EsaA antiserum.
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and none when Triton X-100 was used. The most
effective detergent at extracting EssC was Fos-choline-
12 which extracted between 50 and 100% of the EssC
present in the membrane. This detergent was also able
to extract most of the EssB and EsaA.
As Fos-choline-12 was able to extract all three pro-
teins from the membrane, we next tested whether
they were part of the same complex by undertaking
blue native polyacrylamide gel electrophoresis (BN
PAGE), a technique that is commonly used for the
analysis of membrane protein complexes [12]. After
solubilisation of membranes with Fos-choline-12, the
sample was separated on gels containing a gradient
of 4–16% acrylamide and blotted with anti-EsaA,
anti-EssB and anti-EssC antibodies. Unfortunately,
the anti-EssC antibody was unable to detect any
EssC-specific bands following BN PAGE (data not
shown). However, bands containing EsaA and EssB
were observed. As shown in Fig. 5(A), two complexes
containing EsaA could be detected, one of which
close to the 150 kDa marker and the second just
above the 200 kDa marker, which could conceivably
correspond to monomers and dimers of EsaA. In
contrast, a single EssB-containing band was detected,
migrating between the 66 kDa and 150 kDa marker,
close to the expected size for an EssB dimer
(Fig. 5B). Thus, given the differences in the masses of
these bands these two proteins are highly unlikely to
be part of the same complex. We confirmed this by
repeating the BN PAGE on Fos-choline-12 mem-
brane extracts from strains deleted for esaA or essB,
and detected the same two EsaA complexes in the
absence of EssB, and the same EssB complex in the
absence of EsaA. We conclude that these two pro-
teins do not interact with each other in isolated mem-
branes.
Fig. 3. Formaldehyde-mediated crosslinking of EsaA, EssB and EssC in whole cells. (A–C) Whole cells of strain RN6390 (WT) or the
isogenic esaA, essA, essB or essC deletion strains, either harbouring the empty pRMC2 vector (lanes labelled ΔesaA, ΔessA, ΔessB, ΔessC
respectively) or pRMC2 overproducing a his-tagged variant of the indicated gene (ΔesaA pesaA++, ΔessA pessA++, ΔessB pessB++, ΔessC
pessC++) or (D) Whole cells of strain RN6390 (WT), the isogenic ΔesaA – SAOUHSC_00269 deletion strain or the isogenic essC deletion
strain, either harbouring the empty pRMC2 vector (lanes labelled Δess and ΔessC respectively) or pRMC2 overproducing a his-tagged
variant of EssC (Δess pessC++ or ΔessC pessC++) were treated with paraformaldehyde (PFA) as described under Experimental Procedures.
Following quenching, cells were lysed and membrane fractions prepared, and 1 lg of total membrane protein loaded on a Bis-Tris gel
containing 8% acrylamide (A and B) or 2 lg of total membrane protein loaded on a SDS gel containing 5% acrylamide (C and D), samples
were transferred to nitrocellulose membrane and proteins detected using polyclonal antibodies raised against A. EsaA, B. EssB or C and D.
EssC, as indicated. Crosslinked products are indicated to the right with an asterisk; the open triangle indicates a nonspecific band that is
detected with the EsaA antiserum.
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Fig. 4. Detergent extraction of EsaA, EssB and EssC. Membrane fractions were treated with 2% of the indicated detergent, as described
under Experimental Procedures. About 5 lg of solubilised (sol) and insoluble material (insol) following centrifugation for 20 min at 89 000 9 g
were loaded on a Bis-Tris gel containing 8% acrylamide for (EsaA and EssC analysis) and 10% acrylamide (for EssB analysis). Subsequently
the proteins were transferred on a nitrocellulose membrane followed by immunological detection of A. EsaA, B. EssB, C. and D. EssC.
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Further analysis using membranes isolated from an
essC strain background showed that the same two
EsaA complexes could be detected in the absence of
EssC (Fig. 5A). Likewise, an identically migrating
EssB band was seen in membrane fractions derived
from the essC and essA mutant strains (Fig. 5B).
Taken together with the results of the crosslinking
analysis and supported by prior observations of EssB
behaviour by Zoltner et al. [15,16], we conclude that
the EsaA, EssB and EssC components of the Type VII
secretion machinery show homotypic interaction but
that there is no evidence that they are able to form
complexes with one another, or with the fourth essen-
tial Ess membrane component, EssA, under the condi-
tions we have examined.
Discussion
In this study, we have probed the organisation of the
S. aureus Ess machinery by examining complexes of
the Ess membrane-bound proteins using crosslinking
and BN PAGE analysis. Our results are consistent
with the EsaA, EssB and EssC proteins forming homo-
meric complexes, but under the conditions we exam-
ined, we found no evidence that these components
interact with one another. Thus, we detected no het-
eromeric crosslinks between any of the proteins or
with the fourth essential Ess membrane protein, EssA.
Likewise the proteins displayed different solubility
with a range of detergents, and only Fos-choline-12 of
the detergents we tested was able to extract reasonable
levels of EssC. BN PAGE analysis of membrane pro-
teins extracted with Fos-choline-12 revealed EsaA and
EssB to reside in separate complexes, neither of which
appeared to contain any EssA or EssC. These findings
contrast with a study of the distantly related ESX
secretion system from Mycobacterium marinum, where
extraction of membranes with DDM led to the isola-
tion of a 1.5 MDa complex containing four conserved
ESX membrane proteins, including the EssC homo-
logue, EccC [9]. However, there is no detectable
homology between EccB, EccD and EccE, which along
with EccC localise to the M. marinum ESX membrane
complex, and EsaA, EssA or EssB, and it is possible
that they may have unrelated functions in the two dif-
ferent secretion systems.
Structural and functional analysis of EccC has
shown that multimerisation is driven by interaction
with EsxB and conversely that EsxA promotes disas-
sembly of the EccC multimer, most likely by binding
to EsxB and forming an EccC–EsxB–EsxA ternary
complex. A pocket within the most C-terminal ATP-
binding domain of EccC binds the C-terminal signal
sequence of EsxB [8], providing structural clues about
how multimerisation is controlled. However, it is not
apparent whether this signal sequence binding pocket
feature is conserved in EssC, and moreover we
detected similar high-order EssC multimers in a strain
lacking EsxB and EsxA suggesting that oligomerisa-
tion is not dependent upon binding of any of the
known S. aureus WXG100 proteins.
In conclusion, we see no evidence for the existence
of a heteromeric Ess membrane complex. It remains
possible that interactions between the membrane com-
ponents are transient and depend upon the presence of
a translocating substrate. An alternative explanation is
that, under the conditions we have examined, the
secretion machinery is not fully active, as it has been
noted previously that Ess secretion is only poorly
active under laboratory growth conditions [3]. Further
work will be required to distinguish between these
possibilities.
kDa
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A B
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αEssB
αEsaA
Fig. 5. Blue native PAGE analysis of EsaA- and EssB-containing complexes. Membrane fractions were prepared from strain RN6390 (WT) or
the indicated deletion mutant, and samples (5 lg protein) were solubilised using 2% Fos-choline-12, as described under Experimental
Procedures. The solubilised material was loaded onto a BN gel containing a gradient of 4–16% acrylamide. Subsequently, the proteins were
transferred to PVDF membrane followed by immunological detection of A. EsaA or B. EssB. The arrows to the right indicate complexes
containing EsaA (panel A) or EssB (panel B).
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Summary
The Type VII protein secretion system, found in Gram-
positive bacteria, secretes small proteins, containing
a conserved W-x-G amino acid sequence motif, to the
growth medium. Staphylococcus aureus has a con-
served Type VII secretion system, termed Ess, which
is dispensable for laboratory growth but required for
virulence. In this study we show that there are unex-
pected differences in the organization of the ess gene
cluster between closely related strains of S. aureus.
We further show that in laboratory growth medium
different strains of S. aureus secrete the EsxA and
EsxC substrate proteins at different growth points,
and that the Ess system in strain Newman is inactive
under these conditions. Systematic deletion analysis
in S. aureus RN6390 is consistent with the EsaA,
EsaB, EssA, EssB, EssC and EsxA proteins compris-
ing core components of the secretion machinery in
this strain. Finally we demonstrate that the Ess secre-
tion machinery of two S. aureus strains, RN6390 and
COL, is important for nasal colonization and virulence
in the murine lung pneumonia model. Surprisingly,
however, the secretion system plays no role in the
virulence of strain SA113 under the same conditions.
Introduction
Most bacteria secrete proteins into their external environ-
ments, where they play essential roles in nutrient acquisi-
tion, colonization and host interactions. Gram-negative
bacteria may elaborate any of six different protein secre-
tion systems (named Type I through Type VI) to move
proteins across their double-membrane cell envelopes, in
either a single step, or by a two-step mechanism (Desvaux
et al., 2009). Protein secretion systems that operate by a
two-step mechanism first rely on the translocation of pro-
teins across the inner membrane by either the general
secretory (Sec) or twin arginine translocase (Tat) machin-
eries, before they mediate the secretion of substrates
across the outer membrane (e.g. Pugsley, 1993; Voulhoux
et al., 2001).
Protein secretion in Gram-positive bacteria is, in most
cases, a simpler process because these organisms
(with the exception of the didermic Mycobacterial and
Corynebacterial species) are bounded by a single mem-
brane. The Sec and Tat pathways, to which proteins are
targeted by the presence of cleavable signal peptides
at their N-termini, directly secrete extracellular proteins in
these bacteria (e.g. Sibbald et al., 2006; Widdick et al.,
2006; Goosens et al., 2014). In addition, a secretion
system that has, to date, only been experimentally
described in Gram-positive bacteria, variously termed the
ESX, Ess or Type VII protein secretion system, also serves
to translocate proteins to the extracellular environment.
This secretion system was first described in pathogenic
mycobacteria where it secretes two T cell antigens,
ESAT-6 (early secreted antigenic target, 6 kDa) and
CFP-10 (culture filtrate protein 10 kDa), now renamed
EsxA and EsxB, respectively, and was shown to be essen-
tial for virulence (Hsu et al., 2003; Pym et al., 2003;
Stanley et al., 2003). This secretion system has variously
been shown to function in other actinobacterial species,
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including non-pathogenic members (Abdallah et al., 2006;
Akpe San Roman et al., 2010; Fyans et al., 2013).
A related secretion system is found in bacteria of the
low-GC Firmicutes phylum. It has been best characterized
in the opportunistic human and animal pathogen Staphy-
lococcus aureus. The relationship between the S. aureus
secretion system and the Mycobacterial ESX machineries
is limited, with only two types of conserved components.
The first is an ATPase of the FtsK/SpoIIIE protein family,
while the second is the presence of one or more of the
secreted EsxA/EsxB proteins (Pallen, 2002). EsxA and
EsxB are small acidic proteins of the WXG100 superfamily
that are structurally organized as a helical hairpin with a
conserved Trp–Xaa–Gly (WXG) motif that localizes in a
loop between the two α-helices (e.g. (Renshaw et al.,
2005; Sundaramoorthy et al., 2008). In Mycobacteria,
EsxA and EsxB form tight heterodimers that are
co-dependent on each other for secretion by the Type VII
system (Renshaw et al., 2002; Stanley et al., 2003;
Champion et al., 2006), whereas in S. aureus and related
bacteria EsxA forms homodimers (Sundaramoorthy et al.,
2008; Shukla et al., 2010; Anderson et al., 2013). Other
essential secretion components are non-conserved (at
least at the amino acid sequence level) between actino-
bacterial and Firmicutes systems, leading to them being
designated as ESX (actinobacteria) and Ess (Firmicutes)
secretion systems respectively (Burts et al., 2005; 2008;
Bitter et al., 2009).
In S. aureus the Ess system has been shown to contrib-
ute to virulence in a mouse model of abscess formation.
Mutations in the S. aureus Newman strain where any of
esxA, esxB or essC (which encodes the FtsK/SpoIIIE
family ATPase) were inactivated resulted in a significant
reduction in cfu recovered from the livers and kidneys of
mice that had been retro-orbitally injected with these
strains (Burts et al., 2005). It was later shown that EsxC
(formerly EsaC), a conserved S. aureus protein, is a sub-
strate of the Ess machinery that has a small role in abscess
formation but a more significant role during long-term
persistence of abscesses (Burts et al., 2008). Recently
EsxD was identified as a further secreted substrate
(Anderson et al., 2013). The precise function of any of the
S. aureus Ess substrate proteins remains to be elucidated.
The S. aureus Ess secretion system is encoded within
the ess gene cluster and transcription of esxA, the first
gene of the cluster, has been shown to be subject to
complex regulation by the alternative sigma factor σB
(Schulthess et al., 2012). In the S. aureus strain Newman
background, esxA appears to be monocistronic and is
not co-transcribed with the downstream ess genes
(Schulthess et al., 2012). However, transposon mutagen-
esis has confirmed that each of EssA, EssB, EssC, which
are encoded downstream of esxA in the ess cluster
(Fig. 1A) are essential for the secretion of EsxA or EsxB
(Burts et al., 2005). The EssA, EssB and EssC proteins are
membrane-bound (Burts et al., 2005; Chen et al., 2012;
Zoltner et al., 2013b) and probably form the membrane-
embedded secretion apparatus. Two further membrane
proteins are also encoded at the ess locus. Of these EsaA
is reported to have no role in EsxA secretion (Burts et al.,
2005), while loss of EsaD (recently re-named EssD)
reduces, but does not abolish, the export of EsxA
(Anderson et al., 2011).
In this study we have examined the organization of the
ess gene cluster in a range of S. aureus strain back-
grounds. Our results indicate that there are unexpected
differences in the organization of the cluster, with the esxA
gene being clearly co-transcribed with downstream ess
genes in the COL, USA300 and SA113 strains, but tran-
scribed as a monocistronic gene in the RN6390 and
Newman strains. In the RN6390 and COL strains, EsxA
and EsxC secretion could be detected throughout the
growth phase, with substantial levels of extracellular
protein accumulating from mid-logarithmic growth
onwards. Systematic deletion analysis in the RN6390
strain background confirmed prior observations that essA,
essB and essC were required for the secretion of EsxA,
but surprisingly we also show that esaA and esaB are
essential for secretion of EsxA and EsxC. Finally we show
that the Ess secretion machinery of two S. aureus strains
(RN6390 and COL) but not a third (SA113) is important for
murine nasal colonization and virulence in the murine lung
pneumonia model.
Results
The esxA gene is co-transcribed with downstream
genes in S. aureus COL, USA300 and SA113 strains,
but not in RN6390 or Newman
The ess gene cluster (Fig. 1A) has been reported to com-
prise at least 11 genes, several of which have essential or
accessory roles in the secretion of Ess substrate proteins
(Burts et al., 2005; 2008; Anderson et al., 2011). Previous
work using the S. aureus Newman strain showed that
esxA was a monocistronic gene, but the arrangement of
the downstream genes was not examined (Schulthess
et al., 2012). We therefore decided to examine whether
any of these genes were co-transcribed.
To this end, mRNA was isolated from each of five dif-
ferent S. aureus strains during exponential growth in TSB
medium (OD600 of 2.0). The strains we selected, RN6390,
Newman, USA300, SA113 and COL are all relatively
closely related strains of S. aureus from clonal complex 8
(CC8). Strains RN6390, Newman, USA300 and SA113
are of the same sequence type, ST8, whereas COL is of
sequence type 250 within CC8 (Herbert et al., 2010). Oli-
gonucleotide primer pairs were designed that either
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primed within the esxA gene (primer pair 1), that spanned
the 83 bp intergenic region between esxA and esaA, or
that spanned intergenic regions between the additional
downstream genes (primer pairs 3 – 7; Fig. 1A, Table S1).
For strains Newman and RN6390, primers amplifying
within esxA gave a product of the expected size; however,
no product was obtained using primers that spanned
between esxA and esaA (Fig. 1C), confirming previous
findings with Newman that esxA is a monocistronic gene
(Schulthess et al., 2012). Unexpectedly, however, the
same primer pairs amplified a clear product of the
expected size from the mRNA of strains COL, USA300
and SA113. Thus it can be concluded that the esxA and
esaA genes are part of the same transcriptional unit in
these three strains, and that there is heterogeneity in the
transcriptional organization of the ess gene cluster
between different strains of S. aureus.
Primer pairs 3–7 gave products of the expected sizes
for mRNA isolated from all five S. aureus strains, strongly
indicating the presence of a single transcript spanning
from esaA to SAOUHSC_00269, for strains Newman and
RN6390, and from esxA to SAOUHSC_00269, for strains
COL, USA300 and SA113. These findings suggest that
the uncharacterized gene SAOUHSC_00269 is associ-
ated with Ess secretion.
A promoter is present in the esxA-esaA intergenic
region in strain RN6390
To confirm the findings from the RT PCR experiments,
5′-RACE was used to identify transcription start sites
within the esxA-esaA intergenic region and upstream of
esxA, using an oligonucleotide that primes within esaA, or
within esxA respectively. We focused on strains RN6390
and USA300, representing the two different transcriptional
organizations of the ess operon, and sampled at two time
points during exponential growth in TSB medium (OD600 of
1.0 and 2.0 respectively). When mRNA from RN6390 was
used as template, a transcriptional start site within the
esxA-esaA intergenic region was identified (labelled TSP2
in Fig. 2). This start site is downstream of a likely promoter
sequence showing a reasonable match to the −35 and −10
consensus sequences. This transcriptional start site was
not identified when mRNA from USA300 was used,
instead the sequence read continued into the upstream
esxA gene. Using a primer that primes within esxA, the
Fig. 1. Organization of the ess locus in different strains of S. aureus.
A. Schematic representation of the S. aureus ess locus derived from the NCTC8325 genome sequence. The region from the start of esxA to
the end of SAOUHSC_00269 covers approximately 14 kb and is almost 100% identical between the RN6390, Newman, COL and USA300
strains (only two nucleotide differences over this region). Genes encoding secreted substrates are coloured in red, membrane components in
green, cytoplasmic components in blue and unknown components in orange. Putative unrelated genes are shaded in grey. Note that the sizes
of the intergenic regions are as follows: SAOUHSC_00256-esxA, 247 bp; esxA-esaA, 83 bp; esaA-essA, −1 bp; essA-esaB, −68 bp;
esaB-essB, 12 bp; essB-essC, 21 bp; essC-esxC, 29 bp; esxC-esxB, 15 bp; esxB-esaE, −1 bp; esaE-esxD, −1 bp; esxD-essD, 9 bp;
essD-SAOUHSC_00269, 10 bp; SAOUHSC_00269-SAOUHSC_00270, 207 bp.
B. Schematic representation of subcellular location and predicted topologies of the proteins encoded at the ess locus (not to scale). Shading
as in part A.
C. RT-PCR analysis of mRNA isolated from each of the five different strains, using primer pairs listed in Table S1. The expected sizes for PCR
products 1–7 are 272, 953, 1023, 1153, 1168, 959 and 946 bp respectively.
Fig. 2. A transcription start site in the esxA-esaA intergenic region of strain RN6390. DNA sequence covering the promoter region and
transcriptional start site of the esxA gene through to the start of esaA. Note that the sequence of this region is identical between all strains
used in this study. Transcriptional start points (indicated TSP1 and TSP2), mapped by 5′-RACE, are indicated in bold. TSP1 was identified
from strains RN6390 and USA300, whereas TSP2 was identified from RN6390 only. Putative −35/−10 regions are underlined, the coding
regions for esxA and esaA are shown in upper case letters and boxed (esxA is truncated to save space), and putative Shine–Dalgarno
sequences are given in italics. A predicted rho-independent terminator for the esxA gene is indicated above the sequence.
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same transcriptional start site (TSP1 in Fig. 2) was identi-
fied from both of the mRNA samples. This is the same start
site for esxA transcription identified by Schulthess et al.
(2012).
It is interesting to note that there is a potential rho-
independent terminator sequence in the esxA-esaA inter-
genic region, overlapping with the transcriptional start site
and putative promoter for esaA. The same sequence is
found in all five strains, and although it presumably acts
as an effective terminator in strains Newman and
RN6390, it must allow at least partial readthrough in the
other strains examined here.
The esxA gene is overexpressed compared to other
genes in the ess cluster
We next examined whether the two different transcrip-
tional organizations of the ess clusters affected the ratio
between esxA transcript level and the levels of down-
stream transcripts. For these experiments, mRNA was
isolated from strains RN6390, USA300 and COL when the
culture optical density at 600 nm (OD600) reached 1.0 and
2.0 respectively. Reverse transcription of the mRNA fol-
lowed by quantitative PCR, using the relative standard
curve method, was undertaken to determine the relative
levels of the ess genes esxA, esaA, essC and esxB, using
the 16s rRNA gene as the endogenous control in these
experiments. The relative expression levels were subse-
quently normalized, against essC, which was set to a
relative expression level of 1 in each case.
As shown in Fig. 3, esxA is by far the most highly
expressed of the ess genes tested, at an expression level
approximately 100 times higher than that of essC for all
three strains. The esaA gene is also more highly
expressed than essC, being up to around 10 times more
highly expressed, while esxB is expressed to similar
levels as essC in all three strains. We conclude that
despite the different mechanisms for transcriptional
control of the ess genes in different S. aureus strains they
ultimately give similar transcript level ratios among the
encoded genes.
The Ess secretion system is active in different
S. aureus strains
The experiments described above show that mRNAencod-
ing Ess secretion system components is expressed in
S. aureus strains cultured in the laboratory growth medium
Trypticase Soy Broth (TSB). To determine whether the
secretion system is active under these growth conditions,
each strain was cultured under similar growth conditions
and samples were withdrawn when the culture OD600
reached 1.0, 2.0, 3.0 or 5.0. The withdrawn samples were
centrifuged to separate the cells from the culture superna-
tant, and each fraction was analysed by Western blotting
with antibodies to each of the two Ess-secreted proteins
EsxA and EsxC, and the cytoplasmic marker protein TrxA.
As shown in Fig. 4, secretion of both of the Ess sub-
strates tested could be detected for strains RN6390,
USA300, COL and SA113. Ess secretion activity of
USA300 grown in TSB medium has also been reported
previously (Anderson et al., 2013). For strains COL and
RN6390 secretion of EsxA and EsxC could be detected at
the earliest growth point tested, whereas secretion of these
proteins was not detected for USA300 until the cells had
reached an OD600 of 2, and for SA113 secretion was only
clearly detectable when cells reached an OD600 of 3 or
above. It should be noted that the presence of EsxA was
detected on the surface of cells in shaving experiments of
COL harvested in early exponential phase (Dreisbach
et al., 2010; Solis et al., 2010). At the latest growth point
tested, EsxA (but not EsxC) had disappeared from the
culture supernatant of RN6390, although it was still present
Fig. 3. The esxA gene is overexpressed compared to esaA, essC
and esxB. mRNA isolated from the indicated strains that had been
grown aerobically in TSB medium to an OD600 of 1 (A) or 2 (B) was
reverse transcribed into cDNA for use in quantitative RT-qPCR
experiments. Relative cDNA of esxA, esaA and esxB, calibrated in
relation to essC levels, were calculated by the relative standard
curve method (Larionov et al., 2005), using 16S cDNA as
endogenous control.
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in the supernatants of the other three strains. It has been
reported that RN6390 is deregulated for the production of
extracellular protease which may account for the loss of
EsxA from the supernatant at high cell density (Karlsson
and Arvidson, 2002; Rigoulay et al., 2005). Indeed, we did
note the presence of an additional smaller form of EsxA in
the supernatant fractions of RN6390 (but not of other
strains) with some batches of our polyclonal EsxA antise-
rum (not shown).
By contrast with the other four strains, no secretion of
EsxA was detectable for strain Newman at any of the
growth points examined. Some EsxA antigen was
detected at OD600 of 2 and above, but this was found
exclusively in the cellular fraction. We were unable to
detect any clear signal for EsxC in either the supernatant
or cellular fractions (not shown) – this is consistent with a
previous study which showed that EsxC was repressed
when Newman was grown in broth (Burts et al., 2008).
Deletion analysis confirms that EssA, EssB and EssC
are essential to support Ess-dependent secretion in
strain RN6390
To identify genes encoded at the ess locus that are essen-
tial for Ess secretion system activity, we constructed
in-frame deletions of each of esaA, esaB, essA, essB,
essC, esxA, esxB and esxC in S. aureus strain RN6390.
We first confirmed that each of the individual deletion
strains did not have a polar effect on downstream genes
by blotting for the presence of the secretion substrate
EsxC (Fig. 5) and/or the membrane components EsaA,
EssB and EssC (Fig. S2). We then tested the effect of
each individual deletion on the presence of Ess sub-
strates EsxA and EsxC in the culture supernatant.
EssA and EssB are monotopic membrane proteins
(Fig. 1B) that are conserved components encoded at ess
loci in Firmicutes (e.g. Burts et al., 2005; Baptista et al.,
2013). Previous studies in the Newman strain background
reported that transposon insertions in either essA or essB
abolished secretion of EsxA (Burts et al., 2005). In agree-
ment with this, it can be seen (Fig. 5) that in-frame dele-
tion of either essA or essB resulted in a complete absence
of EsxA from the culture supernatant. However, in the
Newman background insertional inactivation of either of
these genes resulted in a destabilization of EsxA and
EsxB (Burts et al., 2005), whereas in RN6390 (Fig. 5), as
in USA300 (Anderson et al., 2013), EsxA protein is clearly
detectable in the cellular fraction, even when the Ess
system is inactivated. Analysis of EsxC localization
showed a similar pattern, i.e. that deletion of essB
Fig. 4. The Ess secretion system is active in different S. aureus strains. The indicated S. aureus strains were cultured in TSB medium, and
once the OD600 of the culture reached each of 1, 2, 3 or 5 an aliquot was removed and centrifuged to give the culture supernatant (sn) and
cellular (c) fractions. Samples were separated on 15% bis-Tris gels and immunoblotted using anti-EsxA, EsxC or TrxA antisera. For the EsxA
blots, 7.5 μl of culture supernatant and 5 μl of cells adjusted to an OD600 of 0.25 were loaded (5 μl of OD600 1 cells for Newman and SA113).
For the TrxA blots, twice the amount of supernatant and cells samples as described for the EsxA blots were used. For the EsxC blots, TCA
precipitated supernatant equivalent to 100 μl culture supernatant and 10 μl of cells adjusted to an OD600 of 1 were loaded.
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resulted in no detectable secretion of EsxC, and that
deletion of essA also resulted in a very severe EsxC
secretion defect, although we routinely always detect a
very low level of EsxC in the supernatant fraction of this
strain. Again it should be noted that, similar to EsxA,
cellular EsxC appeared stable even when the Ess system
was inactivated.
EssC is a bitopic membrane protein that is conserved
among the Ess and ESX secretion systems. Sequence and
structural analysis indicates that the Firmicutes proteins
have an N-terminal cytoplasmic region that adopts a
tandem forkhead-associated domain fold and two itera-
tions of the FtsK/SpoIIIE family domain in the C-terminal
region that contain putative ATP binding P-loop motifs
(Tanaka et al., 2007). Wherever examined, the EssC-like
proteins have been shown to be essential for Ess secretion
(e.g. Burts et al., 2005; Garufi et al., 2008; Baptista et al.,
2013), and indeed in-frame deletion of essC in S. aureus
RN6390 leads to total absence of EsxA and EsxC from the
culture supernatant (Fig. 5).
To determine where the EsxA and EsxC proteins were
localized when the secretion system was inactivated, we
fractionated cells of the essA and essC mutant strains,
along with the wild-type into the cell wall, membrane and
cytoplasmic fractions. These samples were then probed
with anti-EsxA and anti-EsxC antisera, along with antisera
to the control proteins thioredoxin A (TrxA), protein A (Spa)
or sortase A (SrtA). In the wild-type strain, EsxA and EsxC
were detected largely in the cytoplasmic and supernatant
samples, although some antigen was detected in the cell
wall and traces of EsxC were also present in the mem-
brane fraction. By contrast, in the essC mutant strain
EsxA and EsxC were detected exclusively in the cytoplas-
mic fraction, confirming that EssC is essential for secre-
tion of these proteins across the cytoplasmic membrane.
Fractionation of the essA strain gave a slightly different
result. Although EsxA was found exclusively in the cyto-
plasmic fraction in the absence of EssA, some EsxC
protein could be detected in the cell wall and membrane
fraction in the essA mutant. This is consistent with the
results presented in Fig. 4, where low levels of EsxC were
detected in the supernatant of the essA strain. We con-
clude that although clearly important, EssA is not abso-
lutely essential for secretion of EsxC.
Deletion analysis reveals an essential role for EsaA and
EsaB in the export or extracellular stability of Ess
substrates in strain RN6390
EsaA is a polytopic membrane protein with a long extracel-
lular loop that has been shown through protease shaving
experiments to extend to the surface of S. aureus
(Dreisbach et al., 2010). The homologous protein in Bacil-
lus subtilis, YueB, is also surface-exposed and serves as a
receptor for phage SPP1 infection (Sao-Jose et al., 2004;
2006). It has previously been reported in the Newman
strain background that a transposon insertion in esaA had
no effect on EsxA and EsxB secretion (Burts et al., 2005).
Interestingly, however, we noted that deletion of esaA
completely abolished secretion of EsxA and EsxC in strain
RN6390. It is unlikely that the secretion defect seen with
the RN6390 esaA− strain arose due to polar downstream
effects because (i) the EssB and EssC proteins that are
encoded immediately downstream of esaA are clearly
Fig. 5. EsxA and EsxC are not detected in culture supernatants if esaA, esaB, essA, essB, or essC are deleted in the RN6390 strain
background. The RN6390 wild-type (wt) or isogenic deletion strains, as indicated, were cultured in TSB medium until an OD600 of 2 was
reached. Samples were withdrawn and separated into culture supernatant (sn) and cellular (c) fractions. An equivalent of 200 μl of culture
supernatant and 10 μl of resuspended cell sample adjusted to a calculated cell density of OD 1 was loaded in each lane, samples were
separated on 15% bis-Tris gels and immunoblotted with anti-EsxA, anti-EsxC or anti-TrxA antibodies. For the EsxA immunoblot, 1 ng of
purified EsxA protein (pure) was loaded as control. Molecular weight markers are indicated to the left of the blot.
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detectable in the esaA mutant strain (Fig. S2), and (ii)
re-introduction of plasmid-encoded his-tagged EsaA into
the esaA mutant background restored EsxA secretion (Fig.
S3). We therefore conclude that in RN6390, EsaA is an
essential component of the Ess secretion machinery. It
should be noted that the B. subtilis EsaAhomologue, YueB,
which is encoded within the B. subtilis ess gene cluster, is
similarly also essential for the secretion of B. subtilis EsxA
(YukE) (Baptista et al., 2013). Subcellular fractionation of
the esaA strain showed that EsxA and EsxC were located
almost exclusively in the cytoplasm (Fig. 6).
We also examined the roles of soluble Ess-encoded
components on secretion of EsxA and EsxC. EsaB is a
small (93 aa) protein that is structurally closely related to
ubiquitin, although it lacks the conserved C-terminal
double glycine motif (van den Ent and Lowe, 2005). It has
been reported to act as a negative regulator for EsxC in S.
aureus Newman and EsxC could only be detected when
esaB was deleted. EsxC antigen could be detected in other
strains of S. aureus, but again in the USA300 background
deletion of esaB resulted in upregulation of EsxC levels. In
each case loss of esaB did not affect secretion of EsxC to
the growth medium (Burts et al., 2008). Deletion of esaB in
strain RN6390 resulted in an unexpected phenotype,
because it abolished detectable secretion of EsxA and
EsxC, indicating that it is essential for Ess secretion system
activity in this strain background. It should be noted that a
homologue of S. aureus EsaB (YukD) is also encoded
within the B. subtilis ess gene cluster and is likewise
essential for the secretion of EsxA (Baptista et al., 2013).
Thus, an essential role for EsaB in Ess secretion appears
to be at least partially conserved.
Previous reports have indicated that in strain Newman
the presence of EsxB is essential for the stability of EsxA
(Burts et al., 2005). However in RN6390, loss of esxB does
not affect the stability or secretion of EsxA (Fig. 5). This is
also in contrast to reports of the interdependence of EsxA
and EsxB for secretion by the ESX machinery in Mycobac-
teria (Champion et al., 2006), although it should be noted
that Mycobacterial EsxA and EsxB interact strongly
(Renshaw et al., 2002; 2005) whereas there is no detect-
able interaction between S. aureus EsxA and EsxB
(Sundaramoorthy et al., 2008; Anderson et al., 2013).
Loss of esxB does, however, abolish secretion of EsxC
(Fig. 5).
Similar to the esxB deletion, the deletion of esxA
severely affected the secretion of EsxC (Fig. 5). In con-
trast, deletion of the esxC gene did not affect the secretion
of EsxA. Thus EsxC depends upon EsxA for secretion but
this is not a reciprocal requirement.
From the results presented here we conclude that in
S. aureus strain RN6390 the Ess secretion system com-
Fig. 6. Subcellular location of EsxA and EsxC in RN6390 and isogenic esaA, essA and essC mutant strains. The RN6390 wild-type (wt) or
isogenic deletion strains, as indicated, were cultured in TSB medium until an OD600 of 2 was reached. The cells were spun down and the
supernatant (sn) was retained as the secreted protein fraction. The cell pellets were subsequently fractionated into cell wall (cw), membrane
(m) and cytoplasmic (cyt) fractions as described in Experimental procedures. An equivalent of 100 μl of culture supernatant and cell wall,
membrane and cytoplasmic samples corresponding to the respective fractions from 10 μl of cells adjusted to an OD600 of 1 were separated on
bis-Tris gels and immunoblotted using the anti-EsxA or EsxC antisera, or control antisera raised to TrxA (cytoplasmic protein), protein A (Spa,
cell wall) or sortase A (SrtA, membrane).
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prises the membrane proteins EsaA, EssA, EssB and
EssC, along with the secreted protein EsxA and the cyto-
plasmic protein EsaB.
The Ess system in two strains of S. aureus contributes
significantly to virulence in a murine pneumonia model
It has previously been demonstrated that components
and secreted substrates of the Ess system in the
S. aureus Newman strain contribute to virulence in a
mouse model of abscess formation (Burts et al., 2008).
We therefore first sought to test whether Ess secretion
was required for virulence in additional models of infec-
tion, and second whether there might be any strain-
specific differences in Ess requirement for virulence.
To this end, we constructed complete deletions of the
entire 12 gene ess loci in each of the RN6390, COL and
SA113 strains. Deletion of this locus had no effect on
growth rate of the strains in different laboratory growth
media (Fig. S4 and data not shown). Loss of ess also had
no detectable effect on virulence of RN6390 or COL in the
insect infection model, Galleria mellonella (Fig. S5). We
conclude that loss of Ess secretion does not have a phe-
notypic effect on growth of these S. aureus strains.
Staphylocccus aureus frequently colonizes the anterior
nares of humans, and is an important cause of ventilator-
associated pneumonia in hospital settings (e.g. Rocha
et al., 2013). It is also one of the earliest bacterial patho-
gens to colonize the airways of cystic fibrosis patients,
where it often persists for many years (e.g. Kahl et al.,
1998; Kahl et al., 2003; The United States Cystic Fibrosis
Foundation, 2011, Patient Registry Annual Data Report).
We therefore sought to assess whether the Ess secretion
system was required first for nasal colonization and
second for the development of pneumonia in the cystic
fibrosis mouse infection model (McCarthy et al., 2010;
Twomey et al., 2012).
To test the ability of RN6390, COL and SA113 or the
cognate ess deletion strains to colonize the mouse nasal
passages, C57BL/6 mice were inoculated with 108 colony-
forming units (cfu) of each of the strains, and the number
of cfu colonizing the nares were assessed after 3 days.
Significantly lower cfu ml−1 were recovered from the nares
for the Δess strains of RN6390 (P = 0.003) and COL
(P = 0.02) compared to the cognate wild-type, demon-
strating that the Ess system is required to support nasal
colonization in these strain backgrounds (Fig. 7D). Sur-
prisingly, no difference in colonizing ability was observed
between SA113 and its corresponding Δess mutant
(P = 1.0). It should be noted that SA113, which carries a
mutation in agr, forms more robust biofilms than RN6390
and COL (e.g. Beenken et al., 2003; Herbert et al., 2010),
and that SA113 also reportedly produces larger amounts
of certain MSCRAMM adhesins, for example Spa, than
COL (Herbert et al., 2010). It is possible that these fea-
tures of SA113 may over-ride for any role of the Ess
system in colonization by this strain.
To determine whether the Ess system was required for
virulence in the murine pneumonia model, we infected
cystic fibrosis transmembrane conductance regulator
(CFTR) knockout mice intra-nasally with either of RN6390,
COL and SA113 or the cognate ess deletion strains
(Fig. 7A–C). Again, it can clearly be seen that there were
strain-specific differences in the contribution of the Ess
secretion system to virulence in the pneumonia model.
Thus, mortality was significantly reduced following infec-
tion with the Δess mutants at 48 h in the RN6390 strain
background (P = 0.03 by log-rank test), and in the COL
background (P = 0.008). Strain SA113 was less virulent
than the other strains we tested in our particular virulence
model, which may arise due to the agr mutation that is
known to lead to a downregulation of virulence factor
production (e.g. Abdelnour et al., 1993; Novick et al.,
1993). However, again we noted that there no difference in
survival was observed between SA113 the cognate Δess
strains (P = 1.0).
Discussion
In this study we have investigated the genetic organiza-
tion of loci encoding the Type VII/Ess protein secretion
system in closely related strains of S. aureus and
assessed whether the secretion systems are active in
these organisms and contribute to virulence. We chose to
focus on five strains from clonal complex 8, RN6390,
Newman, USA300, SA113 and COL. While the ess gene
cluster is almost identical in nucleotide sequence between
these strains (two nucleotide differences over the approxi-
mately 14 kb region), the genetic organization surprisingly
differed between RN6390 and Newman on the one hand
and USA300, SA113 and COL on the other. In the latter
three strains the first gene of the cluster, esxA, was coex-
pressed with esaA, which is positioned 83 nucleotides
downstream. By contrast, in RN6390, esxA was monocis-
tronic and esaA was expressed exclusively from a pro-
moter located in the esxA-esaA intergenic region. Despite
the 100% sequence conservation between the five strains
over this region, no promoter activity in this intergenic
region was detected for USA300.
A putative rho-independent terminator sequence is
located in the esxA-esaA intergenic region. Ostensibly, this
must function as a highly effective terminator in RN6390
and Newman, while allowing readthrough in USA300,
SA113 and COL. However, despite the surprising differ-
ences in transcriptional organization of esxA and esaA
between strains, comparison of transcript levels of these
two genes indicate that the ratio of esxA and esaA tran-
scripts remain remarkably similar. The molecular basis for
936 H. Kneuper et al. ■
© 2014 The Authors. Molecular Microbiology published by John Wiley & Sons Ltd., Molecular Microbiology, 93, 928–943
these unexpected transcriptional differences is not known,
but presumably it results from strain-specific variation in
the function of trans-acting factors. Our additional RT-PCR
analyses, coupled with the short intergenic regions
between the remaining genes, make it highly likely that
esaA through SAOUHSC_00269 are all coexpressed.
In addition to the heterogeneity of ess transcriptional
organization, we also saw that there were notable differ-
ences between strains in the activity of the Ess secretion
system. During growth in TSB medium strains RN6390 and
COL secreted EsxA and EsxC at relatively early growth
points, whereas for USA300 and SA113, secretion
appeared to be delayed and was only observed at later
growth points. We were unable to observe any secretion of
EsxA in strain Newman at any of the growth points we
tested, and could not detect EsxC antigen. It has been
noted previously that Newman produces and secretes
EsxA at a low level relative to USA300 (Burts et al., 2008).
Recently, it was shown that the ess cluster in Newman
and USA300 is negatively regulated by the SaeRS two-
component system, but that this system is constitutively
active in the Newman strain due to a point mutation in the
SaeS kinase, accounting for the low Ess activity (Anderson
et al., 2013).
Selecting one of the early secreting strains, RN6390, we
made a series of in-frame deletions in the first eight ess-
encoded genes to determine whether they were essential
to support Ess secretion system activity. Our results were
in partial agreement with prior observations in strain
Newman (Burts et al., 2005; 2008) – thus we confirmed in
the RN6390 background that the EssA, EssB and EssC
membrane components are required for secretion of EsxA
and EsxC. However, we also demonstrated an essential
role for a further membrane protein, EsaA, in secretion
system activity. This contrasts with Burts et al. (2005) who
reported that a transposon insertion in esaA did not abolish
secretion of EsxA or EsxB. However in that study the
transposon was inserted after codon 370 of esaA, raising
the possibility that a truncated protein product was pro-
duced that may retain some function. It should be noted
that EsaAhomologues are conserved in Firmicutes and the
B. subtilis EsaA homologue, YueB, is essential for Ess
secretion activity in this organism (Baptista et al., 2013).
Taken together, these results strongly suggest that EsaA
Fig. 7. The Ess secretion system of strains RN6390 and COL contributes to nasal colonization and virulence in the murine pneumonia
model. For the murine pneumonia model mice (n = 10 mice per experiment) were infected at time zero with 2 × 108 cfu of S. aureus strains
RN6390 (A), COL (B) or SA113 (C) or the cognate Δess mutant strains as indicated. Survival was assessed for up to 48 h. (B) For the murine
nasal colonization model, mice (n = 10 mice per experiment) were infected with 2 × 108 cfu per nostril of the indicated strains and colonization
status determined following nasal excision at 48 h.
Type VII secretion in S. aureus 937
© 2014 The Authors. Molecular Microbiology published by John Wiley & Sons Ltd., Molecular Microbiology, 93, 928–943
proteins are essential components of the Ess secretion
machinery.
A striking finding was that for all strains examined,
secretion appeared to be relatively inefficient, with signifi-
cant amounts of EsxA and EsxC detected in the cellular
fraction, and subcellular fractionation of RN6390 showed
that they were primarily located in the cytoplasm. We also
noted that for USA300 and SA113, cellular EsxA was
detected at early growth points, but did not appear in the
growth medium until later. These findings raise the possi-
bility that the system may be subject to post-translational
regulation. Other protein secretion systems are also regu-
lated at the post-translational level, for example the Type VI
secretion system in Gram-negative bacteria. In Pseu-
domonas aeruginosa it has been shown that a serine-
threonine kinase, PpkA, phosphorylates a FHA domain-
containing protein, regulating the activity of the Type VI
secretion system (Mougous et al., 2007). It is interesting to
note that in Firmicutes, the EssC component has tandem
FHA domains at its N-terminus (Tanaka et al., 2007) that
may be involved in controlling secretion activity. The small
ubiquitin-related protein, EsaB, could also play a role in
post-translational regulation of the secretion system. Here
we found that esaB is essential for secretion of EsxA and
EsxC, and Baptista et al. (2013) similarly reported that the
B. subtilis EsaB homologue, YukD, was required for activ-
ity. By contrast, in the S. aureus Newman strain EsaB is
dispensable for secretion of EsxA or EsxB but has a
negative regulatory effect on the expression of esxC at the
post-transcriptional level (Burts et al., 2008). Given that
EsaB is not universally essential for Ess secretion it is
unlikely to be a structural component of the machinery.
Instead we favour the idea that it plays a regulatory role
albeit one that may differ between strains.
Our qRT-PCR analysis has shown that esxA is very
highly expressed relative to the other genes at the ess
locus, approximately 100 times more than essC or esxB.
The role of EsxA in Type VII secretion systems is not
completely clear. It is evident that it is secreted by the
Type VII machinery, but deletion or insertional activation
of esxA always results in a complete absence of all other
secreted substrate proteins in the growth medium (Burts
et al., 2005; Anderson et al., 2013; this study). In this
respect it behaves like one of the core components of the
secretion machinery (potentially an extracellular structural
component or chaperone) rather than a secreted sub-
strate. By contrast, deletion of genes coding for two
further secreted substrates, esxB and esxC, did not affect
secretion of EsxA in RN6390, placing EsxA at the top of
the hierarchy of Ess-secreted proteins. It should be noted
that complex effects have been observed in other strain
backgrounds, for example EsxA was destabilized in the
esxB mutant of Newman (Burts et al., 2005) but not
USA300, although EsxA was not secreted in this case
(Anderson et al., 2013). Likewise, absence of EsxC, with
which EsxA was demonstrated to interact, appeared to
destabilize EsxA in USA300 (Anderson et al., 2013), but
this was not evidenced here for RN6390. Such complex,
strain-specific effects make it difficult to tease out the
roles of individual secreted proteins in secretion system
function and to pin-point what contribution, if any, each
secreted protein has to S. aureus virulence.
Prior reports have defined a role for the Ess system of
strain Newman in virulence in a murine abscess infection
model. Here we asked whether the Ess system was
required for S. aureus to colonize the murine nasal
passage, which is usually asymptomatic and benign, and
to cause pneumonia following intra-nasal inoculation. Sur-
prisingly we found for two of the three strains tested,
RN6390 and COL, that the Ess system was important for
both of these processes. Currently it is not clear how the
Ess system could contribute to nasal colonization,
although it has been observed that other secretion systems
also play a major role in this bacterial behaviour (e.g.
Skinner et al., 2004). Very recently it was reported that the
essC gene in strain Newman was upregulated in the
presence of pulmonary surfactant and that deletion of essC
was accompanied by a similar attenuation in virulence in
the murine pneumonia model as we report here (Ishii et al.,
2014). By contrast, the third strain we tested, SA113,
showed no significant contribution of the Ess system to
either colonization or disease. The underlying reasons for
these strain-specific differences are not known, and do not
entirely correlate with the activity of the Ess secretion
systems in laboratory growth media. Taken together with
previous findings, the results presented here demonstrate
that there are notable differences between the transcrip-
tional organization of the ess locus, the absolute require-
ment of individual ess-encoded genes for secretion system
function, secretion activity in laboratory broth and require-
ment for virulence between relatively closely related
strains of S. aureus and that findings cannot necessarily be
extrapolated between strains. Therefore, the precise role
of individual machinery components and contribution of
specific secreted substrates to disease requires further
study.
Experimental procedures
Bacterial strains and growth conditions
Strains and plasmids used in this study are listed in Table 1.
S. aureus strains were grown in TSB at 37°C under vigorous
agitation. Chloramphenicol (Cm) at a final concentration of
10 μg ml−1 or erythromycin (Erm, 5 μg ml−1) was added for
plasmid selection. Anhydrotetracycline (ATc) was used at
various concentrations as a selection during allelic gene
replacement using the pIMAY system [1 μg ml−1 (Monk et al.,
2012)] or for induction of target gene expression from the
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pRMC2 plasmid (Corrigan and Foster, 2009). Escherichia coli
was grown aerobically in Luria–Bertani (LB) medium at 37°C.
If required, cultures were supplemented with ampicillin (Amp,
100 μg ml−1) or chloramphenicol (15 μg ml−1) for plasmid
selection.
Strain and plasmid construction
In-frame deletions of individual ess genes or a 12-gene ess
deletion (encompassing esxA through SAOUHSC_00269)
were performed by allelic exchange using either plasmid
pMAD (for essA, esaB, essB, esxC, esxB) or pIMAY (for esxA,
esaA, essC, and the 12 gene ess deletion) as described
(Arnaud et al., 2004; Monk et al., 2012). For each gene, the
upstream and downstream regions including at least the first
three and last three codons were amplified from RN6390
genomic DNA using primers listed in Table S1. In the case of
overlapping genes within the ess cluster (esaA-essA, essA-
esaB, esxB-esxD), the amplified flanking regions were
designed to leave the putative ribosome binding site and start
codon or stop codon of the overlapping gene intact. Clones
containing the amplified flanking regions in vectors pMAD or
pIMAY were selected in E. coli and plasmids were subse-
quently electroporated into S. aureus strains using published
methods (Monk et al., 2012). Chromosomal deletions were
verified by amplification of the genomic region from isolated
genomic DNA (GeneElute Bacterial Genomic DNA Kit, Sigma
Aldrich) and DNA sequencing of the amplified products. To
ensure that no unwanted secondary mutations arose in viru-
lence regulators such as agr or sae, each mutant was also
tested for haemolytic activity on sheep blood agar plates. In
each case no detectable difference in haemolytic activity
between the wild-type and any of the mutant strains was
observed.
A variant of plasmid pRMC2 coding for an N-terminal hexa-
histidine tag (pRMC2h) was generated by insertion of the
additional coding sequence into the multiple cloning site
(MCS). Briefly, the region between the XhoI site and the MCS
of pRMC2 was amplified with primers pRMC2seq1 and
Nhisins, adding an 18 bp stretch corresponding to the short
sequence of DNA from the ribosome binding site to the ATG
start codon of the esxA gene followed by the hexahistidine
coding sequence (6× CAT repeats) between the KpnI and BglII
restriction sites of the MCS. pEsaA-nhis was constructed by
amplification of the esaA coding region from RN6390 genomic
DNA using primers esaA nhis fw and esaA nhis rev (see Table
S1) and cloning between the BglII and SacI sites of pRMC2h.
RT-PCR and 5′-RACE experiments
mRNA extraction from S. aureus strains grown aerobically
in TSB to an OD600 of 1 or 2 was performed using the SV
Table 1. Strains and plasmids used in this study.
Strain or plasmid Description Reference
Strains
S. aureus
RN6390 NCTC8325 derivative, rbsU, tcaR, cured of φ11, φ12, φ13 Novick et al. (1993)
COL MRSA, agr Dyke et al. (1966), Gill et al. (2005)
USA300 Community-acquired MRSA McDougal et al. (2003)
Newman ATCC 25904 Duthie and Lorenz (1952), Baba
et al. (2008)
SA113 NCTC8325 derivative, agr, rbsU, tcaR, hsdR Iordanescu and Surdeanu (1976)
RN6390 ess Complete deletion from esxA – SAOUHSC_00269 This work
RN6390 esxA esxA deletion This work
RN6390 esaA esaA deletion This work
RN6390 essA essA deletion This work
RN6390 esaB esaB deletion This work
RN6390 essB essB deletion This work
RN6390 essC essC deletion This work
RN6390 esxC esxC deletion This work
RN6390 esxB esxB deletion This work
COL ess Complete deletion from Sacol0271 (esxA) -Sacol0282 This work
SA113 ess Complete deletion from esxA – SAOUHSC_00269 This work
E. coli
JM110 rpsL thr leu thi lacY galK galT ara tonA tsx dam dcm glnV44 Δ(lac-proAB)
e14- [F’ traD36 proAB+ lacIq lacZΔM15] hsdR17(rK−mK+)
Stratagene
MC1061 F− Δ(ara-leu)7697 [araD139]B/r Δ(codB-lacI)3 galK16 galE15 λ− e14−
mcrA0 relA1 rpsL150(strR) spoT1 mcrB1 hsdR2(r−m+)
Casadaban and Cohen (1980)
DC10B dam+ dcm− hsdRMS endA1 recA1 Monk et al. (2012)
Plasmids
pBluescript KS+ General purpose E. coli cloning vector, ampr Stratagene
pMAD E. coli/S. aureus shuttle vector, temperature sensitive, ampr, eryr Arnaud et al. (2004)
pIMAY E. coli/S. aureus shuttle vector, temperature sensitive, cmlr Monk et al. (2012)
pRMC2 E. coli/S. aureus shuttle vector, inducible protein expression, ampr, cmlr Corrigan and Foster (2009)
pRMC2h pRMC2 variant coding for N-terminal hexahistidine tag This work
pEsaA-nhis pRMC2h expressing His6-EsaA This work
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Total RNA Isolation Kit (Promega) with some minor modifi-
cations. Briefly, cell samples were stabilized in 5% phenol/
95% ethanol and centrifuged at 2770 g for 10 min. Cells
were resuspended in 100 μl TE buffer containing 500 μg
ml−1 lysostaphin and 50 μg ml−1 lysozyme and incubated at
37°C for 30 min followed by isolation of the RNA according
to the manufacturer’s instructions. Isolated RNA was further
purified using the DNA-free kit (Ambion) to remove DNA
and salt.
RT-PCR to probe co-transcription of ess genes was carried
out using the Superscript III Reverse Transcriptase kit (Invit-
rogen) using region-specific primers (region-x-f and region-
x-r) listed in Table S1, followed by incubation with 2 units of
E. coli RNaseH (Invitrogen) to remove template RNA. PCR
products were purified using the PCR purification kit (Qiagen)
and visualized on 1% agarose gels.
First-strand cDNA synthesis for 5′-RACE was performed
following the protocol for the Roche second-generation 5′/3′-
RACE kit using 500 ng of template RNA prepared as
described above, gene-specific primers for esxA or esaA
GSP1-3 and anchor primers listed in Table S1. Single PCR
products were purified using the PCR purification kit (Qiagen),
digested with ClaI/XhoI (esxA) or ClaI/EcoRI (esaA) and
cloned into pBluescript KS+. Transcriptional start points were
determined by sequencing with primer M13-F.
RT-qPCR
RNA was extracted as described above and 600 ng of total
RNA was used to generate 20 μl of cDNA using the QuantiTect
Reverse Transcription Kit (Qiagen), following the manufactur-
er’s instructions. For each sample, a negative control was
prepared replacing the enzyme mixture with additional water.
Quantitative PCR was performed using a Stratagene
Mx3005P thermal cycler. Triplicate reactions for each culture
condition were set using 7.5 μl Brilliant II SYBR Green Low
Rox SuperMix (Agilent), 0.6 μl 10 mM primers (see Table S1)
and 3.0 μl of cDNA diluted 1:20, and made up to 15 μl with
sterile water. PCR was performed using an initial 10 min 95°C
denaturing step followed by 40 repeated cycles of 30 s 95°C
denaturing, 30 s 55°C annealing, and 30 s 72°C extension
steps.Afinal 10 min denaturing curve analysis was performed.
Standard curves were generated from serial 10-fold dilutions
of genomic DNA (see Fig. S1). Amplification results were
analysed with MxPro QPCR software to give the levels of
mRNA normalized to the level of 16S rRNA amplification in
each sample. Results were further analysed in Microsoft Excel
to calculate relative expression levels using essC mRNA as
the comparator.
Antibody production
Coding sequences for S. aureus EsxA, EsaC (Uniprot:
Q99WU4 and Q99WT8), predicted cytoplasmic fragments of
EssB (Uniprot: Q99WU0, residues: 12–226) and EssC
(Uniprot: Q932J9, residues: 964–1479) and predicted extra-
cellular fragment of EsaA (Uniprot: Q99WU3, residues: 313–
749) were PCR amplified from synthetic genes [codon
optimized for E. coli K12 (Genscript)] and individually cloned
between the SalI/XhoI sites of a modified pET27b vector
(Novagen). All primers are listed in Table S1. The plasmids
produce proteins with an N-terminal hexahistidine tag sepa-
rated by a tobacco etch virus (TEV) protease cleavage site.
Proteins were expressed and purified as reported previously
(Zoltner et al., 2013a), except in the final size exclusion chro-
matography step a HR 30/100 GL Superdex75 column
(CV = 24 ml, GE healthcare) equilibrated with 20 mM Tris pH
7.8, 100 mM NaCl was used.
The purified proteins (retaining a Gly–Ala–Ser–Thr
sequence at the N-terminus after the cleavage step) were
utilized as antigens to immunize rabbits for polyclonal anti-
body production in a standard three injections protocol
(Seqlab, Goettingen, Germany).
The anti-TrxA antibody was described earlier (Miller
et al., 2010) and commercially available antibodies against
Spa (HRP-conjugate, LifeSpan Biotechnologies) and SrtA
(Abcam) were used according to the manufacturers’
recommendations.
S. aureus sample preparation and Western blotting
Staphylococcus aureus strains were grown overnight in
TSB at 37°C. Cells were diluted 1/100 into fresh TSB
medium and growth was monitored by measuring the
optical density of the cultures at 600 nm. At indicated time
points, samples were withdrawn and cells pelleted by cen-
trifugation at 2770 g. Supernatant samples were further
filtered through a 0.45 μm filter and proteins precipitated
with trichloroacetic acid (TCA, 10% final concentration)
in the presence of 50 μg ml−1 deoxycholate, which has
been reported to improve recovery of precipitated proteins
(Bensadoun and Weinstein, 1976). Precipitates were centri-
fuged (10 000 g, 4°C, 15 min), washed with 80% ice-cold
ethanol and resulting pellets resuspended in 50 mM
Tris-HCl pH 8, 4% SDS. Samples were mixed with NuPage
LDS loading buffer (life Technologies) and boiled for
10 min.
Cells for whole cell fractions were pelleted by centrifuga-
tion, washed with 1× PBS buffer and normalized to an OD600
of 2 in 1× PBS. Cells were lysed by addition of 50 μg ml−1
lysostaphin (Ambi) and incubation at 37°C for 30 min.
Samples were mixed with an equal volume of LDS buffer and
boiled for 10 min.
Samples for further subcellular fractionation were pelleted
and washed as above and resuspended in fractionation
buffer (50 mM Tris-HCl pH 7.6, 0.5 M sucrose, 10 mM
MgCl2). Lysostaphin was added as above and the cell wall
was digested at 37°C for 30 min. Protoplasts were sedi-
mented (10 000 g, 10 min) and the supernatant kept as the
cell wall fraction. Protoplasts were resuspended in 1× PBS
and broken by sonication (2 × 15s, 20% amplitude, Branson
Digital Sonifier). Samples were subjected to ultracentrifuga-
tion (227 000 g, 30 min, 4°C), the supernatant was removed
as the cytoplasmic fraction and the membrane pellet resus-
pended in 1× PBS, 0.5% Triton X-100.
Samples were mixed with LDS loading buffer and boiled for
10 min prior to separation on bis-Tris gels. Western blotting
was performed according to standard protocols with the fol-
lowing antibody dilutions: α-EsxA 1:2500, α-EsxC 1:2000,
α-EsaA 1:10 000, α-EssB 1:10 000, α-EssC 1:10 000, α-TrxA
1:25 000, α-Hla 1:2000, α-Spa 1:10 000, α-SrtA 1:3000.
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Virulence assays
For the G. mellonella virulence assay, overnight cultures of S.
aureus and the isogenic Δess mutant were used to prepare a
10-fold dilution series in phosphate-buffered saline (PBS).
The infecting dose of wild-type RN6390 and COL strains
required to cause 80% mortality (LD80) in the model was
determined (1 × 107 cfu ml−1 for RN6390 and 1 × 108 cfu ml−1
for COL) and used in subsequent experiments. Larvae were
removed from storage at 4°C and allowed to warm to room
temperature. Prior to inoculation, larvae were briefly placed
on ice; then a Hamilton syringe was used to inject larvae with
10 μl of culture in PBS via the hind left proleg (n = 10 larvae
per experiment; repeated three times). Ten control larvae
were injected with PBS only. Following injection, larvae were
incubated in the dark at 25°C. After 24 h, larvae were scored
as dead or alive, with larvae considered dead if they did not
respond to touch and were usually visibly black. Infection
models were continued for 7 days and differences in survival
assessed using the Kaplan-Meier method.
The murine pneumonia model was performed using CFTR
−/− mice, a relevant model of pulmonary S. aureus infection
(Bragonzi, 2010) as S. aureus is the most common organism
colonizing children with cystic fibrosis. Briefly, S. aureus
strains were grown in TSB medium at 37°C overnight with
shaking, after which bacteria were collected by centrifugation
and resuspended in PBS. The exact number of bacteria was
determined by plating serial dilutions of each inoculum on
Luria broth agar plates. Female C57BL/6 mice CF transmem-
brane conductance regulator (CFTR) knockout (CF) mice
(approximately 10 weeks old) were anaesthetized and
infected by the intranasal route with 10 μl of culture of
RN6390, RN6390 Δess, COL, COL Δess, SA113 and SA113
Δess strains to have a final inoculum of 2 × 108 colony-
forming units (cfu) per mouse. Survival was assessed up to
48 h after induction of pneumonia and compared using the
Kaplan-Meier method.
Murine nasal colonization assays were carried out as pre-
viously reported (Kiser et al., 1999). Briefly, an inoculum of
each of the S. aureus strains, 108 cfu in 10 μl of PBS, was
pipetted slowly onto the nares of wild-type female C57BL/6
mice. After inoculation, mice were killed 3 days post-infection
by intraperitoneal injection of 0.3 ml of 30% pentobarbital.
Nares were harvested aseptically and homogenized in sterile
PBS. A 10-fold serial dilution and plating was carried out to
assess cfu. All animal experiments were approved by the
Animal Ethics Committees of University College Cork.
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